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Temperate bacteriophage have a complex, dynamic relationship with bacteria: 
parasitizing in the lytic cycle, but often increasing bacteria’s fitness as lysogens. 
The phage-bacteria relationship is vast and has evolved over more than an 
estimated three billion years, and there are likely many uncharacterized, intricate 
events between host and phage with important impacts on bacterial pathogenesis. 
This Thesis explores some of these lesser-studied phage-bacteria interactions, 
describing atypical mechanisms (“conversion events”) by which phage shape the 
populations of Bacillus anthracis and Staphylococcus aureus, driving their 
increased diversity and likely impacting their natural behaviors.  
In B. anthracis, phage contributions to virulence are largely unknown.  The first 
part of this Thesis describes how an induced phage from a highly virulent, B. 
anthracis-like isolate affects the well-characterized strain Sterne and selects for a 
phage-resistant variant with a markedly altered phenotype, but with no apparent 
difference in virulence potential. In this work, we characterize this variant strain by 
a variety of techniques, including whole-genome DNA and RNA-sequencing. In 
addition, we connect the Sterne variant phenotype to that of the phage’s parent 
strain, B. cereus Biovar anthracis CA, uncovering lytic phage-bacteria interactions 
 
(i.e., selection by lysis) that may act to promote phenotypic diversity and shape 
populations of B. anthracis and B. anthracis-like pathogenic species in the wild.  
 
Unlike B. anthracis, S. aureus has well-characterized bacteriophage contributions 
to its virulence potential, with known lysogens carrying virulence factors stably 
integrated into the host chromosome. The second part of this Thesis describes an 
extra-chromosomal DNA sequencing screening that uncovers the presence of 
episomal prophages in a number of S. aureus clinical isolates. QPCR 
characterization of one of these strains, MSSA476, reveals that the episomal nature 
of one of its prophages, fSa4ms, would have been missed if sequencing whole-
genomic and not specifically extra-chromosomal DNA. In addition, we find that 
fSa4ms excision into the cytoplasm is a temporal event, and that the prophage does 
not appear to undergo lytic cycle replication after excision—suggesting that its 
excision is part of a lysogenic switch. Follow-up experiments show that fSa4ms 
excision can alter expression of htrA2 and promote increased heat-stress tolerance. 
This work suggests that for S. aureus, in addition to carrying important virulence 
determinants, phage may also play a rather widespread role as DNA-level switches 
to control virulence factor expression and/or generate distinct subpopulations. While 
this Thesis discusses atypical phage conversion events, it also illustrates perhaps 
the most important, universal role of phage in bacterial pathogens: tools to create 
diversity and allow for bacteria’s increased infection and success under different 
evolutionary selections and environmental conditions.
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CHAPTER 1. INTRODUCTION 
Bacteriophage, or phage for short, are viruses that infect bacteria. They are the 
most abundant “organisms” on earth, have co-evolved with their hosts, and 
unsurprisingly, exert significant influence over the bacterial domain, in pathogenic 
and non-pathogenic species alike. Estimates of the total phage population in the 
biosphere are 1031, an order of magnitude greater than their hosts (Wommack and 
Colwell, 2000), and in addition, the scale of bacteria-phage infections is also 
exceedingly large. There are an estimated 1024 infections per second, and as well-
discussed by (Hendrix, 2005), biological interactions on this scale offer nearly 
unlimited opportunities for genetic exchange, horizontal gene-transfer (HGT), and 
evolution among phages and their bacterial hosts (Bertozzi Silva et al., 2016; 
Samson et al., 2013). Research in phage biology has uncovered the numerous roles 
the viruses play, of course as bacterial predators, but also as genetic elements 
imparting hosts with virulence factors (Beres and Musser, 2007; Coleman et al., 
1989), promoting the bacterial colonization of animals (Schuch and Fischetti, 2009), 
and even driving global nutrient cycling (Wilhelm and Suttle, 1999). While bacteria 
are natural human pathogens, they and the microbiome are also positively 
implicated in human health, impacting immune system development and 
inflammation (Cho and Blaser, 2012), shaping the gut-brain axis (Yano et al., 2015), 
and preventing the development of cancer (Zitvogel et al., 2017), and phage have 
been shown to play a clear role in shaping microbiome composition and its 
associated effects (Mirzaei and Maurice, 2017). With many reports suggesting that 
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bacteria may be “controlling” us and research describing phage control over 
bacteria, it is intriguing to think that perhaps our ultimate “masters” are actually 
bacteria’s predators—the bacteriophage—and research efforts focused on 
uncovering new phage-bacteria interactions should no doubt lead to greater insights 
on human health. This Thesis aims to better understand the interactions between 
phage and bacteria, and explores some of the atypical ways in which phage 
influence their bacterial hosts, focusing on their roles in the Gram-positive 
pathogens Bacillus anthracis and Staphylococcus aureus.  
1.1 A brief history and classification of virulent and temperate 
bacteriophage 
Bacteriophage first appeared in the literature just over a century ago, with their 
independent discovery by Twort in 1915 and d’Herelle in 1917. In his seminal work, 
Twort discovered that some colonies of micrococci would turn “glassy” in cultures, 
that non-glassy micrococci could transform to this phenotype upon exposure to 
glassy colonies, and suggested that this transformation was propagated by ultra-
microscopic viruses of a lower order than bacteria (Twort, 1915).  Shortly after, 
d’Herelle uncovered microbes that would lyse “Shiga-bacilli”, terming the microbes 
“bacteriophage” for “bacteria eaters” (D'Herelle, 2007). Earlier reports of likely 
phage discovery exist in the literature as well, with one report from 1898 
uncovering the phage-mediated lysis of B. anthracis (Gamaleya, 1898). The 
discovery of bacteriophage however is generally credited to Twort and d’Herelle. 
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The one-hundred years since these initial discoveries have found phage to exist and 
exert their influence over almost all corners of the biosphere, but in addition to their 
biological roles, bacteriophage were (and still are) indispensable tools in molecular 
biology (well-reviewed in (Summers, 2005)), are used directly as or provide the basis 
for novel antibiotics (Fischetti, 2005; O'Flaherty et al., 2009), and have numerous 
other biotechnological applications. This Thesis however, focuses on the natural, 
biological roles of phage. 
The phages uncovered by Twort, d’Herelle, and other early researchers were likely 
virulent rather than temperate phage, and a broad distinction can be made between 
the two. Virulent phage are obligate predators of bacteria (existing in a lytic cycle), 
while temperate phage, in addition to predating bacteria via the lytic cycle, can 
associate with a bacterial host in a more “quiescent” state known as lysogeny. 
(Examples challenging the notion of lysogeny as truly “quiescent” though, will be 
discussed later in the text.) Virulent and temperate phage are selfish elements, 
focusing on their own survival and replication, and using bacterial hosts to 
accomplish these goals. Outside of their own propagation however, both also engage 
in activities that serve to generate diversity in bacterial pathogens and non-
pathogens alike. Though when considering the mechanisms by which phages shape 
bacterial diversity, temperate phages outshine virulent phages because of their 
capacity to exist in the lysogenic state. This Thesis, and the remainder of the 
introduction, focus on temperate phage and discuss some of the known ways in 
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which they generate diversity among their bacterial hosts. Chapters 2 and 3 
highlight research uncovering more atypical and subtle impacts of temperate phage 
on Gram-positive pathogens. A brief section detailing temperate phage biology is 
below, followed by a discussion of how such phage impact their bacterial hosts. 
1.2 Temperate phage biology 
Temperate phage were first described by Bordet in 1919, who showed that bacteria 
isolated from infected mice could be induced to produce phage particles in the 
laboratory, though he incorrectly predicted that such particles were a product of the 
bacteria itself rather than a separate biological entity (Summers, 2005). Esther 
Lederberg later uncovered phage l (Lederberg and Lederberg, 1953), a lysogenic 
phage of Escherichia coli, setting the stage for fundamental discoveries in phage 
biology, particularly in the factors that govern maintenance of lysogeny and the 
switch to the lytic state. (Early bacteriophage work and a history of lambda are 
reviewed in (Summers, 2005; Casjens and Hendrix, 2015; Ptashne, 2004). 
Unlike virulent phages, temperate phages are capable of a multitude of lifestyles, 
including the lysogenic and lytic cycles, as well as pseudolysogeny and chronic 
infection. Briefly, they are described and distinguished. Phage replication via the 
lytic cycle consists of: 1) viral adherence to a bacterial cell, 2) injection of genetic 
material (typically double-stranded DNA), 3) replication of DNA and synthesis of 
viral building blocks, 4) phage structural assembly and packaging of DNA into 
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heads, and 5) lytic burst from the host cell and release into the surrounding 
environment (Figure 1-1a). In the lysogenic cycle, phage co-exist with the bacterial 
host. Like the lytic cycle, phage 1) adhere to the bacterial cell and 2) inject genetic 
material, however following this step, phage genomes integrate within the bacterial 
chromosome or get maintained as cytoplasmic plasmids, but do not undergo 
replication and production of progeny viral particles. These phage DNA elements, 
termed prophage, divide with the host cell (Figure 1-1b). They can exit the lysogenic 
cycle however, and be induced into the lytic cycle (often in times of bacterial stress 
or DNA damage), executing steps 3-5 and killing the host cell. (Factors governing 
the lytic/lysogenic switch in phage l will be briefly discussed in the following 
paragraph.) Pseudolysogeny is an intermediate state where phage 1) adsorb to the 
bacterial cell and 2) inject genetic material, however are held in a purgatory-like 
state, putting off the decision to enter the lysogenic or lytic cycle until a change in 
the external environment (Figure 1-1c). Lastly, chronic phage infection (not 
pictured), is a state where phage stably infect the bacterial cell, but continuously 
release progeny into the external environment without host cell death. Such a 
phage state occurs in the filamentous phage of E. coli for example, but does not 
occur in lambdoid (lambda-like) phages (Rakonjac et al., 2011). 
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Figure 1-1. The lytic, lysogenic, and pseudolysogenic cycles of 
bacteriophage. A) In the lytic cycle, phage recognize a specific cellular receptor 
and adsorb to the outside of the bacterium before injecting genetic material, then 
begin genome replication and synthesis of viral proteins. Packaging of genetic 
material into viral proteins forms functional virions, which burst from the cell in 
controlled host lysis. B) In the lysogenic cycle, phage recognize specific bacteria and 
inject their DNA as in A), however do not undergo a viral particle replication 
program. Instead, the prophage genome either integrates into the host chromosome 
or is maintained as a plasmidial element, and replicates in tune with host cellular 
division. C) In the pseudolysogenic state, phage follows the first steps in A) and B), 
however the prophage element is maintained in a non-replicative state, unlike the 
lytic and lysogenic cycles, which remains until changes in the external environment 




1.2.1 The lytic/lysogenic switch 
The molecular processes governing the lytic/lysogenic switch in l are well studied 
(Casjens and Hendrix, 2015; Ptashne, 2004) (Figure 1-2). Briefly, the decision 
hinges on successful repression of the lytic state by the CI repressor protein. CI 
repressor protein has two core activities: 1) repression of Cro (an activator of the 
lytic cycle), and 2) autoregulation of CI production. Cro and CI have opposite-facing 
genes (5’ ends closest) and share operator regions in their promoters, producing the 
following functional switch. CI protein binds upstream of its encoding gene, 
promoting its own production while simultaneously blocking the promoter for Cro. 
As long as CI is stably produced and maintained, the phage remains in the 
lysogenic state. When cellular DNA damage occurs, RecA (a bacterially-encoded 
protein) becomes activated and promotes the cleavage of CI, preventing CI positive 
autoregulation and the repression of Cro. With CI no longer repressing Cro, the 
lytic cycle activator is now produced and accumulates, binding CI operators, 
repressing CI production, allowing its own production, and activating the 
prophage’s lytic cycle program (Calendar and Inman, 2005). The lytic/lysogenic 
decision for newly infecting phage depends upon levels of another protein, CII, 
which promotes the initial production of CI (Echols, 1986; Ptashne, 2004).  
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1.2.2 Prophage replication 
Replication of prophage is necessary to ensure its survival. In the lysogenic cycle, 
replication allows for phage dissemination to the host’s daughter cells, and for lytic 
phages, the spread to new, uninfected hosts.  For integrated lysogenic prophage, 
this is accomplished during host chromosomal replication, with chromosomes 
containing the prophage genome segregating to each daughter cell. Lysogenic 
plasmidial phages must ensure their own dissemination, and encode genes for their 
replication, equal segregation to daughter cells, and often, anti-curing, plasmid-
addiction systems (Abeles et al., 1984; Łobocka et al., 2004).  
Replication of l (and l-like) phage in the lytic cycle is well-studied and will be 
briefly summarized (Enquist and Skalka, 1978) (Figure 1-2). Following induction 
into the lytic cycle, the prophage excises from the chromosome into the cytoplasm as 
a circular DNA element and begins bi-directional, q-replication, creating multiple 
circular copies of its genome. Following q-replication, unidirectional rolling-circle 
replication generates long, linear prophage concatemers, containing multiple copies 
of prophage genome per DNA molecule. For l, these concatemers are cut at specific 
sites, creating individual phage genomes with single-stranded cohesive ends of DNA 
(cos sites). Genomes are then packaged into phage particles. Other lambda-like 
phages can contain either cos sites or are packaged through an alternative 
mechanism known as headful packaging. Here, a linear concatemer is recognized at 
a “pac”-site, cut, and DNA injected into a phage head until it can no longer contain 
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any more DNA. This is typically about 105% of the phage genome. After the second 
cut, the next phage genome in the molecule is packaged in the same manner until 
the phage head is full, however the resulting phage contains different DNA ends 
than the first phage. This process continues until the rest of the DNA molecule is 
packaged, and results in a phage population that contains terminally redundant 
and circularly permuted genomes.  
The discussion of phage biology thus far has not addressed host impacts of phage 
carriage. Clearly, phage infection (lytic or lysogenic) does not exist in a vacuum, and 
the bacterial cell should not be thought of as merely a factory for phage 
propagation, but rather a dynamic organism that is drastically changed by carriage 
of viruses. The following section discusses a number of the known mechanisms by 
which temperate phage impact and influence their bacterial hosts. 
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Figure 1-2. Overview of the l (and l-like) phage lysis/lysogeny switch and 
replication in the bacterial host. 1), 2) and 3) The lytic and lysogenic cycles 
begin with the same series of steps: phage adsorption to the cell surface, DNA 
ejection from the phage head, and circularization of the genome (for l this is 
achieved through annealing of single-stranded, complementary cos ends). 4) A 
decision is made to enter the lytic or lysogenic cycle, dependent upon levels of CII 
protein. If levels of CII are relatively high, the phage enters the lysogenic cycle, 
typically integrating within the host chromosome via recombination between attB 
and attP sites, and the state stabilized by CI production, also providing 
superinfection immunity. Under inducing conditions, CI is cleaved, allowing Cro 
production, phage excision and exit from the lysogenic cycle. Alternatively, phage 
can enter the lytic cycle immediately following injection of DNA (2). 5) In the lytic 
cycle, phage replicate their genome, first undergoing q-replication resulting in 
multiple circular genome copies, followed by 6) rolling circle replication where long 
linear concatemers containing multiple phage genomes are generated. Then, 7) 
transcription and production of phage structural proteins occurs. Lastly, 8) single 
phage genomes are cut from concatemers, packaged into phage particles, and 9) 
virions released by endolysin-induced cell lysis. Figure reprinted with permission 
from ViralZone and SIB Swiss Institute of Bioinformatics. Ó 2014 ViralZone and 
SIB Swiss Institute of Bioinformatics. 
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1.3 Temperate phage as agents of diversity and benefactors of bacteria 
Temperate phage, especially within the lysogenic cycle, impart important 
advantages to their bacterial hosts. This positive feature of phage infection for the 
bacteria is an evolutionary trade-off: bacteria house elements that can and will 
likely kill them at signs of damage or stress, but they allow better survival and 
adaptation to the external environment than in their absence. The benefits of this 
tradeoff are no doubt why we see so many diverse bacterial species harboring 
lysogenic prophage today. Besides, it is possible that if a bacterium harbors no 
phage, it will be outcompeted by related phage-harboring strains and fail to survive 
regardless. This section outlines some of the ways phage impart benefits to their 
hosts as “benefactors of bacteria”. While the following mechanisms discussed are 
diverse, they all result in the same end goal: generating diversity within bacterial 
species. Phage can drive the diversity of and benefit bacteria through a number of 
mechanisms including: 1) positive (lysogenic) conversion, 2) negative conversion, 3) 
genome diversity and chromosomal rearrangements, 4) lytic induction, and 5) 
transduction and other DNA transfer events. Phage-driven diversity, coupled with 
evolutionary selection, likely accounts for the excellent pathogens many bacterial 
species are today. A discussion of each diversity mechanism follows, however the 
contributions of phage to bacteria are also well reviewed in (Brussow et al., 2004; 
Canchaya et al., 2004; Feiner et al., 2015; Nanda et al., 2015). 
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1.3.1 Positive (lysogenic) conversion 
Perhaps the most impactful role of temperate phage in bacteria is through positive 
(lysogenic) conversion, or the introduction and expression of foreign genes in a 
bacterial host. The genes implicated in lysogenic conversion are often termed 
“morons”, for more DNA on the prophage genome than necessary for survival, 
replication, or establishment of the lysogenic state (Brussow et al., 2004). Any 
connotation of these genes being useless or “moronic” should however be quickly 
dispensed of; as a consequence of selection, morons typically encode important 
virulence determinants or other bacterial fitness factors responsible for survival or 
severe invasive disease (e.g. streptococcal toxins and superantigens) (Beres and 
Musser, 2007)). The term positive conversion itself denotes the bacterial phenotype 
being converted by harboring prophage (i.e. non-lysogenized bacterium: phenotype- 
à lysogenized bacterium: phenotype+). A few important examples of lysogenic 
conversion are discussed below. 
The pathogenicity of S. aureus depends on an arsenal of virulence factors, many of 
which are encoded on temperate prophage genomes (Thammavongsa et al., 2015; 
Thomer et al., 2016). In S. aureus Newman, for example, the strain displays 
severely reduced virulence in a mouse model when cured of its four resident 
prophages (Bae et al., 2006). One of its prophages, fNM3, encodes virulence factors 
including staphylokinase (SAK), staphylococcal enterotoxin A (SEA), chemotaxis 
inhibitory protein of S. aureus (CHIPS), and staphylococcal complement inhibitor 
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(SCIN), and its curing significantly reduces abscess formation. Importantly, fNM3 
is a b-hemolysin (hlb)-converting phage, indicating that while it positively converts 
cells for SEA, SAK, CHIPS and SCIN, it integrates within the gene for another 
virulence factor, hlb, disrupting its transcription, and negatively converting cells 
(i.e., Newman: hlb-/sea+/sak+/scin+/chips+ ; Newman DfNM3: 
hlb+/sea-/sak-/scin-/chips-). Negative conversion will be discussed further in the next 
section.  
 
In Streptococcus pyogenes, prophages carry DNases, hyaluronidases, as well as a 
number of superantigens called SPEs (streptococcal pyrogenic exotoxins), which are 
non-specific T-cell activators that contribute to the symptoms of “Scarlet Fever” 
(Beres and Musser, 2007). Their direct contributions to disease however, have not 
been fully elucidated. Notably, The Rockefeller University was founded following 
the death of John D. Rockefeller Sr.’s grandson from streptococcal disease. Whether 
or not lysogenic conversion is responsible for the foundation of other universities is 
unclear, but it appears we owe it to phage for the development of our home 
institution. 
 
In a distinct manner from strict virulence factor carriage, morons can also encode 
fitness factors (Brussow et al., 2004), including transcription and sigma factors that 
alter the activities of the cell. Lysogeny of B. anthracis by Bacillus spp.-infecting 
phages was shown to alter the pathogen’s biofilm formation capacity, promote 
	16 
earthworm colonization, promote or block sporulation, and induce 
exopolysaccharide coatings on vegetative cells and spore structural changes (Schuch 
and Fischetti, 2009). These phenotypes were found to be mediated by phage-
encoded sigma factors. Whether or not these factors are truly morons with no role in 
the phage lifecycle however, is unclear. Also notable for B. anthracis and the related 
species Bacillus cereus and Bacillus thuringiensis are the findings that while these 
three species have highly related chromosomes, they exhibit markedly different 
phenotypes (Kolstø et al., 2009). In addition, these strains have been shown to 
harbor an array of inducible prophage, suggesting that positive conversion may play 
a role in generating the unique phenotypes among the three species (BUCK et al., 
1963; Kiel et al., 2008). 
While not encoded by morons per se, superinfection immunity (blocking of infection 
by similar phage) may also be considered a feature of lysogenic conversion. 
Typically, superinfection immunity occurs through the production of compatible CI 
repressor, preventing infecting phage from executing a lytic cycle. In some cases, 
however, prophage will encode specialized immunity genes to prevent 
superinfection. E. coli fV10, for example, encodes an O157 antigen-modifying 
enzyme (oac) that alters the fV10 receptor, preventing superinfection (Perry et al., 
2009). 
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1.3.2 Negative conversion 
Negative conversion is not quite the direct opposite of positive conversion, but 
rather is a potential consequence of carrying integrated prophage. Prophage 
integration occurs in various parts of the chromosome (or on resident plasmids) and 
depending upon where prophage integrate, the transcription of genes may be 
interrupted and cells converted to a negative phenotype. As previously mentioned, 
the hlb-converting phages of S. aureus integrate within the b-hemolysin gene, and 
disrupt transcription of the full-length gene product. For S. aureus, the trade-off 
appears evolutionarily favorable, as the phage carries multiple virulence factors, 
and strains containing hlb-converting phages are most commonly associated with 
infection (Coleman et al., 1989; 1991; Goerke et al., 2006). In a similar manner, 
fL54a and related phage of S. aureus integrate within the lipase (geh) gene, 
shutting down its functional production. These phage however, do not appear to 
code for known virulence determinants, morons, or other fitness factors (Lee and 
Iandolo, 1986; Lee et al., 1985). Lipase is a known virulence factor, making the 
evolutionary appeal for phage carriage and associated negative conversion as of yet, 
unclear (Hu et al., 2012).  
In S. pyogenes, a different type of “negative conversion” occurs with the phage-like 
chromosomal island SpyCIM1 (formerly termed f370.4). This prophage-like element 
integrates within the mismatch-repair (MMR) operon on the chromosome, 
negatively converting cells for the loss of MMR activity, resulting in an increase of 
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the cellular mutation rate approximately 200-fold (Scott et al., 2008; 2012). 
Interestingly, this element displays a unique excision/integration pattern dependent 
on cell density, allowing the cell to regain MMR activity while still retaining the 
phage-like element. A more detailed discussion of SpyCIM1 and similarly related 
events in other bacterial species is located in Chapter 3.  
1.3.3 Phage as drivers of DNA sequence diversity in bacteria 
Lysogeny is also a key driver of sequence diversity among strains within a given 
bacterial species. Bacterial pathogens carry essential and non-essential genes, with 
the latter typically involved in virulence and other fitness-associated activities. 
These non-essential genes are typically different among strains, and often are the 
key differences allowing strain differentiation. Fitzgerald et al. report that nearly a 
quarter of the S. aureus genome (22%) encodes such non-essential genes, and it is in 
fact prophage sequences that comprise the majority of these regions. Similar 
patterns are also present in other pathogenic species such as E. coli and 
Helicobacter pylori (Fitzgerald et al., 2001). Such differences in prophage content 
may drive the pathogenicity of select strains and differences in clinical 
manifestations of disease (Goerke et al., 2004; 2006). In S. pyogenes, the majority of 
sequence-level differences among strains and M-types are prophage related (Beres 
and Musser, 2007). M1 and M18 strains differ primarily in prophage sequences 
(Smoot et al., 2002), and the enhanced virulence of the M3 strain MGAS315 is 
speculated to arise from a diverse array of phage-encoded morons that all appear in 
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the poly-lysogenized strain (Beres et al., 2002). The M3 strain in particular is an 
example of an additional method by which prophages can introduce diversity: 
serving as anchor points for chromosomal rearrangements. In the SSI-1 M3 strain 
of S. pyogenes, the presence of two integrated prophage allowed a 1 Mbp 
chromosomal inversion and the generation of this unique strain. The inversion itself 
also resulted in a swap of phage virulence genes, and as a consequence, the strain 
contains novel prophage genomes in addition to altered M3 chromosomal synteny 
(Nakagawa et al., 2003).  
Prophage genomes are arranged in modules, or groups of genes with specific 
functions. Typically these are: lysogeny, DNA replication, transcriptional control, 
DNA packaging, head/tail morphogenesis, lysis, and in some cases, accessory genes. 
This structure allows the rapid swapping of modules between prophage genomes in 
multiply phage-infected cells and the fast evolution of prophage genomes. Such 
exchanges occur because the DNA sequences on module borders tend to be highly 
homologous among phages, while the genes of the modules themselves can be vastly 
different. Thus, phage can easily exchange modules via homologous recombination 
and markedly change their genomes, potentially affecting both their host-range and 
the virulence or fitness of their hosts. For example, if phage “A” with a broad host 
range swaps accessory gene modules with a co-infecting narrow-range phage “B” 
(which encodes potent virulence factors), phage B’s original morons can now rapidly 
disseminate to new strains, or even species. The g-phage of B. anthracis is believed 
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to have undergone such a homologous recombination, exchanging a spore-antigen 
moron for a fosfomycin resistance-encoding gene from f4066 (Schuch and Fischetti, 
2006). A particularly interesting case is seen in the phages SpaA1 and BceA1. These 
phages are nearly identical by sequence, are a chimera of different prophage regions 
from B. thuringiensis and B. cereus, and remarkably, also contain an additional 
complete prophage (MZTP02) in their genomes, in what is termed a “Russian Doll” 
arrangement. BceA1 has a broad host range, capable of infecting Staphylococcus 
pasteuri and B. cereus/B. thuringiensis, however it is unclear if the phage carries 
lysogenic conversion genes that can affect both hosts (Swanson et al., 2012). 
Regardless, these phages represent the extent to which module exchange produces 
novel prophage genomes, generating new elements to affect bacterial hosts. 
1.3.4 Lytic induction of temperate prophage 
The methods by which temperate phage drive diversity and impact hosts discussed 
so far have mainly dealt with phage in the lysogenic cycle. The induction of 
temperate phage into the lytic cycle however, also has a number of consequences 
both on the individual cell and population levels. For individual bacterial cells, 
induction into the lytic cycle likely leads to cell death, and cannot be seen as 
beneficial. On the population level however, limited induction of lysogenic phage 
can be beneficial, especially when the induced phage carry important lysogenic 
conversion genes. Quite often, morons are carried in the late lytic region of the 
prophage genome, such that when phage induction occurs, these genes are 
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significantly upregulated. In S. aureus MSSA476, the hlb-converting phage fSa3ms 
carries sak, sea, and scin, located adjacent to the host lysis cassette. Induction of 
phage by mitomycin C increases transcription of sak and sea, from both native and 
phage lytic cycle promoters (Sumby and Waldor, 2003). In an infection environment, 
fSa3ms induction in a small proportion of the MSSA476 population could provide 
the whole population with increased levels of SEA and SAK, and allow more 
successful infection of hosts.  
 
In a similar manner, pathogenic E. coli harboring Shiga-toxin converting phage (stx 
phage, encoding the Shiga toxin) are found to be induced in mammalian hosts and 
low-iron conditions. The location of the stx gene (controlled by lytic cycle promoters) 
allows its increased expression during phage induction, and phage-mediated lysis of 
E. coli cells allows the release of toxin into the external environment. Shiga toxin 
itself liberates iron from mammalian host cells, and in this case, the sacrifice of a 
few E. coli cells improves conditions for the remainder of the pathogenic bacterial 
population (Nanda et al., 2015). For S. aureus and E. coli, phage induction allows 
clonal populations to diversify into “toxin producing factories” and their 
beneficiaries who will go on to survive. Separate from the increased transcription of 
virulence genes, the controlled induction of temperate phage in Pseudomonas 
aeruginosa allows for the release of DNA and other cellular debris to seed biofilms, 
benefiting the rest of the population (Webb et al., 2003). 
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In a distinct manner, induction of temperate phage can also alter populations for 
the selection of phage-resistant variants.  While not benefitting the bacteria 
directly, selection for phage resistance can impart protection against other phages 
present in the environment if they use similar mechanisms for adsorption, entry, or 
replication. In clonal populations, phage reinfection of cells is generally blocked by 
superinfection immunity, however there are reports of successful superinfection by 
Bacillus-infecting phage (BUCK et al., 1963). In these cases, development of phage-
resistance (or keeping a small phage-resistant subpopulation) may benefit the 
whole population, serving as insurance in case of exposure to superinfecting phages. 
In general however, the selection of phage-resistant variants is typically associated 
with negative fitness, and phage-resistant strains often show decreased virulence 
(Filippov et al., 2011; León and Bastías, 2015). In S. aureus, phage-resistant strains 
were found to be attenuated for virulence, and even used for successful vaccine 
development (Capparelli et al., 2010). In E. coli, phage-resistant mutants can lack 
antigenic capsular polysaccharides (Stirm, 1968). Some reports, mainly outside of 
pathogenesis, have shown phage resistance as a potential benefit, with 
Streptoccocus thermophilus resistant variants showing equivalent levels of 
acidifying activity in milk cultures (Binetti et al., 2007). This benefit, however, is 
likely directed toward humans using the strain in industrial fermentations, and not 
bestowed upon the bacteria themselves. Chapter Two details the discovery of a 
phage-resistant mutant in B. anthracis that harbors a unique phenotype without 
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apparent attenuation of virulence potential, challenging the notion that 
development of phage-resistance by genomic alteration results in negative fitness. 
1.3.5 Transduction and other gene transfer events 
Also occurring outside of the lysogenic cycle is transduction, or the transfer of non-
phage DNA by phage. (Virulent phage are also capable of transduction.)  
Generalized or specialized transduction (movement of any DNA versus typically 
phage genome-adjacent or -associated DNA) by phage allows the rapid spread of 
genes that may encode virulence determinants or other fitness factors (e.g. 
antibiotic resistance). In S. aureus, for example, bacteriophage transduction was 
shown to transfer mecA, encoding methicillin resistance (Chlebowicz et al., 2014).  
Such activity becomes increasingly important given the present-day relative ease of 
phage (and pathogenic bacteria as well) to travel to far reaches of the globe. For 
bacteria, phage can serve as an easy delivery system to acquire new sequence 
diversity and functional genes from related strains or species to increase survival, 
fitness, or virulence. 
In addition to these forms of transduction, phages can also serve as helpers for the 
dissemination of other non-self, phage-like elements. One key example is found in 
the phage-like chromosomal islands of S. aureus. S. aureus pathogenicity islands 
(SaPIs) can fill phage heads of a “helper” phage with their own genetic material, 
akin to a hijacker stealing a car. Here, the hijacker (SaPI) gets to its desired 
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destination (uninfected surrounding bacteria), but the owner (the helper phage 
genome) is left behind (Novick et al., 2010). SaPIs have been found to encode for 
virulence factors, including those responsible for toxic-shock syndrome, and phages 
allow their dissemination and generate increased diversity among S. aureus isolates 
(Lindsay et al., 1998). SpyCIM1, the phage-related chromosomal island of S. 
pyogenes is thought to require helper phages as well, but such potential phage 
vehicles have not yet been uncovered (Nguyen and McShan, 2014). 
 
1.4 Exploring phage contributions to the lifestyles of B. anthracis and S. 
aureus 
 
Classifications of phage and bacteria-phage interactions are often thought of in 
broad strokes: virulent versus temperate, lytic versus lysogenic, and concepts of 
positive and negative conversion as 100% absolute. Indeed, this introduction has 
presented some major concepts in this way. Thinking in this manner is useful for 
initially understanding phage biology, however it oversimplifies the vast nature of 
phage and their interactions with bacterial hosts. Recent reports have illustrated 
that a more complex and dynamic relationship exists between bacteria and their 
phages as well as between phages themselves (Goerke et al., 2004; 2006; Swanson 
et al., 2012). The phage-bacteria relationship is estimated to be greater than three 
billion years old (Hatfull and Hendrix, 2011), and no doubt intricacies exist between 
bacteria and phage beyond these broad strokes. The following chapters explore a 
couple of these more atypical, intricate phage-bacteria interactions: the selection 
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and expansion of phage-resistant subpopulations in B. anthracis, and the 
excision/integration dynamics of episomal lysogenic prophage in S. aureus. 
Both projects were initially undertaken to explore potential lysogenic conversion in 
each Gram-positive pathogen. In S. aureus, extra-chromosomal DNA isolation and 
next generation sequencing screened clinical isolates for the presence of rare, 
lysogenic plasmidial phages that could be “hidden in plain sight”. Such work aimed 
to uncover novel phages encoding virulence determinants and lend greater 
understanding into the virulence potential of clinical strains. For B. anthracis, the 
impacts of phage from non-pathogenic environmental sources are well-described 
(Schuch and Fischetti, 2009), however this project sought to help understand how 
lysogenic conversion of B. anthracis by phage from anthrax-endemic environments 
could affect the bacteria, and whether such phage played any role in pathogenesis. 
In both projects, we did not identify novel phage capable of lysogenic conversion, but 
rather, uncovered more subtle, intricate mechanisms by which phage influence 
bacterial hosts. In S. aureus, we find that episomal lysogenic prophage are fairly 
widespread among clinical isolates, and that their excision/integration dynamics 
have important impacts on the host. In B. anthracis, we discover that phage-
resistant subpopulations may play a role in the lifestyle of the pathogen, and 
uncover a phage-resistant variant with a unique and highly unusual phenotype.  
The following Chapters describe these projects, and begin with introductions 
detailing relevant project- and species-specific background information.  
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CHAPTER 2. SELECTION BY PHAGE LYSIS AMPLIFIES A PHAGE-
RESISTANT BACILLUS ANTHRACIS VARIANT SUBPOPULATION WITH 
UNUSUAL AND DYNAMIC PHENOTYPES 
INTRODUCTION 
2.1 A brief overview of B. anthracis biology, the B. cereus sensu lato group, 
and the discovery of B. anthracis-like B. cereus isolates 
Bacillus anthracis is a Gram-positive, spore-forming pathogen that exists as a 
monomorphic species within the Bacillus cereus sensu lato (s.l.) group. This group 
contains six species in total, including B. cereus and B. thuringiensis which are 
highly related to B. anthracis. The three species share a conserved chromosome, 
core set of genes, and an array of chromosomally-encoded virulence factors (Kolstø 
et al., 2009; Radnedge et al., 2003; Zwick et al., 2012). Genomically, B. anthracis is 
distinguished in the group by the presence of four chromosomally-integrated 
prophages (Sozhamannan et al., 2006) and a specific nonsense mutation in the plcR 
(phospholipase C regulator) gene, which encodes a transcriptional activator of 
virulence factors such as enterotoxins, hemolysins, phospholipases, proteases, and 
other extracellular protein-encoding genes (Kolstø et al., 2009). Phenotypically, B. 
anthracis is a non-hemolytic, non-motile, penicillin-sensitive and g-phage sensitive 
species with some of these phenotypes linked to PlcR transcriptional activation. B. 
cereus on the other hand is typically hemolytic, motile, penicillin-resistant, g-phage 
resistant, and encodes a functional PlcR protein. Despite clear phenotypic 
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differences, differentiation between B. anthracis and some B. cereus strains has 
become increasingly difficult with the emergence of pathogenic B. cereus strains 
presenting anthrax-like disease (Brézillon et al., 2015; Hoffmaster et al., 2004; 
Wang et al., 2013). One report however, distinguished B. anthracis, B. cereus, and 
B. thuringiensis on the basis of csaB (cell surface anchoring) gene nucleotide 
sequence analysis, finding the three B. cereus sensu lato species clustered into two 
groups, with all B. anthracis and the majority of mammalian-isolated pathogenic B. 
cereus in one cluster, and B. thurningiensis insect-infecting strains clustered in the 
other (Zheng et al., 2013). The csaB gene itself encodes a pyruvyl-transferase 
essential for Surface-layer (S-layer) and S-layer-associated protein (BSL) anchoring 
to the B. anthracis secondary cell wall polysaccharide (SCWP) (Mesnage et al., 
2000). Specifically, CsaB catalyzes the addition of a ketal pyruvyl group onto the 
terminal N-acetylmannosamine (ManNAc) of the SCWP, allowing the non-covalent 
anchoring of S-layer proteins and BSLs via a surface layer homology (SLH) domain 
(Figure 2-1a) (Anderson et al., 2011; Missiakas and Schneewind, 2017; Soufiane et 
al., 2011).  
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Figure 2-1. B. anthracis SCWP and S-layer structures. A) Molecular structure 
of B. anthracis SCWP. The B. anthracis SCWP contains a repeating backbone of N-
acetylglucosamine-N-acetylmannosamine (GlcNAc-ManNAc) linkages, with b- and 
a-galactose (Gal) substitutions on GlcNAc as shown (Choudhury et al., 2006). The 
terminal unit of the SCWP contains acetylated and ketal-pyruvylated ManNAc, 
with the pyruvyl group serving as an anchor for non-covalent bonding of the S-layer 
proteins Sap and EA1, and in addition, BSLs. B) Diagram of the B. anthracis cell 
envelope. B. anthracis contains a single plasma membrane and peptidoglycan to 
which the SCWP and poly-g-D-glutamic acid capsule are attached. The S-layer 
proteins are attached to the SCWP by non-covalent anchoring of SLH-domains 
(green) to pyruvylated terminal ManNAc (arrow). Figure adapted from (Missiakas 





The B. anthracis S-layer itself has been well-characterized (Etienne-Toumelin et al., 
1995; Mesnage et al., 1997; Missiakas and Schneewind, 2017) and is an important, 
distinguishing feature for B. anthracis and B. anthracis-like pathogenic strains of 
B. cereus (Figure 2-1b). Fagan and Fairweather describe the S-layer as a 
modulating, functional structure allowing the cell to carry out specific activities and 
interactions with its external environment (Fagan and Fairweather, 2014). For B. 
anthracis, the S-layer is chiefly comprised of two proteins, Sap and EA1, which 
cover the cell in a para-crystalline lattice and have demonstrated murein-hydrolase 
activity (Ahn et al., 2006). Twenty-two other BSLs have been confirmed or predicted 
with roles in cell-separation (Anderson et al., 2011), virulence (Kern and 
Schneewind, 2008), and nutrient acquisition (Tarlovsky et al., 2010). These include: 
adhesins (BslA) (Kern and Schneewind, 2008), N-acetylglucosaminidases (BslO) 
(Anderson et al., 2011), amidases (BslS, BslT, BslU, AmiA) (Fagan and 
Fairweather, 2014), b-lactamases (BslM) (Fagan and Fairweather, 2014), and heme-
scavenging proteins (BslK) (Tarlovsky et al., 2010). Clearly, the S-layer is an 
important structure for B. anthracis to execute activities important to its survival 
and pathogenesis (Nguyen-Mau et al., 2012; Oh et al., 2017; Schneewind and 
Missiakas, 2012). Perhaps unsurprisingly, given the number of proteins that 
comprise the S-layer and their total reliance on CsaB-mediated SCWP pyruvylation 
for anchoring (Kern et al., 2010), mutation in csaB carries multiple downstream 
effects on the cell. (Mesnage et al., 2000) describe a B. anthracis csaB knockout 
harboring a phenotype of small convex colonies, clusters of cells that fall to the 
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bottom of tubes in liquid culture, and long chains of twisted cells. This csaB 
knockout was also unable to deposit Sap and EA1 on the cell wall (Mesnage et al., 
2000). Similarly, (Wang et al., 2013) show that BslO is not deposited on the cell 
walls of a B. cereus G9241 csaB mutant. In addition, phage-resistance has also been 
linked to csaB mutation (Bishop-Lilly et al., 2012; van Zyl et al., 2015), with CsaB-
deficient mutants selected for by infection with AP50c phage.   
In addition to the S-layer, the well-described virulence plasmids pXO1 and pXO2 
are key components of pathogenic B. anthracis (Figure 2-2a). The pXO1 plasmid 
encodes for the three anthrax-toxin components: protective antigen (pag), lethal 
factor (lef), and edema factor (cya), as well as the regulator genes atxA and pagR, 
while pXO2 encodes for the poly-g-D-glutamic acid (PDGA) capsule important for 
host immune system evasion (Moayeri et al., 2015; Mock and Fouet, 2001; Young 
and Collier, 2007). Previously, the presence of pXO1 and pXO2 was used to 
differentiate B. anthracis from B. cereus and B. thuringiensis. It is now recognized 
however, that the presence of these plasmids is not solely B. anthracis-specific 
(Kolstø et al., 2009). A number of B. cereus disease-causing isolates with anthrax-
like pathogenesis have been found to carry the highly homologous virulence 
plasmids, pBCXO1 and pBCXO2. G9241 is one such isolate, harboring pBCXO1 
with 99.6% sequence similarity over homologous regions to pXO1, and encodes pag, 
lef, cya, atxA and pagR (Figure 2-2b) (Hoffmaster et al., 2004; 2006; Oh et al., 2011). 
Other B. cereus isolates harbor both pBCXO1 and pBCXO2 (Leendertz et al., 2006). 
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B. cereus Biovar anthracis CA harbors both plasmids and is a B. anthracis-like 
strain isolated from the carcass of an ape believed to have died of anthrax infection 
in Cameroon (Brézillon et al., 2015). B. cereus bv anthracis CA, herein referred to as 
“CA”, straddles the classic boundaries of B. anthracis and B. cereus (Klee et al., 
2010). The strain encodes both the B. anthracis-associated PDGA capsule on 
pBCXO2 as well as a hyaluronic acid capsule on pBCXO1 via functional hasA, 
which is typically mutated in B. anthracis (Figure 2-2c).  
(Klee et al., 2006) describe unusual phenotypes in the initial report of the CA strain, 
where colonies at 24 hours growth displayed typical B. anthracis phenotypes 
including: non-hemolytic, rough-edged colonies with grey-green coloring and 
“Medusa heads” (curled projections at the colony edge), but after 48 hours growth, 
the same colonies were found to have transitioned and displayed a smooth, shiny 
phenotype with a yellow-green center, and in addition were smaller than that of 
classic B. anthracis. Subclones of single CA colonies were found to repeatedly 
display a mix of phenotypes, including some small, smooth colonies with b-
hemolytic activity (a hallmark of B. cereus) and sensitivity to g-phage (a hallmark of 
B. anthracis) (Klee et al., 2006). In addition, CA cells contained twisted, corkscrew-
like morphologies, atypical of B. anthracis (Figure 2-3). A summary of CA’s 
characteristics is presented in Table 2-1. The CA strain represents an unusual 
hybrid of B. anthracis and B. cereus, possessing phenotypic hallmarks of both 
species (Kamal et al., 2017; Klee et al., 2006; 2010), while also displaying unusual 
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behavior where subclones of the same colony possess different phenotypes. CA 
represents a unique, disease-causing, anthrax-presenting isolate; research 
described later in this Chapter details efforts to uncover the role and contributions 
of phage to its unusual characteristics and lifestyle. 





B. cereus bv 
anthracis CA 




Hemolysis − +/− − + 
Motility + + − + 
Susceptibility to g-phage − +/− + − 
Penicillin G R R S R 
Capsule + +/− + Absent in 
vitro 
S, sensitive; R, resistant; −, negative; +, positive; +/−, some subclones positive, 
others negative.  
Table adapted and reprinted with permission from (Klee et al., 2006). 
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Figure 2-2. The plasmids and outer cell structures of B. anthracis, B. cereus 
G9241 and B. cereus BV anthracis CI. A) B. anthracis harbors virulence 
plasmids pXO1 and pXO2, encoding the anthrax toxin genes pag, lef, cya as well as 
the regulator atxA. It contains a poly-g-D-glutamic acid capsule and functional S-
layer. B) B. cereus G9241 harbors pBCXO1, highly homologous to pXO1, however it 
encodes functional hasA. It does not encode for a pXO2-like plasmid. Consequently, 
it produces anthrax toxin, as well as a hyaluronic acid and B. cereus-specific 
capsule, but not PDGA. C) B. cereus Biovar anthracis CI is a unique African isolate 
highly homologous to CA, which encodes pXO1- and pXO2-like virulence plasmids. 
It produces anthrax toxin, poly-g-D-glutamic acid capsule. and via functional hasA, 
hyaluronic acid capsule. Figure used with permission from (Missiakas and 
Schneewind, 2017). 
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Figure 2-3. Atypical cellular morphologies of B. cereus Biovar anthracis 
CA. CA has unique cellular morphologies with twisted, corkscrew-like cells seen in 
(A). In addition, clear cell division septa are not apparent. Typical B. anthracis (B) 
contains straight, rod-like cells with clear division septa. The unique structures 
seen in (A) are rarely found (arrows) on B. anthracis cells. Figures reprinted with 
permission from (Klee et al., 2006). 
2.2 Role of phage in B. anthracis 
The roles of phage in B. anthracis are unique from those of other Gram-positive 
pathogens, in that they are traditionally not associated with virulence. In S. aureus, 
lysogenic conversion imparts the bacteria with factors important for pathogenicity 
(Bae et al., 2006), while in S. pyogenes, prophage also encode factors thought to be 
crucial to virulence (Beres and Musser, 2007), however a direct link in vivo has not 
yet been made. Why a similar role for phage in the Gram-positive pathogen B. 
anthracis is not seen is unclear. However, the difference could be perhaps attributed 
to B. anthracis’s virulence plasmids, which may supply sufficient virulence 
determinants for successful infection, rendering such a phage role unnecessary. 
A B
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Despite seemingly no role in virulence, phage have been well-studied in the B. 
cereus sensu lato group (reviewed in (Gillis and Mahillon, 2014)). Such research 
however, has typically focused on their host-range and structural characteristics. A 
brief review of the phages of the B. cereus s.l. group (and in particular, B. anthracis) 
follows. 
The phages of the B. cereus s.l. group belong to the Myoviridae (large phage with 
contractile tails), Siphoviridae (phage with non-contractile tailes), Podoviridae 
(phage containing short non-contractile tails), and Tectiviridae (tailless phage 
containing spikes) families. Many phages in the group have broad host ranges and 
can infect B. anthracis, B. cereus, and B. thuringiensis, and also serve as 
transducing agents for HGT (Gillis and Mahillon, 2014). Other phages however, are 
specific to B. anthracis. Foremost are the chromosomally-integrated prophages 
(lambdaBa01-lambdaBa04) that distinguish B. anthracis from B. cereus and B. 
thuringiensis. Interestingly however, these phages cannot form viable virions and 
lyse cells. Their effects on the host are to date, unclear (Sozhamannan et al., 2006). 
A well-studied non-integrating B. anthracis-infecting phage is the gamma (g) phage. 
The g-phage, and related phages (known as g-like phages) are virulent phages 
highly-specific for B. anthracis (but also a few B. cereus strains) that are believed to 
have originated from the temperate phage Wb and are used for strain typing 
(Schuch and Fischetti, 2006). f20 is a plasmidial temperate phage isolated from B. 
anthracis Sterne (containing the pXO1, but not pXO2 virulence plasmid), however 
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its sequence is unknown as are any of its effects on the bacteria (Inal and 
Karunakaran, 1996).  
Some studies have examined lysogens for phenotypic changes associated with phage 
carriage, however are limited in scope. One early study found capsule-producing B. 
anthracis displayed no difference in a mouse model of virulence between strains 
lysogenized or not lysogenized with phage b. The same strain lysogenized with the 
close relative phage a however, showed decreased virulence, and the phage was 
found to induce into the lytic cycle and lyse cells when exposed to sodium 
bicarbonate and high CO2 levels. It was believed that the decreased virulence of a-
infected cells was due to phage induction occurring in vivo (Iyanovics, 1962). 
Regardless in either case, lysogeny was associated with either no change or 
decreased virulence of B. anthracis, effects typically not associated with phage 
carriage. In another report, the B. anthracis-infecting phage AP50 was found to 
convert colonies to a flat, wrinkled phenotype (Sozhamannan et al., 2008). Recently, 
a lytic variant of the phage, AP50c, was found to select for resistant mutants in a B. 
anthracis population. Resistant mutants all contained inactivating mutations in 
csaB, the pyruvyl-transferase encoding gene, and displayed a mucoid phenotype 
associated with csaB mutation (Bishop-Lilly et al., 2012). While AP50, a, b, f20 and 
lambdaBa01-04 can lysogenize B. anthracis, detailed study of their potential 
impacts on the bacteria’s lifestyle has not been carried out.   
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In general, the effects of phage carriage on B. anthracis are not well-described. One 
recent report from the Fischetti Laboratory has however, provided examples of 
phage-mediated contributions to the B. anthracis lifestyle (Schuch and Fischetti, 
2009). In this report, phages isolated from soil environments were found to stably 
lysogenize B. anthracis, and resulting lysogens harbored new phenotypes promoting 
long-term vegetative survival. Phage promoted biofilm formation, earthworm 
colonization, vegetative cell changes, and also blocked sporulation, enabling long-
term vegetative cell survival outside of an animal host (an environment where cells 
typically sporulate). Some phages, surprisingly however, increased sporulation. 
Regardless, in both cases, phenotypes were found to be driven by phage-encoded 
sigma factors (Schuch and Fischetti, 2009). For B. anthracis, lysogenic conversion 
appears to be crucial in controlling outside-host vegetative cell survival, and stands 
in contrast to typical virulence-associated lysogenic conversion in other pathogens 
(Figure 2-4). 
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Figure 2-4. Phage-mediated lifestyle changes of B. anthracis. Lysogeny of B. 
anthracis by phage from soil-environments can control vegetative cell survival after 
mammalian host death. Phage can promote long-term soil survival by enabling 
biofilm formation, earthworm colonization, cell-surface changes, and by blocking 
sporulation. Other phages however, can promote sporulation in typically 
asporeagenous conditions. Both changes are driven by phage-encoded sigma factors. 
Reprinted with permission from (Schuch and Fischetti, 2009). 
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2.3 How do phage from anthrax-endemic areas affect B. anthracis? 
While the report by Schuch and Fischetti lent critical insights into the roles of 
phage for B. anthracis, it also reinforced the notion that phage do not play a major 
role in the pathogen’s virulence, with phages promoting post-disease vegetative soil 
survival, and the phages used in the study themselves isolated from non-anthrax 
endemic areas (potting soil, earthworm guts, and fern root systems) (Schuch and 
Fischetti, 2009). No studies thus far have examined how phage from anthrax 
contamination zones in particular may affect the Gram-positive pathogen, and if 
they play any role in the virulence of the organism. The following research explores 
this question and describes how a phage induced from the unusual disease-causing 
isolate B. cereus Biovar anthracis CA alters the well-characterized Sterne strain of 
B. anthracis.  
For this study we induced a novel phage (fBACA1) from the pathogenic strain B. 
cereus Biovar anthracis CA, and exposed Sterne to the phage, finding that fBACA1 
could infect B. anthracis Sterne, and that phage exposure selected for a resistant 
variant which displayed unusual and distinct phenotypes surprisingly similar to 
those of the phage’s parent strain, CA. In the following sections, we show that 
infection with fBACA1 selects for a B. anthracis csaB mutant, a gene target with 
high homology between B. anthracis and B. anthracis-like B. cereus pathogenic 
strains (Zheng et al., 2013), with the mutant harboring the phenotype previously 
reported including: long chains of twisted cells, small convex colonies, and clump-
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like growth in liquid culture (Bishop-Lilly et al., 2012). We also describe however, 
novel csaB mutant characteristics in Sterne, including hemolytic activity, small 
colonies without rough edges or “Medusa heads”, the appearance of multi chain 
rope-like bacilli, and altered biofilm formation capacity. In addition, we examine the 
virulence of the csaB mutant and describe a growth media-induced phenotypic 
switch where the csaB mutant displays markedly altered phenotypes in rich media 
versus animal host or serum growth environments, and characterize these 
transcriptional changes via RNA-seq. Lastly, we link the observed csaB mutant 
phenotype in Sterne to that reported for B. cereus bv anthracis CA, uncovering by 
deep-sequencing a subpopulation of csaB mutants in a CA genomic sample. Taken 
together, this research suggests that lytic phage-bacteria interactions (in addition to 
lysogeny) may be an important factor shaping populations of Bacillus anthracis and 
B. anthracis-like pathogenic species in the wild. 
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RESULTS 
2.4 Exposure of B. anthracis Sterne to an anthrax-derived phage identifies 
a Sterne variant with distinct phenotypes 
This study aimed to understand the effects of induced phage from disease-causing 
isolates of B. anthracis and B. anthracis-like species on the well-characterized 
strain B. anthracis Sterne. B. cereus Biovar anthracis CA, a unique anthrax-like 
strain isolated from an infected ape carcass in Cameroon (Klee et al., 2006), was 
cultured with mitomycin C to induce potential prophage.  We incubated Sterne with 
an induced and purified phage from CA, termed fBACA1, and found the resulting 
colonies to harbor a markedly different phenotype after phage exposure. We then 
purified this variant strain, termed Sterne::fBACA1, for further phenotypic 
analysis.  
On BHI plates, Sterne::fBACA1 colonies were smooth, mucoid, and smaller than 
Sterne, did not contain rough edges or “Medusa heads”, and were not easily 
removable with pipet tips or loops; they would stick to plates before being pulled off 
whole (Figures 2-5a and 2-5b). On Columbia blood agar, Sterne::fBACA1 culture 
spots contained a yellow-green center, maintained their smaller size as compared to 
Sterne, and after >24 hrs growth at 37°C, displayed b-hemolytic activity in the 
center of the culture spots (Figure 2-5c) (Table 2-2).  
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In liquid BHI culture, Sterne::fBACA1 settled to the bottom of tubes resulting in 
clear supernatants, while Sterne displayed a uniform turbid culture (Figure 2-5d). 
By microscopy, Sterne::fBACA1 displayed its most remarkable characteristics, 
including increased chain length, a lack of clear division septa, and twisted 
corkscrew-like cellular morphologies similar to structures described for CA (Klee et 
al., 2006) (Figure 2-6). In addition, we observed the appearance of highly organized, 
multi-chain rope-like structures. These structures were observed in static and 
shaken liquid cultures. Staining with acridine orange and DAPI revealed both the 
organized nature of these structures and that cellular division and partitioning of 
DNA was occurring despite no visible division septa (Figure 2-6). The rope like 
structures would often converge at nodes connecting the culture as one contiguous 
mass (Figure 2-7).  












Sterne + - + + S - + 
Sterne:: 
ΦBACA1 
- + + + S - + 
(+) Positive for trait 
(-) Negative for trait 
(S) Penicillin sensitive 
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Figure 2-5. B. anthracis Sterne exposed to fBACA1 displays atypical B. 
anthracis phenotypes.  A) Comparison of Sterne (left) and phage-exposed Sterne 
(right) on BHI agar plates. Sterne colonies display rough edges with larger colony 
size. Phage-exposed Sterne colonies display more compact and smaller colonies with 
smooth edges. B) Photograph of individual Sterne (left) or phage-exposed Sterne 
(right) colonies. Sterne colony contains weak borders with a dense colony center; 
phage-exposed Sterne displays a tight colony border and is of uniform density 
throughout. C) Culture spots of Sterne (left) and phage-exposed Sterne (right) 
grown on 5% sheep blood agar at 37°C. Sterne does not display hemolytic activity, 
while phage-exposed Sterne displays hemolytic activity in the middle of the colony 
and yellow-green color; D) Sterne (left) and phage-exposed Sterne (right) grown in 
liquid BHI culture at 30°C. Sterne culture is uniformly turbid, while phage-exposed 
Sterne culture grows as one bacterial mass settled at the bottom of the culture tube, 
with the surrounding media clear. 
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Figure 2-6. B. anthracis Sterne::fBACA1 harbors phenotypes similar to B. 
cereus Biovar anthracis CA and grows in unique, rope-like multi-chain 
structures.  A) B. anthracis Sterne grown in liquid culture displays chains with 
clear division septa. B) B. anthracis Sterne::fBACA1 grows with an abnormal 
twisted morphology. C) B. anthracis Sterne::fBACA1 grows in longer multi-cell 
chains without clear division septa as compared to Sterne. D) B. anthracis 
Sterne::fBACA1 grows in organized, rope-like, multi-chain structures. E) (top) 
phase-contrast image of Sterne::fBACA1 rope-like structure does not show clear 
division septa; (bottom) Sterne::fBACA1 stained with DAPI shows DNA-
partitioning and cellular division within multi-cell chains. All images captured at 
1000X magnification, except C at 400X. 
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Figure 2-7. B. anthracis Sterne::fBACA1 displays unique growth 
characteristics. A) (top) Sterne::fBACA1 robust rope-like structure with phase-
contrast microscopy; (bottom) Sterne::fBACA1 stained with acridine orange reveals 
clear division septa and organization of the rope-like structure (captured at 1000X 
magnification). B) Representative example of a Sterne::fBACA1 “node” in liquid 






We also tested Sterne::fBACA1 for DNase activity, susceptibility to g-phage, 
penicillin resistance, motility, sporulation, and biofilm formation. Sterne::fBACA1 
and Sterne did not show penicillin resistance or motility as compared to the positive 
control B. cereus T. Sterne and Sterne::fBACA1 were also sensitive to g-phage and 
did not show qualitative differences in DNase activity nor significant differences in 
sporulation (Table 2-2). Sterne::fBACA1 differed in biofilm formation capacity 
compared to Sterne, with the variant strain displaying no biofilm formation at 
room-temperature (RT) or 30°C until 10 weeks, whereas Sterne was capable of 
forming biofilms at earlier time points. However, both Sterne and Sterne::fBACA1 
formed equivalent biofilms at similar time points at 37°C with or without glucose 
(Table 2-3). Sterne::fBACA1’s inability to form a biofilm at RT and 30°C may arise 
from its sticky and clump-like growth, preventing sufficient cellular seeding at the 
liquid-air interface.  
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Table 2-3. B. anthracis biofilm formation capacities. 
3 weeks RT RT + 
glucose 
30°C 30°C + 
glucose 
37°C 37°C + 
glucose 
Sterne - - + ++ +++ +++ 
Sterne::fBACA1 - - - - ++ +++ 
6 weeks 
Sterne - +++ ++ ++ - +++ 
Sterne::fBACA1 - - - + - +++ 
10 weeks 
Sterne + +++ ++ + - ++ 
Sterne::fBACA1 + - - +++ + +++ 
Biofilms were scored weekly for strength/robustness. Scoring key: (-) no biofilm; (+) 
weak growth; (++) medium growth; (+++) strong growth. 
2.5 Sterne::fBACA1 is not lysogenized by fBACA1 
Sterne::fBACA1 had a unique phenotype, and we were curious to understand the 
genomic changes, if any, responsible for its novel characteristics. Re-exposure of 
Sterne::fBACA1 to fBACA1 stocks did not result in cell lysis on plates or in liquid 
cultures, indicating that the variant strain was resistant to infection. Phage-
resistance can occur, in part, due to lysogeny, receptor modification, or other 
genomic changes in the organism. To test if Sterne::fBACA1 was indeed lysogenized 
with fBACA1, we first sequenced the genomic DNA of fBACA1 to allow for 
construction of PCR screening primers. De novo assembly of phage DNA reads 
resulted in two contigs that had a 16 base-pair overlap. RAST and PHASTER 
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analysis of joined contigs predicted an intact prophage element, with Siphoviridae-
like genome organization, and gene sequences commonly resembling those of other 
Siphoviridae phages by BLAST analysis. We did not complete the fBACA1 genome, 
however the de novo assembled contigs of the prophage element are available in 
Appendix 1.  We used this contig sequence to design PCR primers (phiBACA1_F, 
phiBACA1_R) to probe for phage-specific sequence in Sterne and Sterne::fBACA1 
by PCR. Surprisingly, no fBACA1-product was detected in Sterne or 
Sterne::fBACA1, while the phage stock as positive control produced the predicted 
product. Southern blots of whole genome DNA preparations from Sterne and 
Sterne::fBACA1 were also negative for fBACA1 DNA (data not shown).  
2.6 DNA sequencing reveals a single-nucleotide insertion responsible for 
Sterne::fBACA1 phenotypes and fBACA1-resistance 
Results from the PCR and Southern blot experiments indicated Sterne::fBACA1 is 
not lysogenized with fBACA1 and that Sterne likely undergoes selection for phage-
resistant variants upon fBACA1 exposure. Separately, we were able to transiently 
lysogenize Sterne with fBACA1 after repeated attempts, but the lysogens grew very 
weakly on plates and in liquid culture. Restreaking these lysogenic colonies on BHI 
agar often resulted in no growth or colonies that had Sterne::fBACA1-like 
phenotypes. Therefore Sterne can carry fBACA1, however unstably under our 
conditions, with ultimate selection for fBACA1-resistant Sterne variants. 
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To understand the genomic background of Sterne::fBACA1’s phage-resistance and 
its associated phenotypes, we sequenced Sterne and Sterne::fBACA1 for direct 
comparison. De novo assembly of reads from Sterne::fBACA1 did not reveal any 
novel elements nor reads corresponding to fBACA1, supporting PCR and Southern 
blot data that the variant strain is not lysogenized with the phage. However, two 
single nucleotide insertions in Sterne::fBACA1 were uncovered by comparing read 
alignments of the chromosome: a (G)4à(G)5 insertion at position 1,730,529, and an 
(A)7à(A)8 insertion in position 1,710,151 of the chromosome (Table 2-4). Both 
insertions were confirmed by Sanger sequencing. The A(7)àA(8) insertion is in the 
3’ end of a tRNA methyltransferase, and is predicted to change the amino acid 
sequence of the protein product from …KGSFSRQILVCE* to …KRIIF*. It is 
unclear if or how truncation and alteration of the gene product may affect its 
activity. The (G)4à(G)5 insertion lies in the 5’ region of the csaB gene, a pyruvyl-
transferase that acts on the SCWP. The specific (G)4à(G)5 insertion that 
Sterne::fBACA1 harbors appears to be a “hotspot” of mutation in csaB as it has 
previously been implicated in B. anthracis AP50c phage resistance (Bishop-Lilly et 
al., 2012), with AP50c phage unable to adsorb to the csaB mutant’s cell surface. 
Both the AP50c-resistant variant and the fBACA1-resistant variant from this 
current study appear to encode a truncated, inactive CsaB protein (Table 2-4).  
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Table 2-4. Genomic alterations uncovered in Sterne::fBACA1 by whole-
genome DNA sequencing. 
Position Change Type Frequency Coverage P-
Value 
Result 
1730529 (G)4 ® 
(G)5 




1710151 (A)7 ® 
(A)8 
Insertion 97.1% 383 0 Frameshift 





From our sequencing, Sterne::fBACA1 appears to be a csaB mutant that harbors a 
number of reported phenotypes linked to CsaB deficiency, including long bacterial 
chains, twisted cells, and clumping in liquid culture. However, we also report 
additional phenotypes for the fBACA1-selected csaB mutant, including: rope-like 
multi-chain structures, hemolytic activity with small, yellow-green culture spots on 
SBA plates, and resistance to the phage fBACA1. Since no lysogeny was proven to 
exist, we will refer to Sterne::fBACA1 as Sterne dcsaB for the remainder of this 
Thesis. To definitively link fBACA1 resistance and the observed Sterne dcsaB 
phenotypes to csaB and not the single-nucleotide insertion in the tRNA-
methyltransferase, we reverted the (G)4à(G)5 mutation, while leaving intact the 
	54 
(A)7à(A)8 insertion.  Successful construction of the strain was confirmed by Sanger 
sequencing and the strain termed Sterne comp-csaB.  
 
Comp-csaB phenotypes were Sterne-like and reversed those from dcsaB. By 
microscopy, comp-csaB cells had short chain lengths, clear division septa, and the 
absence of any twisted cells or rope-like multi-chain structures. Sterne comp-csaB 
had larger colonies with rough edges and “Medusa heads” on BHI agar, and culture 
spots did not display hemolytic activity (Figure 2-8). BHI liquid cultures of Sterne 
comp-csaB were turbid and similar to Sterne. Biofilm and sporulation analysis of 
the revertant strain did not show qualitative differences in biofilm formation 
capacity, nor significant differences in sporulation (data not shown). In addition, 
sensitivity to fBACA1 was regained in comp-csaB (Figure 2-8). The reversion of 
distinct dcsaB phenotypes observed in comp-csaB therefore links a number of 
reported (Mesnage et al., 2000) and newly discovered pleiotropic effects to the csaB 
gene. The single-nucleotide insertion in the tRNA-methyltransferase does not result 
in observable phenotypes different from Sterne, however we cannot rule out their 
existence. Notably, B. anthracis strains resistant to AP50c phage via csaB mutation 
were also shown to harbor additional SNPs in their genomes (Bishop-Lilly et al., 





Figure 2-8. B. anthracis comp-csaB displays Sterne-like phenotypes. A) 
Sterne comp-csaB visualized under phase-contrast microscopy displays short chains 
and the absence of multi-chain structures (captured at 100X magnification). B) 
Sterne comp-csaB shows clear division septa (captured at 1000X magnification). C) 
A single Sterne comp-csaB colony on BHI agar displays a Sterne-like rough edge. D) 
Sterne and Sterne comp-csaB are sensitive to infection by fBACA1; Sterne dcsaB is 
resistant. All strains grow with PBS spotted as a negative control. E) Sterne, Sterne 
dcsaB, and Sterne comp-csaB grown on Columbia 5% sheep blood agar display 
different growth phenotypes. F) Sterne and Sterne comp-csaB culture spots do not 
display hemolytic activity, whereas Sterne dcsaB displays hemolytic activity in the 
center of growth. RN4220 is included as a positive control for hemolysis. 
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2.7 Sterne dcsaB does not show altered virulence potential in a mouse 
model, and exhibits an altered phenotype in the infection environment 
As the mutant Sterne dcsaB exhibited a distinct phenotype, we tested whether a 
csaB mutation event would affect the virulence potential of Sterne. We compared 
the virulence of Sterne and Sterne dcsaB in a mouse bacteremia model. Since 
Sterne dcsaB had longer chain lengths than Sterne, we normalized the two strains 
to ensure equivalent bacterial dosing. We determined that Sterne dcsaB chain 
length was on average 5-6-fold longer than Sterne under the conditions used for this 
experiment, and therefore Sterne dcsaB was injected at a 5-6-fold lower CFU/mL 
dose. Normalized Sterne and Sterne dcsaB did not show a significant virulence 
difference between survival curves in survival percentage or median time to death 
(P = 0.3450, Figure 2-9). 
Figure 2-9. Survival curves of Sterne and Sterne dcsaB from mouse 
infection model. 
Sterne (n = 12)
Sterne dcsaB (n = 12)
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While Sterne dcsaB did not show altered virulence potential in our animal model, 
we were curious if or how the rope-like structures might contribute to disease, and 
examined various mouse organs 48 hours after initial infection. GFP-PlyGBD 
visualization of bacilli by microscopy surprisingly did not reveal the long chain, 
rope-like structures typical of the variant grown in BHI, but rather shorter chains 
and dispersed bacteria resembling Sterne (Figure 2-10a). Occasionally we observed 
longer-chain rope-like structures and cells with corkscrew-like twisted 
morphologies, however they did not comprise the majority of visualized Sterne 
dcsaB cells (data not shown). We also passaged Sterne dcsaB directly from infected 
tissues into liquid BHI culture for growth at 37°C overnight. Remarkably, these 
cultures harbored the phenotype initially observed with long chains of cells, rope-
like multi-chain structures, cells with a lack of clear division septa and 
corkscrew/twisted morphologies (Figure 2-10b). The distinct change in growth 
characteristics of Sterne dcsaB in mouse tissues as compared to BHI suggested a 
phenotypic switch dependent upon the bacteria’s external environment.  
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Figure 2-10. B. anthracis Sterne dcsaB displays a unique and reversible 
phenotype in the infection environment. A) Sterne dcsaB extracted from 
mouse kidney, labeled with GFP-PlyGBD displays Sterne-like morphology and chain 
lengths (captured at 200X magnification). B) Reculturing Sterne dcsaB from the 
mouse into liquid BHI reveals long-chain, rope-like bacterial structures and twisted 
morphologies (captured at 100X magnification). 
2.8 Sterne dcsaB grown in fetal bovine serum displays a similar phenotype 
as observed in mouse tissues   
Results from mouse infection experiments suggested that the animal host 
environment induces a switch that alters the phenotype of the variant Sterne dcsaB 
strain. To mimic this growth outside the mouse, we cultured Sterne dcsaB in fetal 
bovine serum (FBS). Sterne dcsaB in FBS displayed turbidity similar to that of 
Sterne, without the appearance of any bacterial clumping or masses. By microscopy, 
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cells resembled Sterne: short chains with clear division septa, and the total absence 
of any multi-chain or rope-like structures (Figure 2-11).  While we observed 
occasional disorganized clusters of cells in the Sterne dcsaB FBS culture, we 
observed similar structures to the same degree with the Sterne FBS culture.  
Figure 2-11. Sterne dcsaB in FBS harbors Sterne-like and similar 
phenotypes to those seen in mouse infection. A) B. anthracis Sterne (left) and 
Sterne dcsaB (right) grown in FBS at 37°C display similar phenotypes (captured at 
100X magnification). B) (left and right) Sterne dcsaB displays clear division septa in 
FBS culture and a distinct phenotype as compared to BHI growth (images captured 
at 1000X (left) and 100X (right) magnifications). 
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Sterne dcsaB in Figure 2-11 was grown in FBS at 37°C to mimic temperatures in 
the mouse. Interestingly, when we cultured dcsaB in liquid BHI at 37°C, we 
normally observed growth of the strain as a single mass, but occasionally, the 
bacteria would disperse and grow as a turbid culture. When grown in BHI at 30°C 
however, we did not observe this behavior; Sterne dcsaB cultures always remained 
as one mass at the bottom of tubes with a non-turbid, clear supernatant (Figure 2-
12). Growth in FBS at 30°C did not alter the observed serum phenotypes of Sterne 
dcsaB, however 36 hours of growth was required for the entire culture to be devoid 
of any bacterial clumps or masses.   
Figure 2-12. B. anthracis Sterne dcsaB displays different growth 
characteristics in BHI liquid culture at 30°C versus 37°C. Labeled liquid 
culture tubes of Sterne dcsaB show characteristic “clumped” growth in BHI at 30°C, 
and occasionally observed turbid growth in BHI at 37°C. Sterne dcsaB grown in 
FBS at 37°C, in which turbidity was always observed, is shown for reference.  
o o o
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Using this temperature-based growth characteristic of dcsaB, we examined the 
minimum FBS dose necessary to observe the growth media-induced phenotypic 
switch by culturing Sterne dcsaB in increasing ratios of BHI:FBS at 30°C. Cultures 
showed higher turbidity with increased concentrations of FBS, with a complete loss 
of the BHI-associated phenotype at a 90:10 BHI:FBS ratio, suggesting that serum-
derived factors are too dilute to elicit a phenotypic switch below a 10-fold dilution 
(Figure 2-13).  
Figure 2-13. FBS induces phenotypic changes in B. anthracis Sterne dcsaB 
in a dose-response-like manner. BHI:FBS mixed media cultures of Sterne dcsaB 
ranging from 100:0 BHI:FBS to 0:100 BHI:FBS. Cultures display little to no 
turbidity from 100% to 90% BHI by volume, but become increasingly turbid and 
uniform as % FBS increases. 
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In addition, growth of Sterne dcsaB in 85°C heat-treated FBS displayed similar 
phenotypes and morphologies to growth in non-heat-treated FBS, suggesting that 
heat labile factors are not responsible for the observed switch (Figure 2-14). 
Preliminary fractionation experiments to uncover the serum factor(s) responsible 
suggested multiple components may be at play for the phenotypic switch, but we did 
not characterize these factors for this study; experiments are ongoing for their 
future discovery and purification (Appendix 2).  
Figure 2-14. B. anthracis Sterne dcsaB grows in turbid culture in heat-
treated FBS.  Sterne dcsaB was grown in heat-treated FBS and observed for 
growth phenotypes and morphologies. A) Sterne dcsaB grown in heat-treated FBS 
at 37°C displays short chains and the absence of multi-chain structures, with 
similar growth to that of FBS culture (captured at 100X magnification). B) Sterne 
dcsaB grown in heat-treated FBS shows clear division septa and short chains 
(captured at 1000X magnification).  
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2.9 RNA-seq reveals global gene expression differences between Sterne 
and Sterne dcsaB in BHI and FBS growth environments 
The distinct phenotypes of Sterne dcsaB suggested there may be large-scale gene 
expression changes due to csaB mutation and the bacteria’s external environment. 
In addition, we hypothesized that differential expression (DE) between Sterne and 
Sterne dcsaB may be occurring to a greater degree in BHI than FBS due to the 
disparate BHI-associated phenotypes observed. We designed an RNA-seq 
experiment to test these hypotheses and compare gene expression patterns between 
and within Sterne and Sterne dcsaB grown in BHI or FBS media, resulting in four 
group comparisons: 2 of genotype (Sterne against dcsaB in BHI and FBS), and 2 of 
growth condition (Sterne or dcsaB BHI against FBS). RNA-seq was carried out as 
described in Materials and Methods, and a summary of the differential expression 
data is presented in Tables 2-5a and 2-5b; the full data set is given in Appendix 3. 
Our RNA-seq experiment revealed several changes associated with both genotype 
and growth condition. Despite imparting strict limits on calling DE due to the 
number of sample replicates, our 4 group comparisons yielded a percentage range of 
called DE genes from 10.94 - 56.56% of the genome. CsaB mutation has a noted 
pleiotropic effect on the bacterial cell (Mesnage et al., 2000); by RNA-seq, it also 
appears to fundamentally alter its transcriptome. 
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Table 2-5a. B. anthracis Sterne and Sterne dcsaB whole-genome 
differential expression (DE) summary. 
Group 
Comparison 
(A vs. B) 
#  downregulated 
DE genes (in A) 
# upregulated 
DE genes (in A) 
% downregulated 
/ % upregulated 
genes 
% DE genes of 
all B. anthracis 
Sterne genes 
dcsaB BHI vs. 
dcsaB FBS 
1620 1606 50.2/49.8 56.6 
Sterne BHI vs. 
Sterne FBS 
828 849 49.4/50.6 29.4 
dcsaB BHI vs. 
Sterne BHI 
1194 1106 51.9/48.1 40.3 
dcsaB FBS vs. 
Sterne FBS 
237 387 48/62 10.9 
Table 2-5b. B. anthracis Sterne and Sterne dcsaB pXO1-only differential 
expression (DE) summary. 
Group 
Comparison 
(A vs. B) 
#  downregulated DE 
genes (in A) 
# upregulated 
DE genes (in A) 
% downregulated 
/ % upregulated 
genes 




dcsaB BHI vs. 
dcsaB FBS 
56 11 83.7/16.4 39.9 
Sterne BHI vs. 
Sterne FBS 
67 2 97.1/2.9 41.07 
dcsaB BHI vs. 
Sterne BHI 
30 9 76.9/23.1 23.2 
dcsaB FBS vs. 
Sterne FBS 
23 4 85.2/14.8 16.1 
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For Sterne dcsaB, phenotypic differences are markedly pronounced between BHI 
and FBS growth, and a similar gene expression pattern is reflected in the RNA-seq 
data. 56.56% of Sterne dcsaB genes were DE comparing growth in BHI versus FBS. 
For Sterne, this value was 29.4%. Sterne and Sterne dcsaB showed a number of 
different phenotypes in BHI, but less so in FBS. This is also reflected in the 
differential expression data. 40.3% of genes were DE between the two strains grown 
in BHI, but this value was reduced to 10.9% for FBS. Principal component analysis 
(PCA) of the RNA-seq samples shows a similar result (Figure 2-15). Sterne and 
Sterne dcsaB BHI samples are distinctly clustered from each other, as are intra-
strain BHI and FBS samples. Sterne and Sterne dcsaB samples grown in FBS 
however, cluster closer together in the plot. 
Figure 2-15. Principal component analysis (PCA) plot of samples from 
RNA-seq. Sterne and Sterne dcsaB RNA-seq sample distances visualized using 
PCA. Sterne BHI and Sterne dcsaB BHI biological groups form distinct clusters 
with their respective replicates clustered together. Sterne and Sterne dcsaB FBS 
groups cluster both near each other and with their respective replicates clustered 
together, indicating smaller sample distance between the two biological groups than 
between Sterne and Sterne dcsaB BHI groups.  
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For Sterne and Sterne dcsaB whole genomes, DE in BHI versus FBS environments 
is equally split between upregulated and downregulated genes. Examining pXO1-
encoded genes only however, reveals that most of its DE genes are upregulated in 
FBS (Table 2-5b, Appendix 3). In Sterne dcsaB, 67 pXO1 genes were differentially 
expressed in total, with 56 upregulated in FBS growth. For Sterne, of 69 DE genes, 
67 are upregulated in FBS growth. The upregulation of pXO1 virulence-associated 
genes we observe is similar to reports of pXO1 upregulation in CO2/bicarbonate 
atmospheres (McKenzie et al., 2014; Passalacqua et al., 2009a). Therefore, we 
believe upregulation of pXO1-encoded genes in FBS suggests the media may be a 
partial mimic of the infection environment. The RNA-seq data we present shows 
global transcriptional changes in Sterne and Sterne dcsaB, revealing a growth-
media induced switch of the transcriptome and the dynamic nature of B. anthracis 
Sterne, wild-type and dcsaB. In addition, our data highlights the pleiotropic effects 
of csaB mutation and correlates the disparate phenotypes of Sterne and Sterne 
dcsaB with differential expression. At this time however, we cannot describe specific 
transcriptional changes that may account for the two strains’ similarities in FBS 
and distinct differences in BHI growth media. Experiments to uncover key genes 
involved in this event are ongoing. 
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2.10 Western blot of protective antigen correlates with RNA-seq data 
To validate data generated from our RNA-seq experiment, we took an orthogonal 
approach, measuring levels of protective antigen (PA) in culture supernatants by 
Western blot. Growth condition comparisons revealed that in Sterne, pag is 
upregulated 4-fold in FBS as compared to BHI culture, while in dcsaB this 
upregulation is 50-fold. Genotype comparison data showed Sterne expresses pag 10-
fold higher than dcsaB in BHI, while in FBS there is no significant difference in pag 
expression between the two strains. Results from Western blots corroborated these 
data (Figure 2-16). A combined blot (Figure 2-16a) displays normalized samples 
from Sterne, Sterne dcsaB, and Sterne comp-csaB grown in BHI or FBS, as well as 
negative controls of DSterne (lacking pXO1 and pXO1-encoded pag), and BHI or 
FBS growth media alone. The combined blot shows equivalent detection of 
protective antigen at the expected molecular mass among Sterne, Sterne dcsaB, and 
Sterne comp-csaB in FBS-growth environments in agreement with our RNA-seq 
data, and the absence of PA in DSterne and FBS-only samples. As FBS contains a 
high level of endogenous proteins, to obtain distinct bands on a gel, dilution of 
samples 1:100 in 1X PBS was required. PA protein levels were below the limit of 
detection for all BHI samples at this dilution, suggesting lower levels of PA 
expression in BHI culture. Therefore, an additional blot was generated using 
concentrated BHI supernatants. This blot (Figure 2-16b) shows normalized, 
concentrated supernatants from Sterne, Sterne dcsaB, and Sterne comp-csaB BHI 
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samples, as well as DSterne and BHI-only controls. Sterne and Sterne comp-csaB 
display equivalent band intensities for PA, while Sterne dcsaB displays a fainter 
band. No PA is detected in DSterne and BHI-only controls. This blot indicates that 
pag expression for Sterne dcsaB is downregulated compared to Sterne, and reversal 
of the single nucleotide insertion in csaB (and not within in the 3’ tRNA-
methyltransferase) restores pag expression to that of wild-type Sterne.  Our 
Western blot is in accordance with data generated from our RNA-seq, and validates 
its results in an orthogonal manner.  
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Figure 2-16. Western blot of protective antigen in culture supernatants 
validates RNA-seq data. Western blot of culture supernatants from Sterne, 
Sterne dcsaB, and Sterne comp-csaB grown as described for RNA-seq are probed for 
protective antigen. Selected area of blots between 75-100 kD are shown for clarity. 
A) 1:100 diluted and normalized samples in 1X PBS from strains grown in BHI or
FBS are shown. Normalized BHI samples are below the limit of detection. For FBS 
samples, Sterne, dcsaB, and comp-csaB show approximately equivalent bands for 
protective antigen. Negative controls DSterne and FBS-only do not show bands 
corresponding to protective antigen. B) Western blot of concentrated, normalized 
BHI supernatant samples shows approximately equal band intensity for Sterne and 
Sterne comp-csaB, but decreased band intensity for Sterne dcsaB. DSterne and BHI 





2.11 Deep-sequencing reveals unstable carriage of fBACA1 and that csaB 
mutation does not readily revert 
Given the phenotypic similarities between Sterne dcsaB and B. cereus bv anthracis 
CA, we were curious if a proportion of the CA population may harbor mutations in 
csaB, potentially uncovering a genomic basis for the previous phenotypic 
observations of CA (Klee et al., 2006). We used a deep-sequencing approach to 
examine csaB variants in CA as well as several Sterne strains. Prior to carrying out 
deep-sequencing of csaB amplicons however, we determined the spontaneous 
resistance rate of Sterne to fBACA1 and examined Sterne dcsaB for potential 
reversion to wild-type.  Sterne fBACA1-resistant colonies were found to appear at 
an average rate of 4.8 x 10-7 resistant colonies/CFU. We also examined if Sterne 
dcsaB would revert its csaB mutation in the absence of phage selection. Potential 
csaB reversion was not observed in cultures, suggesting that under our conditions 
and in the absence of phage, there is not a high selective pressure for revertant 
cells. 
The spontaneous fBACA1 resistance rate and lack of csaB reversion suggested that 
uncovering csaB variants in Sterne or Sterne dcsaB by deep-sequencing was 
unlikely unless sequencing was carried out with a very high read depth and 
coverage of the csaB amplicon was in excess of 2,000,000x. For CA, phenotypes 
suggestive of CsaB deficiency were readily seen (Klee et al., 2006), and given that 
this strain harbors fBACA1, we hypothesized that selection for csaB mutation 
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might occur at a higher rate and be uncovered by deep-sequencing. We carried out 
deep-sequencing of csaB amplicons from CA, Sterne and the Sterne-derived strains 
dcsaB and comp-csaB. Summarized results are in Table 2-6, including percentage 
variant type classified as harboring nonsense, nonsynonymous, or silent mutations. 
Individual variants uncovered by deep-sequencing are listed in Tables 2-7a-d.  
Table 2-6. csaB variant frequencies of selected Bacillus anthracis strains. 
Strain % Frequency of mutation type in population 
Nonsense Nonsynonymous Silent 
Sterne 0 0 0.3 
Sterne dcsaB 0 0 0 
Sterne comp-csaB 0 0.2 0.1 
CA 1.9 6.7 0.2 
We found Sterne did not contain any variants with nonsense or nonsynonymous 
mutations, but 0.3% of the population carried silent mutations in three distinct loci. 
Sterne dcsaB did not contain any mutations in its population, excluding the 
(G)4à(G)5 insertion. Sterne comp-csaB did not contain any nonsense mutations, 
however 0.2% of the population did contain a nonsynonymous AàG transition 
resulting in a serine to glycine substitution. It is not clear the downstream effect of 
this substitution on CsaB activity. Sterne comp-csaB also harbored silent mutations 
in 0.1% of its population. While Sterne and Sterne-derived strains did not harbor 
any nonsense mutations, sequencing of CA revealed nonsense, single-nucleotide 
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substitutions in 1.9% of the population and nonsynonymous, single-nucleotide 
substitutions in 6.7% of the population. Silent mutations were present in 0.2% of 
the CA population.  
We have not verified that the nonsense mutations disrupt CsaB activity, however of 
the 5 nonsense mutations found, 4 (1.7% of the CA population) occur upstream of a 
mutation in csaB as reported by (Bishop-Lilly et al., 2012) to inactivate the CsaB 
protein. It is unclear if the C878A variant also encodes for inactive CsaB. 
Nonsynonymous mutations have been reported to inactivate CsaB in addition to 
truncations of the protein. The nonsynonymous mutations we uncovered were not 
the same nucleotide changes as previously reported (Bishop-Lilly et al., 2012), 
however they are predicted to result in similar amino acid substitutions (charged 
(+/-) to noncharged, noncharged to charged (+/-)). It is possible that a number of 
these nonsynonymous mutations may reduce or disrupt CsaB activity. Results from 
this deep-sequencing experiment show that B. cereus bv anthracis CA has an 
increased level of variation and mutation in the csaB gene as compared to Sterne 
and other Sterne-derived strains. We believe this variation is likely driven by 
interaction of CA with fBACA1. From PCR screening, CA appears to carry 
fBACA1, however variation in csaB suggests this lysogeny is not entirely stable, 
and fBACA1 may drive the selection of CsaB-deficient mutants through lytic 
interactions, giving rise to CA’s unique and atypical phenotypes. 
Table 2-7. Individual variants uncovered by deep-sequencing of csaB PCR amplicons. 













T 123 T ® C 237,223 0.10% 3.80E-26 N ® N silent 34 59.4 
A 144 A ® G 240,118 0.10% 1.60E-26 K ® K silent 32 94.6 
T 1,059 T ® C 175,980 0.10% 1.70E-18 S ® S silent 33 97.3 
B. Sterne 
dcsaB 
No variants passing cut-off filter requirements 
C. Sterne 
comp-csaB 
A 144 A ® G 214,453 0.10% 7.90E-10 K ® K silent 30 90.6 
A 223 A ® G 266,763 0.20% 8.40E-22 S ® G nonsynonymous 31 61.8 
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D. CA 
C 48 C ® A 155,561 0.30% 3.20E-191 D ® E nonsynonymous 34 71.5 
C 94 C ® G 218,255 0.20% 1.80E-100 P ® A nonsynonymous 34 57 
C 119 C ® T 200,206 0.10% 1.30E-15 S ® S silent 31 89.2 
A 122 A ® G 203,609 0.30% 1.80E-56 N ® S nonsynonymous 30 96.7 
G 124 G ® T 205,618 0.10% 2.80E-10 D ® Y nonsynonymous 31 57.8 
C 127 C ® A 219,922 0.20% 1.50E-76 P ® T nonsynonymous 32 65 
A 144 A ® G 209,668 0.10% 1.20E-15  K ® K silent 32 94.6 
G 293 G ® T 220,697 0.10% 8.30E-22 R ® I nonsynonymous 31 76.3 
C 301 C ® A 212,536 0.20% 8.70E-46 R ® S nonsynonymous 32 55 
C 332 C ® A 233,478 0.10% 3.10E-07  A ® E nonsynonymous 30 69.7 
C 346 C ® A 300,363 0.70% 0.00E+00 P ® T nonsynonymous 35 51.1 
C 367 C ® A 197,735 0.20% 1.90E-11 R ® S nonsynonymous 31 63.8 
C 392 C ® A 188,342 0.50% 0.00E+00 S ® * nonsense 32 61.2 
G 400 G ® T 182,960 0.90% 0.00E+00 E ® * nonsense 36 53.8 
C 485 C ® A 176,215 0.50% 0.00E+00 P ® Q nonsynonymous 32 56.7 
C 499 C ® A 204,695 0.20% 6.90E-24 Q ® K nonsynonymous 31 58.5 
G 559 G ® T 211,738 0.40% 0.00E+00 A ® S nonsynonymous 34 59.3 
C 560 C ® A 221,461 0.20% 1.10E-32 A ® E nonsynonymous 30 62.1 
G 562 G ® T 199,746 0.40% 0.00E+00 V ® F nonsynonymous 35 58.3 
G 613 G ® T 270,400 0.40% 0.00E+00 D ® Y nonsynonymous 35 57.7 
C 725 C ® G 236,197 0.10% 2.10E-87 A ® G nonsynonymous 36 51.5 
C 776 C ® A 232,652 0.10% 1.10E-09 S ® * nonsense 30 75.8 
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C 785 C ® A 250,178 0.20% 2.80E-23 S ® * nonsense 30 74.2 
G 846 G ® T 223,686 0.50% 0.00E+00 M ® I nonsynonymous 35 53.7 
G 862 G ® T 204,780 0.20% 1.20E-102 D ® Y nonsynonymous 32 68.3 
G 874 G ® T 186,993 0.10% 8.40E-08 D ® Y nonsynonymous 31 55.8 
C 878 C ® A 203,659 0.20% 7.20E-13 S ® * nonsense 30 73.2 
C 973 C ® A 161,633 0.60% 0.00E+00 Q ® K nonsynonymous 34 86.1 
G 999 G ® T 199,199 0.40% 0.00E+00 L ® F nonsynonymous 33 82 
G 1,060 G ® T 126,765 0.20% 6.00E-07 D ® Y nonsynonymous 30 72.9 
A 1,072 A ® G 110,304 0.20% 7.50E-17 K ® E nonsynonymous 30 93.8 




Previous work in the Fischetti Lab uncovered the influence of bacteriophage on the 
environmental lifecycle of B. anthracis, finding that phage-bacteria interactions—
and in particular lysogeny—control and can enable phenotypes that promote long-
term vegetative survival (Schuch and Fischetti, 2009). These changes were driven 
by sigma factors, encoded by phage isolated from diverse land and marine 
environments. For this current study, we aimed to uncover how phage induced from 
disease-causing isolates may shape B. anthracis. We found that exposure of Sterne 
to fBACA1, a novel Siphoviridae-like phage induced from B. cereus bv anthracis CA 
(itself a strain recovered from an ape presumed to have died of anthrax in 
Cameroon (Klee et al., 2006)), selects for a phage-resistant variant with a unique 
phenotype. 
2.12 Selection by lysis drives unique phenotypes in CA and Sterne dcsaB 
Whole-genome DNA sequencing revealed that exposure of Sterne to fBACA1 
selected for and expanded a csaB variant population. This variant displayed a 
unique phenotype atypical of classic B. anthracis, and remarkably, a number of its 
observed traits were also reported for CA (Klee et al., 2006). These included colonies 
lacking “Medusa heads” that were smaller, mucoid and smooth, and in addition, the 
variant also displayed hemolytic activity on blood-agar plates. Under the 
microscope, we observed increased chain lengths of bacilli without clear division 
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septa, and like CA, the appearance of twisted and corkscrew-like cells. The number 
of characteristics shared between dcsaB and CA suggests that the same factor(s) 
(likely fBACA1) drives the appearance of atypical B. anthracis traits in both 
strains. In dcsaB, we also observed a novel characteristic of multi-chain and 
organized rope-like growth. It is presently unclear how these structures form, as 
they were observed in both shaken and static cultures, and if the individual twisted 
cellular morphologies observed translate into the genesis of these macromolecular 
structures.  
Sterne dcsaB shared a number of characteristics with CA, but also harbored 
classical B. anthracis traits different from the African strain, including penicillin 
sensitivity, a lack of motility, and sensitivity to g-phage. CA is penicillin resistant 
and motile, however as previously reported (Klee et al., 2006), some subcultures of 
the strain display inconsistent hemolytic activity, g-phage sensitivity, and capsule 
production.  Why the two strains differ is likely due to the evolutionary lineage and 
associated genomic background of each strain. B. anthracis is a monomorphic 
lineage within B. cereus sensu lato, while CA lies at the frontier between Bacillus 
anthracis and Bacillus cereus sensu stricto (Antonation et al., 2016; Brézillon et al., 
2015). Thus, it is not surprising that CA possesses a mixture of typical B. anthracis 
and B. cereus phenotypes. While the exact regulation mechanism behind CA’s 
dynamic phenotypes is unclear, our data suggests that for CA, hemolytic activity, 
twisted cellular forms, atypical growth and the appearance of small, smooth, shiny 
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and mucoid colonies could in part, arise from selection for CsaB-deficient 
subpopulations. We show that the phage fBACA1, isolated from CA itself, selects 
for a phage-resistant csaB Sterne mutant that harbors CA-like phenotypes. Deep-
sequencing revealed that selection for csaB mutation occurred at a higher rate in 
CA than for other B. anthracis strains tested. Whether fBACA1 is the agent 
responsible for the selection of these mutants in CA is presently unclear and should 
be studied further, but is a likely candidate. The previous reports of CA colonies 
transitioning from a classic B. anthracis phenotype at 24 hours growth to colonies 
with a CsaB-deficient phenotype at 48 hours growth (Klee et al., 2006), coupled with 
our deep sequencing data and Sterne dcsaB’s phenotype suggest that lytic 
interactions may indeed be occurring between CA and fBACA1 selecting for csaB 
mutants in the CA population. We cannot yet state if such phage-bacteria 
interactions are happening out of the laboratory setting and in native infection 
environments such as the primate, but such future study will be crucial to better 
understand the influence of phage on pathogenic Bacillus spp. 
A simple approach to drive at this unresolved question is through deep-sequencing 
of the csaB gene region from PCR of environmental samples, i.e., PCR using a DNA 
template from direct swabs of ape carcasses without any exposure to the laboratory 
or other artificial environments. Amplification and sequencing of the csaB region 
should reveal if a subpopulation of cells harbor csaB mutation at a frequency 
greater than that of spontaneous mutation. If from these samples, mutation in csaB 
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is found in a significantly higher proportion of the population than suggested by a 
random mutation rate, then phage-resistance and subpopulations of phage-resistant 
cells would be suggested as an important component of the B. anthracis lifecycle, in 
addition to lysogeny. It is also possible however, that csaB mutation is selected for 
after initial strain isolation, and laboratory culturing may actually select for csaB 
mutation instead. This would suggest however the presence of a phage-stabilizing 
factor for fBACA1, specific to CA’s native environment that keeps the phage in the 
lysogenic cycle. Such a factor could come from the animal host, the surrounding soil 
environment, or potentially even the bacteria itself. If this were the case, then it 
would be in contrast to typical events reported in other bacterial pathogens, where 
phage tend to induce in infection conditions. In S. pyogenes for example, a soluble 
factor from human pharyngeal cells was found to induce its phage and allow the 
increased expression of phage-encoded superantigens and DNase which presumably 
increase bacterial fitness (Broudy and Fischetti, 2003; Broudy et al., 2001; 2002). 
fBACA1 does not encode any obvious virulence factors, and any potential benefits 
from its induction are unclear. Thus, it may make sense for B. anthracis to prevent 
phage induction when in an animal host, and for other pathogens to induce phage 
which carry virulence factors located adjacent to or within lytic cycle operons. 
Indeed, CO2/bicarbonate has been shown to cause the induction of B. anthracis 
phage a, and a lysogens were found less virulent than non-lysogenized strains, 
presumably due to indiscriminate lytic cycle induction and B. anthracis cell death in 
the animal host (Iyanovics, 1962). For CA, preventing fBACA1 phage induction 
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may maximize its virulence potential in the host. Given recent reports of other 
lysogenized B. anthracis derivatives and their effects on vegetative cells (Schuch 
and Fischetti, 2009), it may also be worthwhile to study the virulence potential of 
these lysogens and examine if/how they maintain phage in infection environments. 
Such work will better illustrate the roles of phage (if any) in the virulence program 
of B. anthracis. If phage are lost in these lysogens as well, or there is selection for 
resistant subpopulations, then lytic phage-bacteria interactions will appear to have 
a broader role in B. anthracis infection and its further study will be warranted. 
2.13 csaB mutation in B. anthracis may not negatively impact fitness 
As B. cereus bv anthracis CA was isolated from the carcass of an infected ape, we 
were curious of dcsaB’s virulence potential as compared to wild-type Sterne in an 
animal model, and found that Sterne and dcsaB did not show a significant 
difference in virulence potential. To our knowledge, this is the first virulence 
comparison of a csaB mutant in B. anthracis, however comparison in a mouse model 
between B. cereus G9241 and its csaB knockout was performed in Wang et al., 
where the csaB mutant displayed a significantly lower virulence potential (Wang et 
al., 2013). The strains and methods used in our model versus Wang et al. vary 
considerably and therefore cannot be meaningfully compared. It is noteworthy 
however, that while B. cereus G9241 and its csaB knockout differed in virulence 
potential, a larger difference was seen in time to death rather than percentage of 
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animal death. Our animal model work showed no significant difference in either 
comparison, but surprisingly, we found that dcsaB’s distinct BHI-associated 
phenotype was largely absent in mouse tissues. Cells from the mouse examined by 
fluorescence microscopy had Sterne-like morphologies, while reculturing the same 
cells in BHI regenerated the long-chain, rope-like forms. This result suggested an 
environmental dependent switch that alters the dcsaB phenotype. As B. anthracis 
pathogenesis involves multiple organ systems (Moayeri et al., 2015), it is likely that 
the bacteria would evolve strategies to ensure its dispersal throughout an animal 
host and the presence of such a phenotypic switch makes evolutionary sense. If 
dcsaB were to maintain its long chain, rope-like growth, it is unclear if the bacteria 
would be able to disseminate effectively throughout the host and successfully infect 
(Guichard et al., 2012). That dcsaB can effectively disseminate in this context 
suggests csaB mutation may not be evolutionarily disadvantageous (at least in 
Sterne) as the strain can apparently overcome the downstream effects of the 
genomic alteration as needed.  
We successfully mimicked the phenotypic changes seen in the animal environment 
by growing dcsaB in fetal bovine serum, but it is presently unclear how FBS (or the 
animal environment) precipitates this switch. Sterne dcsaB grown in heat-treated 
serum also displays Sterne-like characteristics, suggesting that its serum-
phenotype is not due to direct action by FBS but likely changes from within the 
bacteria itself, and preliminary fractionation experiments suggested there may be 
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multiple components of serum that induce specific phenotypic changes. In addition, 
a seemingly stochastic event was observed with turbid dcsaB growth in BHI at 
37°C, suggesting that temperature can induce phenotypic changes in the csaB 
mutant as well. Regardless, our data suggests that B. anthracis Sterne dcsaB can 
respond to different growth environments, alter its phenotype accordingly and 
overcome some of the effects of csaB mutation.  
2.14 How does csaB mutation and the external environment affect B. 
anthracis? 
Given the phenotypic differences between Sterne and dcsaB as well as the mutant’s 
multiple phenotypes, we designed an RNA-seq experiment to examine the 
transcriptional changes occurring in Sterne and dcsaB during BHI and FBS growth. 
RNA-seq revealed large scale, whole-genome expression differences between Sterne 
and dcsaB as well as within each strain in BHI versus FBS environments. Within-
strain comparisons of Sterne and Sterne dcsaB showed large differential expression 
in BHI versus FBS growth environments, though the changes for dcsaB were 
greater than those of Sterne. Between-strain DE observed in our RNA-seq appears 
to correlate with phenotypic comparisons of the strains; Sterne and dcsaB displayed 
stark differences in BHI media and more similar phenotypes in FBS, and this trend 
is reflected in the transcriptome data. The close transcriptional profile of the two 
strains in FBS may explain why Sterne and Sterne dcsaB exhibit similar virulence 
potentials in our animal model. While csaB mutation should prevent S-layer 
	84 
associated virulence factors such as BslA, an adhesin (Kern and Schneewind, 2008), 
from attaching to the cell wall, the virulence contribution of these gene products 
does not appear large enough to significantly alter virulence in our model. Other 
genes associated with virulence such as lethal factor and protective antigen did not 
meet the criteria for calling differential expression in comparing Sterne and dcsaB 
in FBS, but were called in BHI, highlighting 1) that Sterne and Sterne dcsaB have 
vastly different profiles in a “non-infection” environment but are far more similar in 
an “infection” context, and 2) the dynamic nature and phenotypic switch of dcsaB. 
We showed an orthogonal example of this in a Western blot of protective antigen. 
We found that many of the transcriptional changes associated with a CO2-
bicarbonate environment (upregulation of pXO1 and other virulence-associated 
genes) (McKenzie et al., 2014; Passalacqua et al., 2009a) also appear to occur in 
FBS growth, suggesting that FBS carries chemical queues that B. anthracis 
responds to. Indeed FBS does contain bicarbonate, but there are likely other 
components in the media as well that serve as queues for B. anthracis 
transcriptional modulation. Eag expression is reported to increase with CO2-
bicarbonate exposure, and we note similar expression changes in FBS-cultured 
Sterne and Sterne dcsaB.  To our knowledge, our study is the first to examine via 
RNA-seq the transcriptional changes of B. anthracis in serum versus rich-growth 
media, though a previous report did study the transcriptional profile of B. anthracis 
in bovine blood by microarray (Carlson et al., 2015). We link FBS growth, like that 
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of CO2-bicarbonate enriched environments, to upregulation of genes important in 
virulence, and give a global view of gene expression changes associated with BHI 
and FBS growth for B. anthracis Sterne. We believe these two growth environments 
may be good proxies for “infection” and “non-infection” environments, giving 
researchers a useful resource to study gene regulation associated with growth 
within and outside animal hosts. In addition, our RNA-seq data show the stark 
differences in transcription arising from csaB mutation, again highlighting the 
pleiotropic effects of this gene. CsaB-mediated pyruvylation of the SCWP enables 
anchoring of Sap, EA1, and other Bacillus S-layer associated proteins with 
demonstrated roles in virulence (Wang et al., 2013), cell-wall maintenance (Ahn et 
al., 2006; Anderson et al., 2011), and nutrient acquisition (Tarlovsky et al., 2010). In 
addition, CsaB may be acting in an, as of yet, uncharacterized manner on the 
transcriptional level, similar to Sap and EA1 (Mignot et al., 2002). We believe csaB 
mutation likely leads to a cascade of downstream effects, driving the large-scale 
differential expression observed. 
 
2.15 What accounts for dcsaB’s Sterne-like phenotype in FBS? 
 
While our RNA-seq generated global transcriptional data, we cannot yet highlight 
specific mechanisms behind the FBS-induced phenotypic switch for Sterne dcsaB. 
Mesnage et al. reported the presence of csaB-independent pyruvylation pathways in 
B. anthracis, detecting a pyruvylated fraction of SCWP in a B. anthracis csaB 
knockout (Mesnage et al., 2000). It is unclear if SCWP pyruvylation is occurring in 
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Sterne dcsaB in FBS growth environments, which would allow anchoring of SLH-
domain proteins. Interestingly, expression of csaA-csaB is downregulated roughly 7-
fold in the csaB mutant grown in FBS compared to BHI. In Sterne, the operon does 
not show differential expression between FBS and BHI culture, and comparison of 
Sterne and dcsaB in FBS does not reveal differential expression of the genes, while 
in BHI, dcsaB has increased csaA-csaB expression. This indicates that dcsaB 
expression of the csaAB operon is increased in BHI culture. It is unclear why the 
operon is more highly expressed in the mutant than in wild-type in BHI. It is 
possible that CsaB protein might also act to control the expression of the csaAB 
operon, in a similar manner to that of Sap and EA1, and that the truncated CsaB 
product cannot exert such activity, offering a potential mechanism behind csaAB 
upregulation. Alternatively, for the mutant in serum environments, CsaB protein 
may play a diminished role.  
 
We examined Sterne and Sterne dcsaB sensitivity to fBACA1 in FBS, finding that 
Sterne—but not dcsaB—cultures were lysed by the phage (data not shown). 
fBACA1 resistance is not reversed by FBS growth, and we believe it is likely the 
fBACA1 receptor is not anchored to the cell wall in BHI or FBS cultures. This 
result also suggests that an alternate pyruvylation pathway is likely not “picking up 
the slack” for inactive CsaB.  If pyruvylation is not occurring on the SCWP in FBS, 
how does dcsaB grow in short chains with clear division septa? Mesnage et al. also 
showed that CsaB-pyruvylated SCWP is not absolutely necessary for all autolysin 
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activity, and Anderson et al. reported that in B. anthracis DcsaB, the addition of 
recombinant BslO to cultures reduced average chain length of the knockout strain, 
despite no apparent SLH-domain anchoring (Anderson et al., 2011; Mesnage et al., 
2000). So, it is possible that BslO or other peptidoglycan hydrolases could allow cell 
wall division in the absence of CsaB activity. Our RNA-seq data shows that BslO 
expression is higher in BHI than FBS, making it unlikely that increased BslO 
concentration is directly contributing to the observed FBS phenotype. We cannot 
rule out however that BslO or other peptidoglycan-modifying enzymes may possess 
the ability to bind dcsaB SCWP in FBS and not in BHI by an unknown mechanism. 
Interestingly, the genes encoding PatA1/B1 and PatA2/B2 (involved in 
peptidoglycan and SCWP O-acetylation (Lunderberg et al., 2013)) also show 
downregulation in dcsaB FBS growth as compared to BHI culture, suggesting a 
possible reduction of peptidoglycan and SCWP O-acetylation in FBS cultured cells. 
For Sterne, there is no DE for patA1/B1 or patA2/B2 between BHI and FBS 
cultures, similar to the pattern seen for csaB. How this is directly related to csaB 
mutation remains to be clarified. While a lack of O-acetylation has been linked to 
limiting azide-induced autolysis in B. anthracis (Laaberki et al., 2011), the presence 
of O-acetylation may contribute to the blocking of autolysin activity via steric 
hindrance (Blackburn and Clarke, 2002). Therefore one possibility is that for dcsaB 
grown in FBS, decreased O-acetylation may lead to increased autolysin activity and 
peptidoglycan processing, allowing cell septation/separation even in the absence of 
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CsaB-mediated SCWP pyruvylation. Given the number of genes involved in 
peptidoglycan synthesis and remodeling, identifying specific gene products involved 
in generating the dcsaB, FBS-associated morphologies may prove to be a difficult 
and exhaustive task. However, focusing on those genes significantly upregulated or 
downregulated in CO2/bicarbonate or FBS environments (Passalacqua et al., 2009a; 
2009b; Rollins et al., 2008) may cull the list and offer potential candidate genes.  
One possible candidate enzyme that may account for the serum-associated 
morphology is EA1. In serum and bicarbonate environments, eag is expressed 
higher than sap, and cells produce the eag-encoded enzyme EA1. In BHI culture, 
the reverse is true, with Sap production dominating. This regulation by B. anthracis 
is previously reported in the literature (Mignot et al., 2002; 2004; Missiakas and 
Schneewind, 2017) and observed in our RNA-seq data set. Both Sap and EA1 
proteins are capable of murein hydrolase activity (Ahn et al., 2006), and it is 
possible that EA1 possesses the ability to septate cell walls in a manner similar to 
BslO, while Sap may not have this activity. Experiments adding recombinant EA1 
and Sap could examine both enzymes’ ability to cut cell walls in the absence of 
CsaB-mediated SCWP pyruvylation and may indicate whether the expression of eag 
relative to sap plays any role in the dcsaB serum phenotype.  
If EA1 does not appear to alter the cell wall of dcsaB, an additional approach to 
uncover factors important to dcsaB serum-associated morphology would be to add 
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the supernatant from a dcsaB FBS culture to dcsaB cells grown in BHI. In the 
absence of SCWP pyruvylation, autolysins and other associated peptidoglycan-
sculpting proteins are likely secreted into surrounding media and FBS culture 
supernatant could contain a variety of murein hydrolases that may have activity 
against dcsaB cells. Addition of filtered supernatant to dcsaB cells in grown in BHI 
could result in their decreased chain length and the loss of the csaB knockout-
associated morphologies. However, peptidoglycan and other SCWP modifications 
present in BHI but not FBS culture may block their activity. If added FBS 
supernatant does however shorten chain length and promote cell septation, then 
these FBS-upregulated enzymes would be implicated in the phenotypic switch. An 
additional experiment comparing added supernatant versus “heat-killed” 
supernatant could show if the factors responsible are proteins susceptible to heat 
degradation. Previous experiments comparing growth of dcsaB in FBS versus “heat-
killed” FBS revealed that serum factors causing dcsaB’s phenotypic switch are not 
heat labile, however the factors produced by the bacteria in response to serum may 
be subject to such degradation. Mass spectrometry and/or fractionation could 
elucidate specific factors.  
 
Perhaps the most direct method to uncover factors critical to the dcsaB phenotypic 
switch is through transposon mutagenesis or a similar gene inactivation approach. 
Here, functional knockouts could be generated in dcsaB; screening libraries of dcsaB 
variants on FBS-agar for clones lacking rough-edges or “Medusa heads” with convex 
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colony morphology (i.e., the dcsaB-associated phenotype) could identify genes 
important to the dcsaB serum switch. Alternatively, single colonies could be grown 
in FBS liquid culture, with candidate clones as those failing to display the expected 
culture turbidity. Either method could highlight gene products important to dcsaB’s 
serum-associated morphological changes, however it is possible that multiple genes 
are involved in this event, which could prevent identification of candidate clones, or 
clones with intermediate phenotypes may appear as well. Regardless of these 
potential shortcomings, this approach may help elucidate how Sterne dcsaB harbors 
phenotypes atypical of csaB mutation when grown in FBS culture and should be 
pursued. Identification of genes crucial to the phenotypic switch would also confirm 
that the dcsaB morphologies associated with FBS culture are caused by B. anthracis 
sensing its environment and adjusting accordingly via transcriptional modulation, 
and not through direct serum activity. 
 
2.16 How does phage-resistance affect B. anthracis? 
 
The ability of Sterne dcsaB to alter its phenotypes dependent upon growth 
environment suggests that csaB mutation may not have a negative fitness cost, at 
least under our conditions. In our case, csaB mutation was selected for by exposure 
to fBACA1, and serves a mechanism for the organism to acquire phage resistance. 
Mutation in csaB was also found to impart resistance to AP50c phage, with multiple 
distinct phage-resistant variants all showing different mutations within the csaB 
gene. Why csaB is selected for by both fBACA1 and AP50c is likely because of its 
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role in anchoring numerous S-layer and S-layer associated proteins which may 
serve as cell-receptors for the phage. Indeed for AP50c, Sap is believed to be the 
phage’s receptor (Bishop-Lilly et al., 2012; Plaut et al., 2014). fBACA1’s receptor 
has not yet been uncovered, but is most likely an S-layer or BSL protein, potentially 
even Sap. It is not clear however why csaB and not sap is selected for mutation as 
knockouts of sap are viable (Plaut et al., 2014). It is also noteworthy that in the 
csaB mutants uncovered in (Bishop-Lilly et al., 2012) as well as our dcsaB strain, 
mutation in csaB always occurred with other secondary SNPs in seemingly 
unrelated genomic loci. It is unclear why this is the case, but csaB appears to be a 
hotspot for mutation in B. anthracis, comparative to other potential genes which 
could also confer phage-resistance. Regardless, for B. anthracis we find that a CsaB-
deficient, phage-resistant variant is selected for by exposure to fBACA1, but 
interestingly and in contrast to what is typically seen with other pathogens 
(Capparelli et al., 2010; Filippov et al., 2011), phage-resistance is not associated 
with decreased virulence and fitness in our experiments. 
 
Why might this be the case for B. anthracis? From our RNA-seq data, csaB 
mutation does not appear to affect the expression of pXO1-encoded genes important 
to virulence in FBS culture. In BHI culture however, the same genes were 
significantly downregulated in the mutant. In other species, phage-resistance is 
often associated with decreased expression of important virulence factors (León and 
Bastías, 2015). While this is true for dcsaB in BHI, B. anthracis appears to encode 
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mechanisms to minimize the virulence-reducing effects of phage-resistance when in 
an “infection environment”. If the expression profile of dcsaB in BHI held firm 
within the animal host, it is likely the variant would show decreased virulence as 
compared to wild-type Sterne. Why B. anthracis appears to get around this phage 
resistance-associated issue may have to do with the fact that it has multiple 
lifestyles and is successful in both soil/earthworm environments as well as 
mammalian hosts. That the pathogen encodes mechanisms to control expression of 
its virulence factors in each environment may allow the success of phage-resistant 
variants. Other bacterial pathogens such as S. aureus or S. pyogenes have more 
limited lifestyles, typically existing solely as colonizers or invasive species of 
humans. Therefore the effects of phage-resistance may be more impactful on their 
virulence potential. It is also possible that the factors affected by csaB mutation in 
B. anthracis (S-layer proteins) happen to not play large a role in virulence. If such 
proteins were critical to virulence, then clearly phage-resistance would decrease 
bacterial pathogenicity. It is unclear if this lack of virulence decrease in our phage-
resistant B. anthracis variant is pure coincidence or was selected for in some 
manner. 
 
While not related to phage-resistance, it is also interesting to note the general role 
of phages and virulence in B. anthracis compared to pathogens such as S. aureus 
and S. pyogenes. Phages are not obviously associated with the pathogenicity of B. 
anthracis, and are not major carriers of virulence determinants, whereas the phages 
	93 
of S. aureus and S. pyogenes are well known to encode important virulence genes 
(Bae et al., 2006; Beres and Musser, 2007). For B. anthracis, plasmids seem to take 
up the virulence role, with pXO1 and pXO2 encoding toxins and capsule, 
respectively, making the bacteria a dangerous pathogen. For S. aureus and S. 
pyogenes, plasmids often encode antibiotic resistance genes, but are not the main 
determinants of virulence potential. In comparing B. anthracis to other Gram-
positive pathogens, there appear to be important differences in the roles of phage 
for the species. Further research may illustrate explanatory mechanisms behind 
these differences.  
 
Given that our experiments did not show a fitness decrease for dcsaB, we were 
curious if reversion would occur in the absence of phage or without environmental 
selection. We examined dcsaB for reversion of the csaB mutation via deep-
sequencing and in culture-based experiments, but did not detect any reversion to 
wild-type. We did successfully revert our csaB mutant to form the viable Sterne 
strain comp-csaB (still containing the tRNA-methyltransferase mutation), 
suggesting reversion to wild-type should be possible as well as the selection of csaB 
mutants without secondary genomic alterations. If csaB mutation was associated 
with negative fitness, then reversion to wild-type would be expected, however it is 
possible that we are not growing the variant in the appropriate environment for 
such selection. We also found that temporal lysogeny of Sterne with fBACA1 was 
possible, but the lysogen grew poorly and would often generate colonies with dcsaB-
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like phenotypes after multiple passages. In Sterne, fBACA1 appears to be carried 
unstably and selects for a CsaB-deficient, phage-resistant population. For CA, our 
deep-sequencing data suggests a comparable event occurs, though only in a portion 
of the population. More stable carriage of fBACA1 in CA could explain why only 
some of the population is CsaB-deficient: the rest may be lysogenized.  
 
For CA, a subpopulation of CsaB-deficient variants may be advantageous, or at the 
very least, not associated with a decrease in overall fitness. Sterne dcsaB has 
increased hemolytic activity, altered cellular and colony morphologies, as well as 
different biofilm formation capacity as compared to Sterne. Such phenotypes could 
alter behaviors such as vegetative survival outside the host, while not impeding the 
population’s virulence potential. Surprisingly, this may be similar to some of the 
effects of phage carriage in B. anthracis (Schuch and Fischetti, 2009), however the 
virulence potential of these reported lysogens has not been studied. CsaB mutation 
however, also likely confers on CA resistance to other phages that also rely upon a 
SLH-domain containing receptor for infection (e.g. AP50). This could protect a CA 
population from complete lysis if encountering a novel phage. (Lysogeny will also 
however typically provide superinfection immunity to compatible phages). It is 
possible that CA may be “using” fBACA1, or at least benefiting from its somewhat 
unstable carriage to drive the expansion of a CsaB-deficient subpopulation, giving 
the bacteria a new tool for survival. Thus, both lysogeny and lysis may play 
significant roles in the B. anthracis lifecycle. The research presented in this 
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Chapter examines this lesser studied aspect of phage conversion—selection by 
lysis—which may serve to enable B. anthracis to maintain a subpopulation with 
different phenotypes “at the ready” for certain environmental conditions.  Given the 
insights from this work, a new, hypothetical model for the B. anthracis lifecycle 
including selection by lysis is shown in Figure 2-17. The magnitude and importance 
of this aspect of phage conversion for B. anthracis in the wild however, remains to 

















Figure 2-17. A new, potential model of the B. anthracis lifecycle. After 
anthrax disease and host death (1), vegetative B. anthracis cells enter the soil 
environment where phage encounter (2) can drive lysogeny or potentially, selection 
by lysis for phage-resistant variants. Both lysogenized cells and resistant variants 
harbor different characteristics from non-lysogenized or wild-type cells, including 
altered biofilm formation, vegetative cell-surface changes, and transcriptional 
modulation (3). Lysogeny can also promote earthworm colonization, and lysogenized 
cells occasionally shed phages into the environment by limited lytic induction. For 
CA, further research is needed to understand the prevalence of phage-resistance in 
its native environment. If a significant proportion of wild, uncultured B. anthracis 
cells harbor resistance-causing mutations, then selection by lysis will appear to play 
an important role in the natural B. anthracis lifecycle, and an updated model is 
warranted. Alternatively, there may exist environmental phage-stabilizing factors 
that prevent phage-shedding and expansion of phage-resistant subpopulations. 
Both phage-resistant and lysogenized cells can sporulate (4), however phage-
encoded sigma factors can promote or block this event. In CsaB-deficient phage-
resistant cells, no effect on sporulation was observed. Spores taken up by an animal 
host (5) can germinate, cause anthrax (1), and restart the B. anthracis lifecycle. 







































In this Chapter, we characterized a Sterne variant, dcsaB, that is resistant to 
infection by fBACA1, a bacteriophage isolated from B. cereus Biovar anthracis CA. 
Phage-resistance was the result of selection for a frameshift mutation in csaB, a 
SCWP pyruvyl-transferase, with the mutation and resistance reversible by genomic 
manipulation. We show that dcsaB harbors distinct phenotypes similar to CA and a 
growth media-induced switch, where dcsaB displays Sterne-like phenotypes in FBS 
or an animal host, and in addition, the variant does not show an altered virulence 
potential. We examined the global transcriptional profiles of Sterne and Sterne 
dcsaB in BHI and FBS by RNA-seq, highlighting the gene expression changes 
associated with both FBS growth and csaB mutation. Lastly, we showed the 
prevalence of csaB variants within a CA population, suggesting that phage-
resistance and selection by lysis may be occurring in the wild, and along with 









MATERIALS AND METHODS 
 
2.18 Bacterial strains and growth conditions 
 
All strains used in this study are listed in Table 2-8. Bacillus strains were grown at 
30°C in brain-heart infusion broth (BHI) with shaking at 150 RPM and aeration 
except as otherwise noted. E. coli was grown at 37°C, 200 RPM in Luria-Bertani 
(LB) liquid media or on LB-agar plates with ampicillin selection or without selection 
as required. S. aureus RN4220 and S. pyogenes SF370 were grown at 200 RPM in 
BHI media. Antibiotics were used at the following concentrations: ampicillin, 100 
µg/mL; kanamycin, 50 µg/mL. 
 
Induction of phage from B. cereus Biovar anthracis CA was performed as follows: an 
overnight culture grown in BHI was back-diluted 1:100 in fresh BHI containing 5 
µg/mL mitomycin C and grown overnight. Cells were pelleted and the clarified 
supernatant filtered with 0.22 µm filters to remove debris. To prepare high-titer 
phage stocks, induced phage supernatants were amplified using B. anthracis Sterne 
cultures. Overnight cultures of Sterne were back-diluted 1:100 in BHI and grown at 
200 RPM, to an OD600 = 0.1 - 0.2. An equivalent volume of phage supernatant was 
added to the bacterial culture and grown at 150 RPM until visible lysis occurred, 
typically 3-4 hrs. Cultures were then spun down at 4000 RPM and filtered with 0.22 
µm filters to remove bacterial debris. This procedure was repeated as necessary to 
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generate large volume phage stocks. All serum growth media used in this study was 
heat-inactivated fetal bovine serum (Sigma) unless otherwise noted. 
To determine the minimum serum dilution required to observe B. anthracis Sterne 
dcsaB phenotypes associated with serum (FBS) growth, BHI:FBS (v/v) mixtures 
were prepared ranging from 100:0 to 0:100. Bacteria from an overnight culture were 
vortexed to homogeneity, back-diluted 1:100, grown 36 hours at 30°C in BHI, FBS 
or BHI:FBS mixtures, and observed. For experiments using heat-treated FBS, the 
media was prepared by placing 30 mL FBS in a Falcon tube in a room temperature 
water bath, and slowly increasing the bath temperature to 85°C to prevent serum 
aggregation. The FBS was heated at 85°C for 60 mins. For all experiments, 
negative, non-inoculated controls were included. Bacteria used in heat-treated 
serum experiments were established from overnight BHI cultures, back-diluted 
1:100 into media and grown at both 30°C and 37°C. 
Table 2-8. Strains, plasmids, and primers used in this study. 
Strains Description Notes 
E. coli TOP10 Cloning host Invitrogen 
E. coli SCS100 dam-/dcm- cloning host NEB 
B. anthracis Sterne Sterne strain Pasteur 7702, pXO1+, pXO2- 
B. anthracis ∆Sterne ∆Sterne strain pXO1-, pXO2- 
B. anthracis dcsaB Sterne strain Pasteur 7702 with 2 single nucleotide 
insertions, inactivating csaB insertion, insertion in 
tRNA-methyltransferase 
B. anthracis comp-csaB Sterne strain Pasteur 7702 with 1 single nucleotide 
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insertion, in tRNA-methyltransferase 
B. cereus Biovar 
anthracis CA 
Transition B. cereus strain containing pXO1 and 
pXO2-like plasmids pBCXO1, pBCXO2 
(Klee et al., 
2006.) 
S. aureus RN4220 Lab strain Hemolysis 
positive 
S. pyogenes SF370 Lab strain DNase 
positive 





pASD2 E. coli - B. anthracis shuttle vector for generating 
genetic knockouts and complements 
(Day et al., 
2007) 
pDD1001 pASD2 with wild-type csaB sequence insert for 
generating Sterne comp-csaB 
this work 
Primers Sequence 
csaB_deep_seq_F CCAACATTCCTTATATATTAATGTTAGG for deep-
sequencing 
experiments 











pASD2_F CAATCAATCACCGGATCCCC for Sanger 
sequencing 
pASD2_R TAACCCTCACTAAAGGGAACAAA for Sanger 
sequencing 










CTCTCAAAACTGAACAAAACGAAA for PCR of B. 
anthracis 
gDNA 
phiBACA1_F AAAATGAACACTTTGAAAGGTCGAATTGA for screening 
of fBACA1 








CGACGATTCGACATGGAATATCGAC for Sanger 
sequencing 
2.19 Exposure and lysogeny of B. anthracis Sterne with fBACA1 
Exposure and lysogeny of B. anthracis Sterne with fBACA1 was achieved following 
a modified protocol (Schuch and Fischetti, 2009). Briefly, 10 mL cultures of B. 
anthracis Sterne were grown overnight in BHI and back-diluted 1:100 in 10 mL 
fresh BHI and grown to OD600 = 0.6. 1 mL of phage stock was added to 4 mL 
bacterial culture and incubated with shaking for 30 min. Bacteria-phage mixtures 
were spun down (4000 RPM, 4°C, 20 min), washed 1X in cold phosphate-buffered 
saline (PBS), resuspended in 5 mL BHI, serially diluted and plated on BHI agar. 
Plates were grown overnight at 30°C, and the resulting individual colonies were 
patched onto new BHI plates, and grown overnight. Potential lysogens were 
screened when applicable via colony PCR using the fBACA1-specific primers 
phiBACA1_F and phiBACA1_R (Table 2-8).  
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2.20 Phenotypic analysis of B. anthracis strains 
Colonies were imaged using the Cell Biosciences AlphaImager HP instrument with 
AlphaImager HP software or an iPhone 6 camera. For microscopy studies, strains 
from overnight cultures were washed 1X with PBS and examined using the Nikon 
Eclipse E400 Phase Contrast Microscope and images captured with QCapture Pro 
5.1 software. Magnification and exposures were adjusted manually as necessary. 
Strains were stained using acridine orange or 4’,6-diamidino-2-phenylindole (DAPI) 
following standard protocols. To visualize B. anthracis extracted from animal 
tissues, manually homogenized tissue samples were incubated with GFP-PlyGBD, a 
B. anthracis-specific protein fusion containing the binding domain of the phage 
lysin PlyG and GFP for visualization (Raz et al., 2017; Schuch and Fischetti, 2009). 
Samples and GFP-PlyGBD were incubated for 10 minutes at room temperature, 
washed 1X in PBS, and visualized using standard protocols.  
To test for DNase and hemolytic activity, strains were grown overnight and spotted 
onto BD Difco DNase Test Agar with Methyl Green for DNase testing, or BBL 
Columbia Agar with 5% Sheep Blood for hemolytic activity tests. Plates were grown 
at 24°C, 30°C, or 37°C overnight. For DNase testing, Streptococcus pyogenes SF370 
was used as a positive control, and strains producing clear halos in the agar were 
recorded as DNase positive. For hemolysis studies, Staphylococcus aureus RN4220 
was used as a positive control, and strains producing clearing zones were recorded 
as hemolysis positive.  
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Penicillin resistance was tested following a protocol outlined in the WHO Manual 
for Laboratory Diagnosis of Anthrax (World Health Organization, 2003). B. cereus T 
was used as a positive control for penicillin resistance, and B. anthracis Sterne as a 
negative control. BD BBL Sensi-Disc Susceptibility Test Discs: Penicillin (10U) 
were used for assays.  For motility assays, 10 µL of overnight cultures were spotted 
on 0.3% BHI soft-agar and allowed to grow at 37°C overnight. Motility was 
measured by outward growth from the initial bacterial spot. B. cereus T was used as 
a positive control and B. anthracis Sterne a negative control for motility.  For 
sporulation studies, strains were grown overnight at 30°C on BHI plates from 
freezer stocks, and the following day, single colonies selected and struck out on LD 
sporulation agar plates sealed with parafilm and grown at 30°C for 7 days. After 7 
days growth, plates were scraped into 0.5 mL BHI, the wet pellets weighed and 
vortexed to homogeneity, and 0.25 mL aliquots removed, heated at 65°C for 30 
mins, placed on ice for 5 mins, diluted and plated for enumeration of spores on BHI 
plates. Viable colonies were counted the following day after overnight growth at 
30°C. Non-heat-treated aliquots were plated and enumerated for viable vegetative 
CFU counts on BHI plates. Sporulation significance testing was performed using 
the Student’s t-test with GraphPad Prism software. Phage susceptibility was tested 
by co-spotting 10 µL mid-logarithmic phase cultures with 5 µL high-titer phage 
stock (or 1X PBS) on Columbia agar plates and growing at 37°C or 30°C overnight. 
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For biofilm formation and analysis, a protocol adapted from (Schuch and Fischetti, 
2009) was used. Overnight 5 mL cultures grown in BHI at 30°C with or without 
0.2% glucose were washed 2X in PBS, resuspended in PBS and diluted 1:1000 into 
10 mL BHI with or without 0.2% glucose. Cultures were grown at 24°C, 30°C, or 
37°C. Biofilm formation capacity was measured visually weekly for 10 weeks and 
assigned values of: no growth, weak, medium, or strong growth.  
2.21 Next-generation sequencing of phage DNA, PCR and Southern blot 
screening for fBACA1  
To prepare phage genomic DNA for NGS, high-titer phage supernatants were 
polyethylene glycol (PEG)-precipitated with 10% PEG 8K and 1 M NaCl added to 
200 mL phage supernatant and shaken overnight (4°C, 80 RPM). The precipitated 
solution was pelleted at 8000 RPM, 4°C for 1 hr, and the pellet resuspended in PBS. 
Phage genomic DNA was extracted and purified using the Norgen Biotek Corp. 
Phage DNA Isolation Kit following manufacture’s protocol. A phage DNA library 
was generated using the Illumina Nextera XT kit, quantitated with the Agilent 
Technologies High Sensitivity DNA kit and paired-end sequenced on an Illumina 
MiSeq using the Illumina MiSeq Reagent Kit v2 (500 cycle). FASTQ files were 
saved and downstream bioinformatic analysis done using CLC Genomics 
Workbench software. Reads were de novo assembled using default parameters. The 
resulting contigs were annotated using RAST (Rapid Annotation using Subsystem 
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Technology) (Aziz et al., 2008) and PHASTER (PHAge Search Tool Enhanced 
Release) (Arndt et al., 2016) online tools.  
PCR screening of Sterne and Sterne::fBACA1 gDNA (prepared as described in 
Section 2.22) was performed using phiBACA1_F and phiBACA1_R primers and the 
KAPA2G Robust Hotstart DNA Polymerase following manufacture’s protocol. 
Purified fBACA1 DNA or fBACA1 stock was used as a positive control. Southern 
blotting was carried out using the same DNA samples. Briefly, gDNA was run out 
on a 0.7% TAE agarose gel, transferred onto Hybond-N+ membrane (GE) using a 
standard capillary action protocol, and UV fixed the following day. fBACA1 DNA 
was used as a positive control. Detection was carried out using the Amersham ECL 
Direct Labeling and Detection System. Probe was generated from a gel-purified 
fBACA1-specific PCR product created using phiBACA1_F and phiBACA1_R 
primers, fBACA1 DNA, and the KAPA2G Robust Hotstart DNA Polymerase. 
2.22 Genomic DNA preparation and sequencing of B. anthracis strains 
Genomic DNA for sequencing was prepared from an overnight culture using the 
QIAGEN Genomic-Tip 100/G kit. PlyG (Schuch et al., 2002) and lysozyme were 
added to Buffer B1 and allowed to incubate with resuspended bacteria at 37°C for 
30 minutes before addition of proteinase K and further incubation at 37°C as per 
manufacturer’s directions. Genomic DNA was dissolved in QIAGEN elution buffer 
(Buffer EB). DNA concentration was measured using Qubit Fluormetric 
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Quantitation and diluted to 0.2 ng/µL. DNA libraries for sequencing were prepared 
using the Illumina Nextera XT DNA Library Preparation and Index Kit following 
manufacturer’s directions. Libraries were quality and size checked with the Agilent 
2100 Bioanalyzer with a High Sensitivity DNA chip, manually normalized and 
pooled together with a 5% PhiX control spike-in. Libraries were paired-end 
sequenced using an Illumina MiSeq with the MiSeq Reagent Kit v3 (150 cycle). 
FASTQ files were saved for each sample and downstream bioinformatic analysis 
was performed using Geneious software. Reads were aligned to the B. anthracis 
chromosome (NZ_CP009541.1) and pXO1 (NZ_CP009540.1) and examined for 
regions of variation and/or SNPs. Unaligned reads were de novo assembled.  
2.23 Molecular cloning and complementation of B. anthracis dcsaB 
The csaB gene and 500 bp upstream and downstream of the gene was amplified 
using B. anthracis Sterne gDNA as template with primers csaB_comp_F and 
csaB_comp_R and Q5 Polymerase (NEB). The PCR product was gel-purified, cut 
with Kpn1-HF restriction endonuclease (NEB) and further purified with QIAquick 
PCR Purification Kit. Plasmid pASD2 (Schuch and Fischetti, 2009) was mini-
prepped from an overnight culture with QIAprep Spin Miniprep Kit, cut with Kpn1-
HF, dephosphorylated with Antarctic Phosphatase (NEB) and ligated with the csaB 
DNA fragment using T4 DNA Ligase (NEB) to form pDRD1001. 2 µL of ligation 
mixture was used to transform One Shot TOP10 Chemically Competent E. coli 
(Thermo Fisher) according to manufacturer’s directions. Colonies were screened via 
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PCR using primers pASD2_F and pASD2_R, and PCR products Sanger sequenced 
with GENEWIZ (South Plainfield, NJ). A single colony harboring the desired csaB 
sequence was grown overnight, miniprepped, and pDRD1001 shuttled into the dam-
/dcm- Competent E. coli SCS100 (NEB) following manufacturer’s transformation 
protocol. Miniprepped pDRD1001 from SCS100 cells was electroporated into 400 µL 
electrocompetent Sterne dcsaB prepared as described in (Koehler et al., 1994) using 
a Bio-Rad Gene Pulser and a 0.4 cm electrode gap Gene Pulser Cuvette with the 
following conditions: 2.5 kV, 400 W, 25 µF.  
 
B. anthracis Sterne dcsaB harboring pDRD1001 was then subjected to the following 
growth protocol to promote plasmid integration followed by excision and curing to 
generate a csaB revertant strain. A single colony from BHI-kanamycin agar was 
grown for 5 hours in 10 mL BHI-kan at 30°C, then grown for an additional 5 hours 
at 39.5°C (non-permissive temperature for plasmid replication), before plating at  
10-1  - 10-4 dilutions on BHI-kan agar and overnight growth at 39.5°C. Single 
colonies the following day were struck on BHI-kanamycin agar and grown overnight 
at 38°C. Colonies were screened via PCR using primers pASD2_F and 
csaB_check_seq_2 for plasmid integration. A single colony with integrated 
pDRD1001 was then grown in 10 mL BHI at 30°C the following day for 8 hours, 
back-diluted 1:100 and grown in 10 mL BHI at 39.5°C overnight. Following 
overnight growth, the culture was plated on BHI agar at 10-3  - 10-6 dilutions and 
grown at 39.5°C. Resulting single colonies were restruck on BHI and grown at 
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39.5°C, then replica plated on BHI-kan agar plates and grown at the non-
permissive temperature to screen for plasmid loss. Colonies that grew on BHI but 
not BHI-kan plates were restruck on BHI agar, grown at 30°C, and the csaB gene 
region amplified via PCR and DNA sequenced via Sanger sequencing (GENEWIZ) 
to check for the wild-type csaB DNA sequence, using primers csaB_check_seq_2 and 
csaB_deep_seq_R. The resulting revertant strain was termed B. anthracis Sterne 
comp-csaB. 
2.24 In vivo virulence mouse models 
The Rockefeller University institutional animal care and use committee approved 
all in vivo protocols. Overnight cultures of B. anthracis Sterne and Sterne dcsaB 
grown at 37°C, 200 RPM in BHI, were back-diluted 1:100 into pre-warmed BHI and 
grown 2.25 hrs at 37°C, 200 RPM. Cultures were spun down at 4000 RPM, 4°C for 
10 min and washed in ice-cold 1X PBS and resuspended in PBS and diluted to the 
following concentrations for chain length normalization: for B. anthracis Sterne, 1.0 
x 107 CFUs/mL; for Sterne dcsaB 1.5 - 2.0 x 106 CFUs/mL. To calculate the 
normalization factor, Sterne and Sterne dcsaB were prepared as described and 
images taken of individual chains on a phase-contrast microscope. Chain lengths for 
each strain were measured for over 100 individual chains using ImageJ and the 
average chain length determined. For mouse experiments, 4-6 week old C57BL/6 
female mice from Charles River Laboratories were injected intraperitoneally with 
0.5 mL bacterial suspensions. Survival was observed and recorded for 10 days 
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following injection after which all animals were sacrificed. Survival and virulence 
comparisons were calculated using the Gehan-Breslow-Wilcoxon Test and curves 
generated using GraphPad Prism software. For experiments examining infected 
tissues, a protocol was followed as described above, except animals with established 
infection were sacrificed 48 hours after injection, with organs removed and 
manually ground to homogeneity in 1X PBS. The cellular suspension was incubated 
with GFP-PlyGBD and bacterial cells imaged as described previously by microscopy. 
2.25 RNA-seq of B. anthracis Sterne and Sterne dcsaB in BHI and FBS 
cultures 
For RNA-seq studies, all growth conditions were 37°C, 150 RPM.  Sterne and Sterne 
dcsaB were established from overnight cultures in BHI, then passaged 1:1000 into 
BHI or FBS and grown overnight. The following morning, cultures were back-
diluted 1:100 into the same pre-warmed media, grown to late-log phase (an OD600
approximately 2/3 of the maximal logarithmic growth OD600), and 1 mL culture 
removed for preparation of RNA. Sterne dcsaB grown in BHI was removed at 
comparable time point as it was not amenable to OD600 readings.  Four groups of 
samples were generated: Sterne-BHI; Sterne-FBS; Sterne-dcsaB-BHI; Sterne-
dcsaB-FBS. Samples were washed 2X in PBS, cells lysed using PlyG and suspended 
in 600 µL TRI Reagent (Zymo Research). Samples were frozen at -80°C, until RNA 
was purified. RNA was prepared using the Zymo Research Direct-zol RNA Mini-
Prep Plus Kit, following manufacturer’s directions including an in-column DNase 
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digestion. Additional DNase digestion was performed with DNase I, Amplification 
grade (Thermo Fisher) as needed until RNA samples showed no DNA 
contamination measured by 40-cycle PCR with B. anthracis-specific 16S rRNA 
primers. RNA samples were quality checked after DNase digestion using an Agilent 
RNA Nano Kit on an Agilent 2100 Bioanalyzer. RNA samples were then rRNA 
depleted using the Illumina Ribo-Zero rRNA Removal Kit for Gram-positive 
Bacteria. All samples were in prepared and sequenced in duplicate, except for 
Sterne dcsaB, which was in triplicate. 
rRNA depleted samples were submitted to The Rockefeller University Genomics 
Resource Center for library construction and sequencing. Libraries were 
constructed using the Illumina TruSeq stranded mRNA LT kit starting at the RNA 
fragmentation step to prepare libraries. Libraries were prepared with unique 
barcodes and pooled at equal molar ratios. The pool was denatured and sequenced 
on an Illumina NextSeq 500 Sequencer, generating 75 bp single reads, following the 
manufacturer’s protocol. Reads for each sample were generated as FASTQ files and 
downstream analysis done offline.  
Reads generated for each sample were first aligned to the Sterne Genome 
(Accessions: NZ_CP009541, NZ_CP009540) using Bowtie2 (Langmead and Salzberg, 
2012) and BAM files sorted, indexed, and converted to SAM files using samtools (Li 
et al., 2009). Files were processed using RStudio and Bioconductor. Count and 
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differential expression (DE) data was processed using a protocol adapted from (Love 
et al., 2016). Read counts were generated using GenomicAlignments package 
(Lawrence et al., 2013) to create a SummarizedExperiment (Morgan et al.) and 
DESeq2 (Love et al., 2014) was used to generate graphical visualizations and 
differential expression analysis. The following four DE comparisons were generated: 
1) Sterne-BHI against Sterne-dcsaB-BHI; 2) Sterne-BHI against Sterne-FBS; 3)
Sterne-FBS against Sterne-dcsaB-FBS; 4) Sterne-dcsaB-BHI against Sterne-dcsaB-
FBS. DE was called using a minimum fold-change cut-off of 2, and an adjusted p-
value of < 0.01. DE comparison tables were saved as CSV files. 
2.26 Western Blot of protective antigen from B. anthracis culture 
supernatants 
Supernatants for Western blot were prepared as follows: Sterne, Sterne dcsaB, or 
Sterne comp-csaB strains were grown as described for RNA-seq sample preparation, 
but upon reaching late-log phase, cultures were spun down, resuspended in fresh 
pre-warmed media and allowed to continue growth for 1 hr. After 1 hr growth, 
cultures were spun down and the supernatant sterile filtered through 0.22 µm 
filters. DSterne supernatant was used as a negative control for protective antigen.  
Supernatants were normalized for OD600 values/cell number and were run on 
Thermo Fisher NuPAGE 4-12% Bis-Tris Protein Gels, with MOPS running buffer at 
200 V for 1 hr. FBS supernatants, and BHI supernatants compared to FBS 
supernatants were diluted 1:100 in PBS to allow for distinct FBS protein bands on 
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the gel. For blots containing only BHI samples, BHI supernatants were 
concentrated 5x using Vivaspin 500 3 kDa MWCO filters (GE). Gels were stained 
with the Colloidal Blue Staining Kit (Thermo Fisher) as per manufacturer’s 
directions. Protein gels for Western blots were transferred onto Immobilon-P PVDF 
membrane (Millipore) following standard protocols, blocked and probed with 
Anthrax protective antigen antibody (Invitrogen Cat. # PA1-41695) as primary and 
Peroxidase AffiniPure Donkey anti-rabbit IgG (Jackson Cat. # 711-035-152) as 
secondary. Blots containing FBS and BHI supernatants were developed using 
SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Fisher). Blots 
containing only BHI supernatant samples were developed using SuperSignal West 
Pico Chemiluminescent Substrate (Thermo Fisher). Developed film was 
photographed using an iPhone 6 camera.  
2.27 Determination of B. anthracis Sterne spontaneous resistance rate to 
fBACA1 
To determine the spontaneous resistance rate of Sterne to fBACA1, an overnight 
culture of Sterne was back-diluted 1:100 in 5 mL BHI and grown at 30°C, 150 RPM 
to an OD600 = 0.1 – 0.2. The culture was then split and infected with MOI = 10 of 
fBACA1 or mock-infected with an equal volume BHI. Cultures were then grown for 
an additional 30 mins, before plating both untreated and treated cultures for CFU 
counts. Resistance rate was determined by comparison of treated to untreated CFU 
counts. Experiments were performed in triplicate. 
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2.28 Determination of B. anthracis Sterne dcsaB genomic reversion 
To observe potential reversion of dcsaB, an overnight culture of Sterne dcsaB was 
back-diluted 1:100 and grown in 5 mL BHI or FBS at 37°C, 150 RPM. Following 
overnight growth, each culture was examined under a microscope for Sterne-like 
morphologies and phenotypes. 10 µL of each culture was then passaged into the 
same media (BHI or FBS) and allowed to grow overnight in the same conditions. In 
addition, 10 µL of each culture was also used to inoculate 10 mL of BHI, grown at 
30°C overnight. 30°C BHI cultures (inoculated from 37°C BHI or FBS cultures) 
were examined the following day for turbidity and visualized for Sterne-like 
morphologies and phenotypes. This protocol was repeated for seven consecutive 
passages. 
2.29 PCR amplicon preparation and deep-sequencing of csaB 
Genomic DNA for use as template in PCR reactions amplifying the csaB gene region 
were prepared as follows: colonies from a BHI plate grown overnight at 30°C were 
scraped and resuspended into 25 µL 0.5 M NaOH, before adding 25 µL of 1 M Tris 
pH 7.0 and 450 µL nuclease-free water. PCR reactions used the Q5 High-Fidelity 
DNA Polymerase (NEB), csaB_deep_seq_F and csaB_deep_seq_R primers, and 0.5 
µL of previously prepared template DNA in a 50 µL reaction. PCR amplicons were 
gel-purified using the QIAquick Gel Extraction Kit, quantified with Qubit, and 
diluted to 0.2 ng/µL in QIAGEN EB. DNA libraries and sequencing was carried out 
	115 
as described previously in Section 2.22, with the exception that library quantitation 
was performed using the Agilent High Sensitivity D1000 ScreenTape Assay on an 
Agilent TapeStation. FASTQ files were saved for each sample, and bioinformatic 
analysis done using Geneious software. Variants with strand biases > 98% or Phred 
quality scores < 30 were filtered out from results.  
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CHAPTER 3. EXTRA-CHROMOSOMAL DNA SEQUENCING REVEALS 
EPISOMAL PROPHAGE CAPABLE OF IMPACTING VIRULENCE FACTOR 
EXPRESSION IN STAPHYLOCOCCUS AUREUS 
INTRODUCTION 
3.1 Impacts of prophage on the biology and virulence of S. aureus 
As discussed in Chapter 1, S. aureus is a major human pathogen which employs an 
array of virulence factors to execute a highly successful infection program 
(Thammavongsa et al., 2015; Thomer et al., 2016). Many of these determinants are 
encoded by prophage elements (Novick and Matthews, 2005). In addition to the hlb-
converting phages previously discussed, other phages of S. aureus carry virulence 
factors important for pathogenesis. These include the pore-forming Panton-
Valentine leukotoxin (PVL), and exfoliative toxin A (ETA), the causative agent of 
staphylococcal scaled skin syndrome (SSSS) (Kaneko et al., 1998; Yamaguchi et al., 
2000). Important phage-encoded virulence factors of S. aureus are listed in Table 
3.1. 
The dependence of S. aureus on its resident prophage is clear, as phage-cured  
strains show markedly reduced virulence (Bae et al., 2006). In addition, the 
coordination of chromosomally-encoded regulators (e.g. Agr) with phage-encoded 
virulence determinants suggests a long co-evolution and dependence on phage by 
the bacterial host (Fischetti, 2006). As such, the importance of positive conversion 
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for S. aureus’s virulence cannot be overstated, however, recent reports have 
revealed that other processes such as phage excision/integration and atypical 
genome localization play roles in the virulence potential of the organism in addition 
to the “traditional roles” of positive and negative conversion (Goerke et al., 2004; 
2006; Utter et al., 2014). 
Table 3-1. Important phage-encoded virulence factors of S. aureus. 
Virulence factor (gene) Encoding Phage 
Leukocidin (lukS, -F, -M) fPVL, fPV83 
Enterotoxin P (sep) fN315 
Enterotoxin A (entA, sea) fMRSA252*, fMu50A* 
Exfolative toxin A (eta) fETA, fSTL 
Toxic shock syndrome toxin (tst) SaPI-1** 
Staphylokinase (sak) f13* 
Chemotaxis inhibitory protein of S. aureus (chips) f13* 
Staphylococcal complement inhibitor (scin) f13* 
*f13 and other hlb-converting phages can encode sak, sea, scin, or chips
**SaPI-1 is a mobile pathogenicity island transduced by helper phage 
Adapted from (Boyd and Brüssow, 2002) with permission. 
For example, in S. aureus isolates from cystic fibrosis and bacteremic patients, 
genomic alterations driven by hlb-converting phages were found to occur in the 
transition from nasal colonization to invasive infection. Specifically, in infection 
isolates, hlb-converting phages (Figure 3-1a) were found integrated at atypical 
chromosomal locations, resulting in Hlb+/sak+ phenotypes (cells with an intact hlb 
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gene, but also positively converted by prophage encoding sak) (Figure 3-1b). Rarely, 
in some strains, prophage appeared to undergo duplication and dual integration, 
generating populations with a Hlb–/sak2 phenotype (cells with one prophage 
integrated in hlb and a duplicated prophage integrated in another chromosomal 
location, with both phages encoding sak) (Figure 3-1c) (Goerke et al., 2006). Such 
phage mobilization occurred to a significantly lesser degree however in nasal 
(colonization) isolates from healthy individuals, indicating selective pressure for 
Hlb-producing strains in the transition to invasive infection, with atypical prophage 
integration as a mechanism to allow for dual Hlb and SAK production. Previous 
work in the Fischetti Laboratory uncovered a plasmidial prophage, fBU01, with the 
phage DNA sequence highly homologous to known hlb-converting phages. 
Importantly, fBU01 did not appear to integrate within the S. aureus chromosome 
(Utter et al., 2014), suggesting that in addition to atypical chromosomal integration, 
maintenance of prophage in the extra-chromosomal compartment can result in a 
Hlb+/sak+ phenotype (Figure 3-1d) (Deutsch et al., 2016). 
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Figure 3-1. Illustration of phage localization in S. aureus cystic fibrosis 
and bacteremic isolates. Atypical hlb-converting phage localization is described 
in (Goerke et al., 2006). A) hlb-converting phage typically integrate in the 
chromosome and disrupt hlb, but positively convert cells for sak, sea, scin, and/or 
chips. Cells are Hlb–, sak+. B) Atypical phage localization (off-target chromosomal 
integration) results in Hlb+, sak+ phenotypes. C) Phage duplication and dual 
integration results in disrupted hlb, and 2 copies of sak. D) Alternatively, phage 
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3.2 The importance of phage-mobilization for bacterial pathogens 
Excision/integration dynamics of lysogenic prophage also have important roles in 
other bacterial pathogens. S. pyogenes SF370 contains the episomal, phage-like 
chromosomal island, SpyCIM1, which integrates within the cell’s DNA mismatch 
repair operon, disrupting transcription of the mutS-mutL genes and consequently 
increasing the mutation rate of the cell approximately 200-fold (Hendrickson et al., 
2015; Scott et al., 2008). The phage-like element was found to be excised at low cell 
densities, allowing fidelitous genome replication, but would integrate and increase 
the cell’s mutation rate at higher cell densities (Scott et al., 2008)—conditions 
where mutation might be beneficial (i.e. low nutrient availability) (Figure 3-2). 
Here, excision/integration is a dynamic, switch-like process; in S. aureus however, 
phage excision and re-integration (or extra-chromosomal localization) as previously 
described creates stable isolates with prophage not believed to continuously pop in 
and out of the chromosome. SpyCIM1’s temporal dynamics suggest that S. pyogenes 
is using the phage-like element for its own benefit as a molecular switch at the 
DNA-level.  
Phage acting as such DNA-switches have been found in a number of distantly 
related bacterial species, suggesting such a phage-role has existed over a long time 
scale.  Feiner et al. review SpyCIM1’s behavior and discuss a number of other 
species (Listeria monocytogenes, Bacillus subtilis, and Escherichia coli) where 
bacterial hosts have been found to employ similar beneficial strategies with their 
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lysogenic phages, allowing control of activities such as phagosomal escape (L. 
monocytogenes) (Rabinovich et al., 2012), sporulation (B. subtilis) (Kunkel et al., 
1990; Takemaru et al., 1995), and biofilm formation (E. coli) (Wang et al., 2009). In 
all three cases, phage excision allows the transcription of key chromosomally-
encoded genes, altering bacterial behavior (Feiner et al., 2015). 
Figure 3-2. Illustration of SpyCIM1 genome and integration dynamics. 
SpyCIM1 is a phage-like chromosomal island of S. pyogenes. In the exponential 
phase, SpyCIM1 excises from the chromosome and the mismatch-repair operon 
(MMR) is fully transcribed. At higher-cell densities, the episome integrates between 
mutS and mutL, disrupting transcription of the operon and increasing the cell’s 
mutation rate. OD600 and % episomal SpyCIM1 analysis reveals excision is a 
temporally controlled process, with the episome acting as a DNA-level switch. 
Reprinted with permission from (Nguyen and McShan, 2014). 
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Importantly, for SpyCIM1 and the phages described in (Feiner et al., 2015), excision 
from the chromosome is not associated lytic induction; if it were, the impacts of 
phage excision would be lost as phage induction leads to likely cell death. (Host 
benefits from phage induction into the lytic cycle are described in Section 1.3.4  
(also well-reviewed in (Nanda et al., 2015).) While excision here is associated with a 
lysogenic state, in some cases it is irreversible, i.e., phages are cured or lost after 
excision. In B. subtilis, for example, excision of the phage-element skin allows 
reconstitution and transcription of a functional sk gene (sigk), promoting 
sporulation. In this case, skin and the bacterial cell die, however a copy of the phage 
genome remains in the new spore (Feiner et al., 2015; Kunkel et al., 1990; 
Takemaru et al., 1995). Regardless of reversible or irreversible excision, Feiner et 
al. describe phage capable of controlled excision/integration within the lysogenic 
cycle as “active lysogens” and termed the process “active lysogeny” (Figure 3-3c). 
Active lysogeny is distinguished from the more traditional effects of the lysogenic 
cycle, as phage excision allows the expression or regulation of chromosomally-
encoded factors, in contrast to positive conversion (Figure 3-3a), or even the 
induction of a proportion of the population into the lytic cycle (Figure 3-3b).  
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Figure 3-3. Forms of lysogeny and mechanisms for expression of virulence 
or fitness factors. A) Lysogenic (positive) conversion involves the expression of 
phage-encoded factors in the bacterial cell. For S. aureus, phages carry an array of 
virulence factors (Table 3.1) and contribute to the pathogen’s virulence potential. B) 
Induction of a subpopulation of cells into the lytic cycle can allow the increased 
production of phage-encoded virulence factors. For S. aureus, enterotoxin A and 
staphylokinase expression increases with induction (Sumby and Waldor, 2003). For 
other species (e.g. E. coli) increased expression of toxins via induction allows for 
more successful host invasion and infection by the remainder of the population. C) 
Active lysogeny is a feature of temperate phage capable of controlled 
excision/integration within the lysogenic cycle. Phage integration can disrupt 
transcription of virulence or fitness factors, and excision (without lytic induction) 
allows the reconstitution and expression of genes. Excision can be reversible or non-
reversible, leading to prophage reintegration or loss, respectively. Reprinted with 
permission from (Feiner et al., 2015). 
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3.3 Uncovering extra-chromosomally localized prophage in S. aureus 
Given the importance of prophages in S. aureus, and the potential impacts of active 
lysogenic phage, research specifically targeted at uncovering extra-chromosomally 
localized phage can lend important insights into the virulence potential of S. aureus 
strains, either through the identification of novel phages, or the discovery of active 
lysogenic phage. Previous work in the Fischetti Laboratory screened clinical isolates 
of S. aureus for the presence of rare, cytoplasmically-localized prophage using an 
extra-chromosomal DNA enrichment and next-generation sequencing (NGS) 
approach. In this report (Utter et al., 2014), the plasmidial (non-integrating) 
prophage fBU01 was identified and sequenced from the vancomycin-intermediate 
S. aureus (VISA) NRS19, and found to encode multiple virulence determinants 
including sea, sak, scin, and chips. In addition, an episomal prophage (found both 
chromosomally-integrated and extra-chromosomal in a population) was also 
uncovered in VISA NRS26 (Utter et al., 2014). Enrichment and screening of the 
cytoplasmic compartment in this previous report revealed that extra-chromosomally 
localized prophage were fairly widespread in S. aureus, and that such “hidden” 
elements could alter the virulence potential of a strain. 
The following sections of this Chapter describe an expansion of this work, 
employing NGS to screen-by-sequencing 15 additional clinical isolates of S. aureus. 
Unlike the prior study however, the strains selected for this study had previously 
sequenced chromosomes, facilitating the classification of any extra-chromosomally 
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enriched prophage uncovered as either episomes or plasmids, and allowing the 
identification of potential active lysogenic phage. In this screening, we find extra-
chromosomal prophage present in 5 of 15 strains, but surprisingly, these strains 
contain only episomal and not plasmidial prophage. Experimental work 
demonstrates that the enriched episomal prophages identified are circular DNA 
elements, and qPCR experiments reveal that enrichment and detection of such 
prophages by NGS would not occur if using conventional whole-genome DNA 
preparations. In addition, we find that in the S. aureus strain MSSA476, 
enrichment of its episomal phage (fSa4ms) is growth-phase dependent and that 
fSa4ms does not appear to replicate after its excision, suggesting its existence as a 
candidate “active lysogenic phage”. Follow-up experiments find that the excision of 
fSa4ms can alter the promoter sequence and transcription of the stress-response 
serine protease-encoding htrA2, with promoter alterations affecting heat-stress 
survival in S. aureus COL. Here, the expanded and improved extra-chromosomal 
enrichment and sequencing of S. aureus clinical strains is shown to allow the 
detection of active lysogenic phage, giving greater insights into the genome 
dynamics and mechanisms by which phage generate diversity and enhance the 
virulence potential of the pathogen. 
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RESULTS 
3.4 Extra-chromosomal sequencing reveals the presence of episomal 
prophage elements within S. aureus clinical isolates 
For this study, we expanded our previously developed extra-chromosomal DNA 
enrichment and sequencing approach to screen S. aureus clinical isolates for 
prophage elements in the extra-chromosomal compartment of the cell (Utter et al., 
2014). We selected 15 clinical isolates sourced from different geographic regions, 
containing a diverse array of antibiotic resistances and virulence factors. In 
addition, these strains had fully sequenced chromosomes, facilitating the distinction 
of any detected prophage as integrated, episomal, or plasmidial. We enriched and 
prepared extra-chromosomal DNA (exDNA) as described in Materials and Methods, 
and sequenced samples with Illumina NGS. Extra-chromosomal DNA samples were 
analyzed by first mapping sequencing reads to their corresponding chromosomal 
sequences, followed by de novo assembly of unmapped reads. Visual examination of 
chromosomal read-mappings revealed areas of increased sequencing coverage, 
especially over prophage regions (Figures 3-4a, 3-4b). Coverage analysis of read-
mappings highlighted regions of significantly increased read depth, indicating the 
presence of episomal elements (and potentially active lysogenic prophage) that were 
enriched in sequencing due to specifically targeting and isolating DNA elements 
from the extra-chromosomal compartment of the cell (Figure 3-1c). Read-mappings 
and coverage analysis are shown for strain MSSA476 as a representative example. 
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Figure 3-4. Read-mapping and coverage analysis of MSSA476 extra-
chromosomal DNA sequencing. A) and B) Read-mappings of sequencing reads 
from MSSA476 exDNA. MSSA476 contains two integrated prophages: fSa3ms and 
fSa4ms. fSa4ms (B) has greater read coverage compared to fSa3ms (A) in exDNA 
sequencing. Selected portions of the read-mappings surrounding prophage 
integration regions for fSa3ms (A) and fSa4ms (B) are shown. Chromosomal 
positions are labeled at top, and consensus regions are shown below for MSSA476 
chromosome sequence and MSSA476 exDNA reads. Locations of fSa3ms (A) and 
fSa4ms (B) integrated prophage genomes are shown. Extra-chromosomal reads are 
shown below for each. C) Coverage analysis of MSSA476 extra-chromosomal read-
mapping. Portions of coverage analysis surrounding prophage regions shown for 
clarity. Chromosomal positions labeled at top of image, and approximate positions 
of fSa3ms and fSa4ms integrated genomes shown below. Histogram representation 
of higher read-coverage regions reveals enrichment of fSa4ms prophage due to 
exDNA isolation. Read-mapping across fSa3ms genome location does not contain 




For each of the 15 strains, we documented whether prophage elements were 
enriched in sequencing due to exDNA isolation and classified strains as: 1) 
containing enriched prophage, 2) not containing enriched prophage, or 3) containing 
unclear prophage enrichment, when partial but not complete prophage regions had 
increased coverage detected (Table 3.2). Surprisingly, de novo assembly of 
unmapped reads did not reveal any prophage elements, suggesting no plasmidial 
prophage in the sequenced strains, and that all prophage uncovered in the extra-
chromosomal compartment by our approach were episomal elements. Importantly, 
episomal prophage were identified in 1/3 (5 of 15) of the staphylococcal strains 
analyzed. These included: fSa4ms in MSSA476 (Sa4-like integrase), a geh-
converting prophage in NRS143 (Sa6-like integrase), one typically intergenic 
prophage in BK2529 (Sa7-like integrase), as well as two strains each with three 
episomal phages. One of these strains, HPV107, contained episomal prophages with 
Sa2- and Sa3-like integrases, and in addition, one prophage with an unclear 
integrase type, however its sequence was homologous to the integrase of a prophage 
from S. aureus SA268 (Qu et al., 2014). The other strain, NRS22, contained 
episomal prophages with Sa2-, Sa5-, and Sa7-like integrase sequences.  
Interestingly, when integrated into the chromosome, the Sa2-like prophage of 
HPV107 disrupts a 6-phospho-b-galactosidase encoding gene, which to our 
knowledge is a novel integration site for a S. aureus prophage. The other phages we 
uncovered as episomes have previously described chromosomal integration sites 
(Bae et al., 2006; Goerke et al., 2006; 2009).  Incidentally, known plasmids, such as 
	131 
pSAS1 in MSSA476, were fully de novo assembled using the unmapped reads, and 
while they are not the focus of this current study, they do point to the sensitivity of 
this exDNA isolation and sequencing method. 
Table 3-2. Detection of episomal prophage in S. aureus strains from extra-






Enriched prophage detected 
MSSA476 MSSA 2 • ΦSa4ms enriched, integrates immediately
upstream of htrA2
• ΦSa3ms not enriched, hlb-converting
NRS22 VISA/MRSA 4 3 enriched prophages: 
• Sa2-lke integrase, intragenic in
RK87_02365 (hypothetical protein)
• Sa5-like integrase, intragenic in
RK87_04825 (radical SAM)
• Sa7-like integrase, intergenic between
rpmF and isdB
NRS143 MSSA 4 • One enriched prophage: Sa6-like
integrase, geh-converting
HPV107 MRSA 4 3 enriched prophages: 
• Sa2-like integrase, intragenic in
RL05_04630
• Sa3-like integrase, hlb-converting phage
(fHPV107.1)
• Unclear integrase type, intergenic
between RL05_02285 (tRNA-Ser) and
RL05_01940 (enterotoxin)
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BK2529 MRSA 4 • One enriched prophage: Sa7-like
integrase, intergenic between rpmF and
isdB)
Unclear enriched prophage 
NRS153 MSSA 4 • Unclear enrichment of Sa1-like integrase
prophage, intergenic between sufB and
transposon-encoded integrase
RK79_06750
NRS387 MRSA 1 • Unclear enrichment of Sa3-like integrase
prophage, hlb-converting
NRS2 VISA/MRSA 2 • Unclear enrichment of Sa7-like integrase
prophage, intergenic between rpmF and
isdB
No enriched prophage detected 
BAA-42 MRSA 4 
NRS156 MSSA 2 
NRS127 MRSA 5 
NRS158 MSSA 3 
NRS271 MRSA 3 • Enriched ICE within RK77_00405
(membrane protein)
E2125 MRSA 5 
HDE288 MRSA 3 
Relevant resistances (MSSA, MRSA, VISA, VRSA) and total number of 
chromosomal prophage for each strain are listed.  
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3.5 QPCR characterization of MSSA476 validates extra-chromosomal 
sequencing data, but also reveals episomal prophage are detectable only in 
extra-chromosomal DNA samples 
Our screening-by-sequencing approach did not reveal any non-integrating 
plasmidial prophage, however, a number of the clinical strains did contain episomal 
prophage elements that were enriched by exDNA isolation. Thus, we were curious 
what insights prophage enrichment, as uncovered by exDNA isolation and 
sequencing, revealed about an individual strain. To better understand the nature of 
enrichment, we chose to focus on the well-characterized S. aureus strain MSSA476 
(Holden et al., 2004; Sumby and Waldor, 2003) and took a qPCR approach to 
determine the excision rates and copy numbers of its prophages. MSSA476 contains 
two prophages, fSa3ms and fSa4ms. fSa3ms is a hlb-converting prophage, while 
fSa4ms integrates 30 bp upstream of the serine protease-encoding htrA2. In our 
sequencing, fSa4ms was found enriched by exDNA isolation, while fSa3ms was not 
(Figure 3-4). Therefore, MSSA476 is ideal to understand the characteristics of both 
enriched and non-enriched phage in our screening.  
We first wanted to validate our extra-chromosomal sequencing results by qPCR, 
measuring prophage copy number in exDNA samples by targeting excised prophage 
attachment sites (attP) normalized to DNA gyrase (gyrA). Sequencing data should 
have a direct correlation to prophage copy number, predicting that fSa4ms copy 
number would be greater than fSa3ms in exDNA samples. Indeed, we found the 
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copy number of excised fSa4ms (copies attP/copy gyrA) was significantly higher 
than fSa3ms (P = 0.0004), supporting our exDNA sequencing data (Table 3-3, 
Figure 3-5a). Following this validation, we next measured the excision rates of 
fSa3ms and fSa4ms, since prophage enrichment in our exDNA samples suggested 
that the excision rate of fSa4ms would be higher than fSa3ms. We calculated the 
excision rates by targeting phage-less bacterial attachment sites (attB) normalized 
to gyrA. As attB sites are present on chromosomal DNA, we prepared the genomic 
DNA (gDNA) of MSSA476 using the same growth conditions as DNA prepared for 
extra-chromosomal sequencing and performed qPCR on gDNA.  Surprisingly, we 
found the excision rate of fSa3ms (copies attB/copy gyrA) to be significantly higher 
than fSa4ms (P = 0.0017), despite fSa4ms enrichment in our exDNA sequencing 
and higher copy number by qPCR (Table 3-3, Figure 3-5b). This result was 
confounding, but suggested that if we also examined the gDNA preparations for 
prophage copy number by qPCR, fSa3ms copy number might be higher than 
fSa4ms. Copy number qPCR of MSSA476 gDNA indeed revealed that the excised 
prophage copy number of fSa3ms was significantly higher than fSa4ms (P = 
0.0015) as suggested by fSa3ms’s higher excision rate, but in contrast to the copy 
number results from qPCR of exDNA samples (Table 3-3, Figure 3-5c). The qPCR 
and sequencing data obtained thus far for MSSA476 appeared conflicting; exDNA 
samples showed enrichment of episomal fSa4ms compared to fSa3ms, however 
fSa3ms had a higher excision rate and higher copy number than fSa4ms when 
	135 
gDNA was examined. We therefore performed additional experiments to uncover 
the basis of these apparent conflicting results. 
Table 3-3. Copy numbers and excision rates of MSSA476 prophages from 
exDNA sequencing conditions. 
Prophage Prophage copy number 
(copies attP/copy gyrA) 
Excision Rate (copies attB/ 
copy gyrA) 
exDNA gDNA 
fSa3ms 0.146 ± 0.010 0.086 ± 0.008 9.35 x 10-4  ± 9.75 x 10-5  
fSa4ms 0.622 ± 0.042 0.023 ± 0.002  1.62 x 10-4  ±  3.37 x 10-5 
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Figure 3-5. QPCR characterization of MSSA476 excised prophage copy 
numbers and excision rates. A) Excised prophage copy number (copies attP/copy 
gyrA) from MSSA476 extra-chromosomally enriched DNA (exDNA) samples. 
Excised prophage copy number is significantly higher for fSa4ms than fSa3ms, in 
accordance with sequencing data. B) Excision rates of fSa3ms and fSa4ms (copies 
attB/copy gyrA). Excision rate of fSa3ms is significantly higher than fSa4ms. C) 
Excised prophage copy number from MSSA476 whole-genome DNA (gDNA) 





3.6 Extra-chromosomal DNA isolation enriches circular prophage elements 
To uncover why fSa4ms was enriched by exDNA isolation but not in gDNA 
preparations, we first compared fSa3ms and fSa4ms prophage genomes for %GC 
content, which could alter DNA capture efficiency. However, %GC content does not 
appear to play a role in enrichment differences as fSa3ms and fSa4ms contain 
almost equivalent %GC content at 33.2% and 33.3%, respectively. Part of the extra-
chromosomal enrichment protocol involves alkaline-lysis followed by centrifugation. 
We hypothesized that this step likely enriches for circular forms of prophage that 
would remain soluble after alkaline-lysis and not pellet during centrifugation (i.e., 
would be captured in the exDNA preparation). Linear prophage concatemers 
(contiguous copies of phage genome arising from prophage induced into the lytic 
cycle in a subpopulation of cells) would likely pellet with chromosomal DNA and 
other cellular debris and be removed from exDNA samples. The same linear 
concatemers however, would not be excluded in whole-genome preparations, 
potentially explaining the differences seen in qPCRs of gDNA and exDNA samples.  
We designed and performed a selective depletion experiment of fSa4ms prophage in 
exDNA samples to test this hypothesis. Specifically, we examined if fSa4ms could 
be selectively removed from samples only by the combination of fSa4ms-specific 
restriction endonucleases (linearizing circular prophage) followed by linear DNA 
digestion, and not solely by the exonuclease treatment. fSa4ms depletion only by 
sequential endo- and exonuclease treatment would indicate the prophage exists as a 
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closed circular DNA element. A schematic of the digestion procedure is shown in 
Figure 3-6. 
Figure 3-6. Schematic of endonuclease and/or exonuclease treatment of 
MSSA476 exDNA. ExDNA of MSSA476 (left) consists of both fSa3ms and fSa4ms 
genomes, in circular and linear (likely concatemer fragments) forms. Here, copy 
number of fSa4ms is higher than fSa3ms. Linear DNase (exonuclease) only 
treatment (A) removes linear concatemers of prophage DNA, leaving only closed 
circular prophage genomes (right). With exonuclease treatment, fSa4ms copy 
number should remain greater than fSa3ms. Sequential treatment (B) of MSSA476 
exDNA with fSa4ms-specific endonucleases (PshAI, PspXI) linearizes fSa4ms 
circular genomes (and cuts fSa4ms linear concatemers) and treatment with linear 
DNase completely eliminates fSa4ms DNA. Following this treatment, only fSa3ms 
DNA should remain.  
Linear DNase 
1. PshAI, PspXI digest
2. Linear DNase










Thus, extra-chromosomal samples were treated as described in Materials and 
Methods and end-point PCR measurement was performed targeting gapdh, the attP 
sites of fSa3ms and fSa4ms, and the naturally occurring MSSA476 plasmid pSAS1. 
An agarose gel containing all PCR reactions is shown in Figure 3-7. Gapdh (a 
marker for linear DNA digestion) was depleted after linear DNase treatment but 
remained in high abundance after treatment with the fSa4ms-specific restriction 
endonucleases PspAH and PspXI. fSa3ms attP target was present in each condition 
tested, indicating that it does exist in the circular form in extra-chromosomally 
enriched DNA samples, however in low abundance. fSa4ms attP target is present 
and in greater abundance than fSa3ms in untreated, restriction endonuclease-only 
and linear DNase-only treated samples. Treatment with fSa4ms-specific 
endonucleases followed by linear DNase treatment results in the complete loss of 
fSa4ms target, verifying that fSa4ms is indeed abundant relative to fSa3ms in 
extra-chromosomally enriched DNA samples, and that this enrichment is due to 
circular forms of the prophage element. pSAS1, a circular plasmid in MSSA476, is 
not affected by any sample treatment (Figure 3-7). 
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Figure 3-7. Agarose gel of PCR reactions from fSa4ms selective-depletion 
experiment. 1% agarose gel stained with SYBR Safe DNA Gel Stain containing 
end-point PCR reactions from MSSA476 samples. MSSA476 exDNA was digested 
with Plasmid-safe exonuclease, PspAH/PspXI restriction endonucleases, both 
Plasmid-safe and restriction endonucleases, or left untreated with treatment 
indicated by (+) and (-). Gapdh, fSa3ms attP, fSa4ms attP, and pSAS1 target were 
amplified from treated and untreated samples. fSa4ms attP target is selectively-
depleted from combination exonuclease and endonuclease treatment but not from 
solely exonuclease treatment, indicating its existence as a circular element in 
exDNA samples. Higher levels of fSa4ms target compared to fSa3ms target 
correlate with the phage enrichment detected by DNA sequencing. Negative 


































































We were now curious if a similar pattern was present in other strains, which also 
contained episomal prophage enriched by exDNA isolation. To test this, we 
performed an inter-strain comparison, examining by qPCR the excision rates and 
excised prophage copy numbers of hlb-converting phages in three strains: BAA-42 
(containing fBAA-42.1), MSSA476 (fSa3ms), and HPV107 (containing fHPV107.1). 
Sequencing data revealed that only fHPV107.1 was significantly enriched by 
exDNA isolation, and qPCR copy number examination of exDNA samples confirmed 
this result.  fHPV107.1 had higher copy number as compared to fBAA-42.1 (P = 
0.0052) and fSa3ms (P = 0.0057) in exDNA samples (Table 3-4, Figure 3-8a (right)). 
When we examined excision rates of the three phages, we found that in this 
comparison, fHPV107.1 did indeed have the highest excision rate. The excision rate 
of fHPV107.1 was significantly higher than fBAA-42.1 (P = 0.0009) and fSa3ms (P 
= 0.002) (Table 3-4, Figure 3-8b). However as observed previously with MSSA476, 
prophage copy number data from gDNA samples did not correlate with exDNA 
data, verifying that the episomal prophage enrichment we uncover is only apparent 
in exDNA samples. Significant copy number differences in gDNA samples were not 
seen between fHPV107.1 and fBAA-42.1 (P = 0.3205), while fSa3ms had a lower 
copy number than either fHPV107.1 or fBAA-42.1 (Table 3-4, Figure 3-8a (left)). 
Similar to results for fSa4ms, qPCR of exDNA suggests that in a HPV107 
population, fHPV107.1 exists as a circular, episomal DNA element likely in a 
higher proportion of cells than that of fBAA-42.1 or fSa3ms in their respective 
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populations. Induction of phage however, likely masks uncovering these events in 
qPCRs of gDNA samples. 
Table 3-4. Copy numbers and excision rates of selected hlb-converting 
prophages. 
Prophage Prophage copy number 
(copies attP/copy gyrA) 
Excision rate 
 (copies attB/copy gyrA) 
exDNA gDNA 
fBAA-42.1 0.138 ± 0.005 0.270 ± 0.016 1.65 x 10-4 ± 5.15 x 10-5
fSa3ms 0.146 ± 0.010 0.086 ± 0.008 9.35 x 10-4  ± 9.75 x 10-5 
fHPV107.1 0.540 ± 0.073 0.291 ± 0.015 1.94 x 10-3 ± 9.94 x 10-5
	145 
Figure 3-8. QPCR characterization of hlb-converting prophages. A) Excised 
copy numbers of hlb-converting prophages fBAA-42.1, fSa3ms, and fHPV107.1. 
Excised copy number experiments of prophage from gDNA (left) reveal no 
significant difference between fBAA-42.1 and fHPV107.1, however fHPV107.1 has 
significantly higher excised copy number than fBAA-42.1 or fSa3ms in exDNA 
samples (right). B) Excision rates of hlb-converting prophages fBAA-42.1, fSa3ms 
and fHPV107.1. fHPV107.1 has a significantly higher excision rate than fBAA-42.1 




3.7 Extra-chromosomal localization of fSa4ms circular prophage is a 
temporal and rare event 
Since fSa4ms enrichment was due to episomal, circular copies of the prophage in 
the MSSA476 population, we were curious if such an event was merely a precursor 
to phage replication and the generation of linear concatemers or occurred without 
subsequent replication, suggesting that fSa4ms might exist in an “active lysogenic” 
cycle. To investigate this question, we repeated our qPCR approach, examining the 
excision rates and excised phage copy numbers of fSa3ms and fSa4ms at different 
time points of the growth cycle, to see if their values changed with different culture 
densities. We sampled cultures at OD600 = 0.35, 0.7, 1.0 and overnight, and 
prepared exDNA (to measure circular prophage copies) and gDNA (to examine 
excision rates and potential increases in overall excised prophage copy number). 
The excision rate of fSa3ms did not significantly change from OD600 = 0.35 to 1.0 (P 
= 0.2403) while that of fSa4ms did significantly decrease during this time (P = 
0.036) (Table 3-5, Figure 3-9a). The fSa3ms excision rate does however, increase 
approximately two-fold from OD600 = 0.35 to overnight. Excised prophage copy 
number, as measured by attP target for whole-genome preparations did not change 
from OD600 = 0.35 to 1.0 for fSa3ms (P = 0.118) nor fSa4ms (P = 0.527) (Table 3-5, 
Figure 3-9b). Levels of excised prophage copy number over the same range for 
exDNA also did not change for fSa3ms (P = 0.0982) but did however significantly 
decrease for fSa4ms (P < 0.0001) (Table 3-5, Figure 3-9c). 
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Table 3-5. Copy numbers and excision rates of MSSA476 prophages at 
selected optical densities. 
Prophage OD600 Prophage copy number 
(copies attP/copy gyrA) 
Excision rate (copies 
attB/copy gyrA) 
exDNA gDNA 
fSa3ms 0.35 0.380 ± 0.049 0.109 ± 0.010 4.64 x 10-4 ± 4.52 x 10-5 
0.7 0.338 ± 0.064 0.095 ± 0.005 4.80 x 10-4 ± 1.10 x 10-5
1 0.265 ± 0.021 0.137 ± 0.013 5.05 x 10-4 ± 2.73 x 10-5
O/N 0.256 ± 0.014 0.123 ± 0.010 9.58 x 10-4 ± 2.14 x 10-5
fSa4ms 0.35 2.220 ± 0.110 0.084 ± 0.006 1.51 x 10-4 ± 2.47 x 10-5 
0.7 1.257 ± 0.229 0.065 ± 0.002 9.91 x 10-5 ± 3.13 x 10-6 
1 0.427 ± 0.030 0.077 ± 0.008 8.44 x 10-5 ± 1.14 x 10-5
O/N 0.207 ± 0.019 0.070 ± 0.008 8.75 x 10-5 ± 8.15 x 10-6 
O/N = overnight culture 
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Figure 3-9. QPCR characterization of MSSA476 prophage excision rates 
and copy numbers from logarithmic and overnight cultures. A) Excision 
rates of fSa3ms and fSa4ms samples at indicated optical densities. fSa3ms does 
not show a significant difference in excision rates comparing OD600 = 0.35 and 1.0 
samples, whereas a significant decrease is found for fSa4ms. B) Excised prophage 
copy number from MSSA476 whole-genome DNA (gDNA) samples at indicated 
optical densities. Neither fSa3ms nor fSa4ms have significantly different excised 
prophage copy numbers comparing OD600 = 0.35 and 1.0 samples. C) Excised 
prophage copy numbers from MSSA476 extra-chromosomally enriched DNA 
(exDNA) samples at indicated optical densities. fSa3ms does not show a significant 
difference in phage copy number from OD600 = 0.35 to 1.0, whereas fSa4ms copy 




The data above indicated fSa4ms was likely an active lysogenic phage, with the 
abundance of circular phage genomes not appearing to be a precursor to lytic cycle 
replication. The prevalence of fSa4ms’s stable excision however was unclear (i.e., 
the percentage of cells with excised “active lysogenic” fSa4ms). We employed qPCR 
using the naturally occurring circular plasmid pSAS1 to understand the level of 
enrichment imparted by our exDNA preparation protocol. We found that pSAS1 
existed on average at 1-2 copies per cell (copies pSAS1 target/copy gyrA) in gDNA 
preparations of MSSA476 at OD600 = 0.35 and 0.7, but that the plasmid was 
enriched 1500-fold to an average of 2322 copies pSAS1/copy gyrA in exDNA. That 
fSa4ms copy number in our qPCR assay reaches, at a maximum, 2.22 copies 
attP/copy gyrA (Table 3-5), suggests that the fSa4ms excision we uncover is a rare 
event. The percentage of cells with stably excised fSa4ms, as well as its copy 
number per cell, is presently unclear. 
3.8 Promoter alteration by fSa4ms excision/integration affects htrA2
transcription and heat-stress survival in S. aureus 
Since fSa4ms could act as an active lysogenic phage, a stable subpopulation of 
MSSA476 cells may exist with an altered important chromosomal sequence, since 
fSa4ms integrates 30 bp upstream of the stress response serine protease-encoding 
gene htrA2. Sumby and Waldor previously noted the possibility of altered htrA2 
transcription by fSa4ms excision/integration (Sumby and Waldor, 2003), and our 
data suggested that indeed a subpopulation of MSSA476 cells would harbor htrA2
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under an altered promoter (Figure 3-10a). We developed a PhtrA2-gfp reporter 
system to examine whether GFP fluorescence would be altered when the GFP-
encoding gene gfpmut2 was under the control of the fSa4ms-integrated (Pint) or 
fSa4ms-excised (Pex) promoters. Experiments were performed in S. aureus RN6390 
and COL htrA2 deletion knockouts, two well-characterized strains where htrA2 was 
shown to impact COL but not RN6390 survival in heat-stress (Rigoulay et al., 
2005). Comparisons of GFP fluorescence at 37°C and 44°C showed that in both 
strains, fluorescence was greater when gfpmut2 was promoted by Pex than by Pint, 
indicating that Pex is a stronger promoter of htrA2 than Pint. GFP fluorescence was 
greater in Pex constructs at both 37°C and 44°C at 3 and 6-hour time points (Figure 
3-10b).  
Due to its reported role in promoting heat-tolerance in COL, we examined if 
promoter alteration could affect survival of htrA2-complemented S. aureus RN6390 
and COL htrA2 knockouts. Complemented strains contained the full-length htrA2
gene under the control of the Pint or Pex promoter on the pCN35 plasmid or were 
left uncomplemented with empty pCN35 and grown in a dilution series at 37°C or 
44°C on agar plates. COL constructs at 37°C did not display any survival 
differences among the three strains, however at 44°C, COL Pex displayed 
approximately 2-log increased survival over COL Pint (Figure 3-10c, top). 
Surprisingly, COL Pint survived 1-log worse than uncomplemented COL htrA2, 
indicating that htrA2-mediated heat-stress survival may depend upon specific 
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promoter sequences and not solely levels of transcription or promoter strength. 
RN6390 constructs showed no survival differences at 37°C or 44°C, in accordance 
with previous reports of HtrA2 activity in the strain (Rigoulay et al., 2005) (Figure 
3-10c, bottom). Environmental conditions may select for cells with one promoter 
versus another, and fSa4ms’s excision/integration dynamics and active lysogeny 
could provide MSSA476 with a potential switching mechanism to create these 
advantageous subpopulations. 
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Figure 3-10. fSa4ms excision/integration alters the promoter and 
transcription of htrA2. A) Diagram illustrating fSa4ms integrated and excised 
states in MSSA476 and the unique DNA regions of the Pint and Pex promoters. 
(Top) When fSa4ms is integrated in the chromosome, htrA2 is promoted by Pint. 
(Bottom) fSa4ms excision joins the Pex region immediately upstream to htrA2, and 
the gene is promoted by Pex. Pint unique DNA sequence is carried on circular 
fSa4ms when the phage is excised. B) Ratio of GFP fluorescence from Pex- versus 
Pint-promoted gfpmut2 constructs in COL and RN6390 htrA2 strains. Bars above 
the dashed line indicate samples where GFP fluorescence is greater with Pex-
promoted gfpmut2 than with Pint-promoted gfpmut2. C) Dilution series of COL and 
RN6390 htrA2 knockout strains complemented with htrA2 promoted by Pint (int) or 
Pex (ex). (-) indicates COL or RN6390 htrA2 knockout strains containing empty 
pCN35 plasmid. COL (top) or RN6390 (bottom) constructs are spotted in a log-
dilution series and grown at 37°C or 44°C for 24 hrs. Dilution factor indicated on 
left of plates; (ND) = not diluted. COL constructs display equal survival at 37°C, but 
COL Pex displays 2-log survival above COL Pint. Unexpectedly, uncomplemented 
COL htrA2 shows 1-log survival above COL Pint. COL Pint shows few colonies at 
44°C in the undiluted culture spot.  RN6390 displays no survival difference among 


























This study described in this Chapter explores the prevalence of extra-chromosomal 
prophages in S. aureus as an extension of previous work uncovering the plasmidial 
phage fBU01 in S. aureus NRS19 (Utter et al., 2014). We isolated and sequenced 
the exDNA of 15 clinically-relevant S. aureus strains with known chromosomal 
sequences, but unlike our previous study, we did not find any prophages existing as 
solely plasmidial elements. We did uncover however, several episomal prophages 
appearing to exist as active lysogenic phages. It therefore seems that the existence 
of plasmidial prophage in S. aureus is uncommon and fBU01 may represent one of 
these rare prophages. Episomal prophages, on the other hand, appear to be fairly 
widespread and were identified in 33% of S. aureus strains (5 of 15) examined in 
this study.  
3.9 Strains and phages possess different mobilization capacities 
We distinguished strains that carried episomal prophage from those with no 
prophage detected in the extra-chromosomal compartment, but our study did not 
reveal why some strains have such a phage-mobilization capacity while others do 
not. Goerke et al. demonstrated a similar observation, finding that phages fs80b 
and fs84b (hlb-converting phages) were integrated within the hlb gene in S. aureus 
s64c, but were found to alternate between integrated and extra-chromosomal 
carriage in strain 8325-4 (Goerke et al., 2006). Both s64c and 8325-4 are phage-
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cured strains, suggesting that a host-factor (or factors) is likely determining phage 
localization and mobilization capacity within the cell. In a separate manner, phage 
induction capacity into the lytic cycle has also been observed to depend upon host 
background, with fSa2mw induced by mitomycin C in strains MW2 and Newman, 
but not 8325-4, RN6390 or ISP479c (Wirtz et al., 2009). We believe that the phages 
we describe here are localized and harbored within the extra-chromosomal 
compartment in a manner distinct from lytic excision and replication (Deutsch et 
al., 2016; Utter et al., 2014), however it is possible similar host factors may govern 
both events. The hlb-converting phages we characterized from strains BAA-42, 
MSSA476 and HPV107 contained high sequence homology over their 
integration/excision modules, however they displayed different levels of enrichment 
in extra-chromosomal sequencing and qPCR characterization, with HPV107 
carrying its hlb-converting phage extra-chromosomally in a greater proportion of 
the population. Host differences similar to those affecting fs80b and fs84b 
localization may account for the differences in hlb-converting phage localization 
among our three strains, however such factors have yet to be uncovered. 
Within individual strains, we also noted differences in phage localization. In 
MSSA476, fSa4ms—but not fSa3ms—was enriched in sequencing, with the 
localization of circular prophage confirmed by qPCR and selective-depletion 
experiments. fSa3ms and fSa4ms share the same host background, indicating that 
a phage factor is responsible for localization differences, but it is currently unclear 
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which factor(s) may be responsible. Prophage excision requires recombination 
mediated by integrase; stochastic higher expression of a phage’s integrase or 
excision-related genes may be one mechanism by which phage localize into the 
extra-chromosomal compartment. The process may also be controlled by as of yet 
uncharacterized factors in a more regulated process. If excision occurs without 
inducing conditions, then phages could be localized into the cytoplasm in a manner 
consistent with the lysogenic cycle. Feiner et al. reviewed such phage activity in a 
range of bacterial species, particularly those whose excision/integration dynamics 
can act as a molecular switch for the cell, terming the process “active lysogeny” 
(Feiner et al., 2015). 
The mechanisms behind differences in mobilization capacity among strains and the 
phages themselves are presently unclear, however an approach using a transposon 
or gene-knockout screening, coupled with a reporter system, may be able to 
elucidate such factors. Screening candidates for increased phage mobilization by 
PCR is too exhaustive a task, but a reporter system in which a visual phenotype is 
apparent with phage excision could facilitate such a screening. For example, a 
reporter gene (gfpmut2, xylE) could be fused to hlb, geh or another relevant phage 
integration site such that a phenotype is apparent when phages are excised, but 
absent with phage integration. Increases in fluorescence or pigmentation of colonies 
could indicate candidate genes that contribute to phage stabilization in the 
chromosome. In parallel, a screening in which potential factors are overexpressed 
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on a plasmid in the same reporter system could identify gene activity necessary for 
the phage excision detected. Outside of screening, candidate genes could also be 
identified between strains in which the same phage shows differential mobilization, 
e.g. S. aureus s64c and 8325-4. Such differences between the strains may attributed 
to changes in gene expression rather than sequence however, and could complicate 
such an approach. Regardless, research focused on uncovering such factors will be 
important in understanding the behavior of various strains versus others and 
contribute to our understanding of the interplay between bacteria and phage. Their 
presence would suggest a mechanism by which bacteria use phage to increase their 
diversity and create new subpopulations, capable of altered gene expression, 
virulence, and/or fitness. 
3.10 Episomal prophage are detected only in extra-chromosomally 
enriched DNA samples, and are circular DNA elements that appear to be 
active lysogenic prophages 
QPCR characterization of prophage excision rates and copy numbers revealed, 
surprisingly, that episomal prophages are detected only in exDNA samples and that 
their presence is masked in gDNA preparations. In MSSA476 for example, overall 
excised prophage copy numbers as measured from qPCRs of gDNA is relatively low, 
with fSa3ms and fSa4ms at 0.086 and 0.023 copies attP/copy gyrA, respectively. 
This would correspond to very low increases in read-depth over the fSa3ms and 
fSa4ms prophage chromosomal locations if MSSA476 gDNA was sequenced and 
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read-mapped to a MSSA476 reference chromosome (likely 8.6 and 2.3% maximum 
increases, respectively). Using gDNA, coverage analysis tools would likely not find 
regions of significantly higher coverage spanning either prophage genome, so while 
fSa3ms copy number was greater than fSa4ms in gDNA samples, neither prophage 
would be found as enriched by this approach, and the episomal nature of fSa4ms 
would be overlooked. fSa4ms excised prophage copy number in exDNA samples 
however is much greater (0.622 copies attP/copy gyrA), and is sufficient for 
significantly high read-depth across the prophage location in the chromosome. The 
excised copy number of fSa3ms in exDNA samples, while elevated from that seen in 
gDNA samples (0.146 versus 0.086 copies attP/copy gyrA, respectively), was not 
high enough to have significantly higher read-depth or coverage over the fSa3ms 
genome in read-mappings. Thus, our exDNA isolation and sequencing approach 
allows the distinction of episomal elements, even when such elements would be 
masked in qPCR and sequencing of DNA prepared by other methods.   
We showed that our extra-chromosomal DNA isolation procedure enriches circular 
DNA elements, allowing the identification of episomes and plasmids, and that 
whole-genome approaches do not impart such selectivity in sample preparations. 
Why fSa4ms copy number was lower than that of fSa3ms in gDNA despite the 
presence of fSa4ms episomes, we believe, is likely due to the presence of linear, lytic 
cycle prophage genome concatemers in the MSSA476 population. pSAS1 plasmid 
enrichment by our protocol was approximately 1500-fold, suggesting that in qPCRs 
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of gDNA, the percentage of total attP targets encoded by circular prophage is very 
low. The copy number of linear prophage concatemers in gDNA samples therefore 
likely masks the presence of circular phage elements, making it doubtful that the 
DNA elements we uncover would be detected by sequencing or qPCR in the absence 
of extra-chromosomal DNA enrichment. That the excised prophage copy number of 
fSa3ms and fSa4ms is so low in exDNA samples despite ~1500-fold enrichment for 
pSAS1 suggests that for MSSA476, both fSa3ms and fSa4ms excised prophage copy 
number is primarily composed of linear elements, likely from a small subset of cells 
whose phages are undergoing spontaneous lytic cycle replication. While both phages 
in MSSA476 are capable of such lytic events, only fSa4ms showed enrichment for 
circular prophage in its cytoplasm, suggesting fSa4ms’s circular prophage is not 
participating in the lytic cycle, but is perhaps in a state akin to active lysogeny 
(Feiner et al., 2015). We also note that samples for sequencing were prepared in 
nutrient-rich conditions at mid-logarithmic phase, conditions unlikely to promote 
DNA damage and associated prophage lytic induction (Nanda et al., 2015). A model 
for how the MSSA476 population might exist in early logarithmic phase is 
presented in Figure 3-11. 
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Figure 3-11. Qualitative model of MSSA476 early logarithmic culture. At 
early log phase, MSSA476 culture contains cells with prophage in both the lytic and 
lysogenic cycles. The vast majority of cells are stably lysogenized (tan) with fSa3ms 
(blue) and fSa4ms (orange). A subpopulation of cells contains excised prophage 
elements that appear to be in an active lysogenic cycle (green). Of these cells, those 
with fSa4ms excised outnumber those with fSa3ms excised. Cells with phage 
induced into the lytic cycle are pictured in gray. Here, fSa3ms-induced cells 
outnumber fSa4ms-induced cells. Subpopulations are shown at relative percentages 
for illustrative purposes, rather than the quantitative levels suggested by qPCR and 





Cell without induced phage
Cell with excised, active lysogenic phage
Cell with induced phage
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However, to further rule out the presence of circular prophage as a precursor to lytic 
cycle replication, we examined MSSA476 samples by qPCR over a range of time 
points. Surprisingly, the results revealed that excision of circular prophage into the 
extra-chromosomal compartment is temporal, with the highest levels of circular 
fSa4ms in early logarithmic growth but rapidly decreasing with increased cell-
density. This decrease occurred without any concurrent increase in overall fSa4ms 
copy number, showing that fSa4ms circular elements were not precursors to phage-
replication and are likely not participating in the lytic cycle, but rather are in an 
active lysogenic state. The data also indicates potential control of this event by the 
bacterial cell, with some factors either promoting excision at early log growth, or 
perhaps increased re-integration at later growth points. In addition, these data 
show that phage enrichment would likely go undetected in MSSA476 if samples 
were prepared at OD600 ³ 1.0. Therefore, it may be beneficial to purify extra-
chromosomal DNA at multiple time points in future studies, elucidating the entire 
mobilization dynamics of a bacterial genome over its growth cycle. 
The time-course qPCR data also showed that the excision rate of fSa4ms decreased 
from early to later log phase, suggesting some circular fSa4ms may be re-
integrating into the chromosome after excision. In addition, whether fSa4ms or 
related circular prophage elements undergo any replication or remain as single copy 
in this excised state is unclear. A previous study reported Hlb–/sak2 S. aureus 
strains with multiple hlb-converting phages integrated in the chromosome (Goerke 
	164 
et al., 2006). Replication of excised lysogenic prophage could be the first step in 
generating such strains. Our qPCR approach examined bacterial populations as a 
whole, but cannot address these specific questions; further experiments on the 
single-cell level are necessary to uncover such exact excision/integration (and 
potentially replication) dynamics. One potential method to address this question is 
through fluorescence microscopy with fluorophores attaching specifically to modified 
phage genomes. Reporter systems have been previously developed to track P22 
phage localization and replication in live cells (Cenens et al., 2015) and a similar 
approach could be used in S. aureus to look at phage replication and determine if it 
occurs in a lytic or lysogenic manner (i.e. the degree of replication and whether cells 
survive after phage genome replication). A complicating factor here is that it 
appears in MSSA476 and likely other strains of S. aureus, prophages can be in the 
lysogenic cycle in integrated and excised states and it is unclear if such systems can 
distinguish these cell types. Additional co-localizing labels specific to the bacterial 
chromosome may be necessary to help determine if for lysogenic cells, phage are 
integrated or excised. Nonetheless, such a system should be able to help uncover the 
dynamics and some of the questions about the phage we uncover by extra-
chromosomal DNA isolation and sequencing.  
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3.11 What is the biological significance of episomal phage? 
The phages we describe as enriched in our sequencing appear to be active lysogenic 
phage that have excised from the chromosome, and the distinction between phages 
in the lytic versus lysogenic or active lysogenic cycle is important when considering 
the roles of prophage as molecular switches or mechanisms to generate diversity in 
bacterial populations. Excision by phage induction leads likely to cell death, 
whereas excision of (active) lysogenic phage will generate stable diversity in the 
population that can be passed on to daughter cells. While under our conditions the 
percentage of excised phage is relatively low, other external environments could 
select for and expand certain prophage-excised subpopulations. For example, 
fSa4ms was shown to alter the htrA2 promoter, with the phage-excised (Pex) 
promoter conferring increased heat-tolerance in COL. It is presently unclear if 
HtrA2 confers this tolerance in MSSA476, however if the protein plays a similar role 
as in COL, then qPCRs of phage excision rates and excised prophage copy number 
in cultures grown at elevated temperatures may show increased proportions of cells 
with excised (or lost) fSa4ms. Such growth could either select for survival of already 
fSa4ms-excised cells, or could drive fSa4ms lysogenic excision by an unknown 
mechanism. In either case, the overall percentage of cells with excised fSa4ms 
prophage would increase.  
In other strains, the external environment could also drive the expansion of 
subpopulations with excised prophage. In HPV107 for example, a subpopulation 
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containing excised hlb-converting prophage might expand in infection conditions 
(i.e., serum culture or low-iron environments). Goerke et al. found that hlb-
converting prophages moved to atypical chromosomal locations allowing Hlb 
production in invasive disease isolates; localization of typically integrated lysogenic 
prophage into the cytoplasm (without induction) could precede generation of such 
unique S. aureus isolates (Goerke et al., 2006), or alternatively, prophage harbored 
in the cytoplasm without reintegration could achieve the same phenotype. The 
extra-chromosomal DNA enrichment and sequencing approach described here may 
allow characterization of strains for such a mobilization capacity or potential. Other 
phages such as those that negatively convert geh could excise under conditions 
selecting for lipase activity as well. 
A clear question that follows from the research described in this Chapter is the 
biological role of phage mobilization. Two approaches may help drive at the answer 
for this question. One approach would be to grow cultures in a variety of conditions 
(e.g., BHI or serum culture, starvation or nutrient-rich conditions, or other relevant 
culture environments) and compare the extra-chromosomal DNA profiles of each 
sample. Comparison may show the favored excision of phage in one condition over 
another and suggest biological roles and help formulate better hypotheses of how 
specific phage may promote increased bacterial fitness. We did a “retroactive” extra-
chromosomal sequencing of S. pyogenes SF370 at mid-logarithmic phase, which 
indeed showed the expected enrichment of episomal SpyCIM1, the phage-like 
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element acting as a switch in the strain’s mismatch repair operon (Deutsch et al., 
2016).  Follow-up experiments examining exDNA of S. pyogenes SF370 in nutrient-
rich versus nutrient-deficient conditions should show the enrichment of SpyCIM1 in 
rich rather than nutrient-poor conditions and could serve as a test case for extra-
chromosomal DNA isolation and sequencing in a variety of environments. While the 
biological role of SpyCIM1 is already partially known (Hendrickson et al., 2015; 
Nguyen and McShan, 2014), without this information, extra-chromosomal DNA 
isolation and sequencing alone could offer promising potential avenues of research, 
i.e., exDNA sequencing of SF370 suggests SpyCIM1’s biological role without 
knowledge of prior reports. While the same conclusions can be drawn from qPCR-
based experiments, given the relative ease and low-cost of sequencing, profiling 
bacterial extra-chromosomal compartments in this manner will allow for multiple 
target identification and less bias in uncovering elements.   
A more direct approach to uncover the biological role of such phage excision would 
be to prevent it outright by creation of phage integrase knockouts. As previously 
described, the movement of hlb-converting prophage in S. aureus to atypical 
chromosomal loci has been shown to occur in isolates from cystic fibrosis and 
bacteremic patients, with phage mobilization thought to be important for infection 
(Goerke et al., 2006). An informative experiment could compare the virulence and 
dissemination of S. aureus harboring hlb-converting phage that can freely 
excise/integrate (WT), versus those that that are “locked into” the chromosome 
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(Dint), or are phage-cured. Here, the comparison of wild-type, Dint, and phage-cured 
strains should help elucidate both the role of the phage as a whole, as well as the 
specific benefits of phage excision/integration. Given that phage mobilization plays 
a key role in the transition from colonization to invasive infection, strains with 
locked-in phage may show a decreased virulence potential. However, negative 
conversion may allow for strains to better colonize in the first place, serving as a 
mechanism for the organism to “get a foot in the door”, or in this case, the nose. 
(Isolates harboring hlb-converting phage are overwhelmingly represented in the 
nasal cavity, but have not been found essential for colonization (Verkaik et al., 
2011).) If this is the case, then phage-cured strains should show decreased initial 
colonization and may be outcompeted by other strains or species. In addition, as the 
virulence factors typically carried on hlb-converting phages were shown important 
for infection (Bae et al., 2006), phage-cured strains may have weaker virulence 
potential. Thus, the most virulent strain of S. aureus may be the one containing an 
hlb-converting prophage capable of atypical localization, allowing colonization of the 
nose via phage gene products, and successful infection by concurrent production of 
Hlb and phage-encoded virulence factors. An illustration of the potential benefits of 
harboring mobilizing phage is shown in Figure 3-12. Comparison of these three 
strain types (WT, Dint, and Dfhlb-c) should illustrate some of the key biological 
roles of active lysogenic phage in the S. aureus lifecycle.  
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Figure 3-12. Mobilizing phage can generate diverse subpopulations of S. 
aureus. An illustration of a hypothetical experiment is shown above. Here, a S. 
aureus strain is lysogenized with a hlb-converting phage that can freely excise from 
and reintegrate into the chromosome (WT). Variants of the strain include an 
integrase knockout where the phage is “locked” in the chromosome (Dint), and a 
phage-cured derivative (Dfhlb-c). The WT strain can generate numerous 
phenotypically- and genotypically-altered subpopulations (I-IV) via phage 
mobilization. The external environment may select for the expansion of one or 
multiple subpopulations. For Dint and Dfhlb-c, the lack of phage mobilization and 
phage, respectively, prevents diversity in their populations. Dint can only exist as 
population I, and Dfhlb-c as population IV. WT can reversibly switch between I, II 
and III, and irreversibly lose its phage, creating population IV. Comparison among 
the three strains for colonization, virulence, and other phenotypes (e.g. biofilm 
formation capacity) could illustrate the importance of phage mobilization in S. 
aureus, and phage as a potential switch allowing the bacteria to alter its phenotypes 
for success in multiple environments. 
WT (Hlb–, SAK+, 
SCIN+, SEA+, CHIPS+)
hlb
I. Hlb–, SAK+, SCIN+, 
SEA+, CHIPS+
II. Hlb+, SAK+, SCIN+, 
SEA+, CHIPS+
III. Hlb+, SAK+, SCIN+, 
SEA+, CHIPS+
IV. Hlb+, SAK–, SCIN–, 
SEA–, CHIPS–
Phage-driven diversity






∆int (Hlb–, SAK+, 
SCIN+, SEA+, CHIPS+)




In a related but converse manner, one study found S. aureus colonization of mouse 
ears was actually enhanced with Hlb production. In this report, the hlb-converting 
phage of S. aureus MW2 (fSa3mw) was frequently lost upon murine ear 
colonization, and a bacterially-controlled phage-switch to alter the organism’s 
infection program was suggested by the Authors (Katayama et al., 2013). Here, in 
contrast to typical observations in human isolates, fSa3mw was preferentially lost 
in mouse ear colonization. It is unclear why the loss of fSa3mw is preferred for 
mouse colonization while strains harboring hlb-converting phage are nearly always 
found in human nares, but it is known that the virulence factors encoded by 
fSa3mw are more human-specific (Katayama et al., 2013). Phage-loss in this case 
may be selected for due to the murine host, whereas in humans, the importance of 
such phage-encoded factors may select for strains harboring hlb-converting phage. 
In addition, this study did not examine the propensity of such strains to cause 
invasive infection; fSa3mw-cured strains may show weaker virulence potential and 
be selected against in such an experiment or environment. Regardless, for S. 
aureus, carrying lysogenic phage capable of excision without induction may allow 
the bacteria to successfully balance the needs of colonization and infection, which 
demand different sets of virulence factors.  
The research detailed in this Chapter uncovered potential active lysogenic phage 
that could modulate the expression of htrA2 (fSa4ms), and allow the full-length 
transcription of hlb (fHPV107.1) by excision from the chromosome. In addition to 
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these phage, this work also uncovered an intergenic prophage in HPV107 (unclear 
integrase type, intergenic between tRNA-Ser and enterotoxin), and 2 intergenic 
prophages in NRS22 and BK2529 (both with Sa7-like integrases, and intergenic 
between rpmF (50S ribosomal protein L32) and isdB (iron-regulated surface 
determinant)). The potential effects of their extra-chromosomal carriage on hosts 
are unclear, and phage integration in these loci has been previously reported (Bae 
et al., 2006; Goerke et al., 2006). Excluding fHPV107.1, the typically-intragenic 
phages we found enriched in our screening included a geh-converting prophage in S. 
aureus NRS143, a 6-phospho-b-galactosidase-integrating prophage in HPV107, and 
2 prophages in NRS22 (one prophage integrated within a hypothetical protein-
encoding gene, and one prophage disrupting a radical SAM-encoding gene). In 
addition, we uncovered an enriched integrative and conjugative element (ICE) 
typically located within a predicted membrane protein encoding locus in NRS271. 
Lipase has been implicated in biofilm and abscess formation in S. aureus (Hu et al., 
2012; Jabra-Rizk et al., 2006; Kuroda et al., 2007), however some clinical strains 
carry geh-converting phages without a clear mechanistic advantage. If some geh-
converting phages are acting as switches to control the expression of lipase for the 
bacteria’s benefit, then advantages to such prophage carriage would be apparent, 
and future work should investigate this possibility. The effects of the other 
intragenic phages are unclear, however their enrichment suggests that they could 
act as switches to also control underlying gene expression. Disruption of genes by 
the intragenic phages in NRS22 has been reported previously in other S. aureus 
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strains (Bae et al., 2006), however to our knowledge, disruption of a 6-phospho-b-
galactosidase encoding gene (HPV107) has not been previously reported and 
represents a novel phage integration site in S. aureus. The role of the uncovered 
ICE is also unclear, but its potential as a DNA-level switch is intriguing. Overall, 
exDNA isolation and sequencing revealed the episomal nature of specific typically-
integrated staphylococcal prophages. The reports of virulence program alteration by 
mobilizing hlb-converting phages suggests that the DNA elements uncovered by our 
extra-chromosomal DNA isolation and sequencing approach may act as diversity 
promoting elements in S. aureus. The prevalence and number of prophage elements 
uncovered in this screening suggests their widespread use and importance to the 




This study screened the extra-chromosomal DNA of 15 clinical S. aureus isolates, 
uncovering the prevalence of episomal prophage with potential roles in virulence 
factor expression and regulation. QPCR characterization of one of these strains, 
MSSA476, verified that one of its phage, fSa4ms, exhibits episomal behavior, and 
may exist as an active lysogenic prophage. We show that episomal fSa4ms exists as 
a circular DNA element off the chromosome, and that it does not appear to be a 
precursor to lytic cycle replication. Importantly, the episomal prophage we uncover 
are only detectable in extra-chromosomally enriched DNA samples, and their 
presence would have been missed in sequencing or qPCRs of whole-genome DNA 
samples. Lastly, this work finds that fSa4ms appears to act as a phage-molecular 
switch, as its excision/integration alters the promoter sequence of htrA2, changing 
its transcription levels and affecting heat-stress survival in S. aureus COL. fSa4ms 
behavior suggests it is an active lysogenic prophage, and the other episomal 
prophages identified may exhibit similar activity, given their integration sites. 
Episomal lysogenic prophage, or active lysogenic phage, promote the generation of 
stable, diverse subpopulations with impacts on bacterial infection; extra-
chromosomal DNA isolation and sequencing should allow the increased discovery of 
such elements in S. aureus and other bacterial pathogens. 
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MATERIALS AND METHODS 
3.12 Bacterial strains and growth conditions 
Strains and constructs used in this study are listed in Table 3-6. For preparation of 
extra-chromosomal DNA, S. aureus strains were established from overnight 
cultures grown in Bacto Brain Heart Infusion Broth (BHI), and back-diluted 1:100 
into 50 mL BHI without shaking at 37°C unless otherwise noted. Strains were 
grown to an OD600 of 0.6 - 0.8. Cultures were centrifuged at 4000 RPM for 10 
minutes at 4°C and used immediately or frozen overnight at -20°C. For qPCR 
studies, strains were back-diluted from overnight cultures and grown to specified 
optical densities. For PhtrA2-GFP reporter studies, overnight cultures were back-
diluted 1:100 in 15 mL BHI and grown at 200 RPM at 37°C to an OD600 = 0.2. E. coli 
was grown at 37°C, 200 RPM in LB media with selection as necessary. 
Concentrations for antibiotics used are as follows, for Escherichia coli: ampicillin, 
100 µg/mL; for S. aureus: erythromycin, 5 µg/mL, spectinomycin, 50 µg/mL. For 
heat shock studies, plates were grown at 44°C.  
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Table 3-6. Bacterial strains and constructs used in this study. 
Strains Notes Source 
E. coli 
E. coli TOP10 Cloning host Invitrogen 
E. coli DC10B Cloning host Lab strain 
E. coli 
DH5⍺::pCN35 
Strain containing pCN35 
plasmid 






(Charpentier et al., 
2004) 
S. aureus 
RN4220 Restriction deficient 
cloning host 
(Kreiswirth et al., 1983) 
RN6390 
htrA2 
RN6390, htrA2::spc SpcR (Rigoulay et al., 2005) 
RN6390 
htrA2 DD01 





RN6390, htrA2::spc SpcR, 
harboring pCN35 with full 





RN6390, htrA2::spc SpcR, 
harboring pCN35 with full 










RN6390, htrA2::spc SpcR, 





RN6390, htrA2::spc SpcR, 
harboring pCN56 with 
phtrA2-ex insert, ErmR
This work 









COL, htrA2::spc SpcR, 
harboring pCN35 with full 





COL, htrA2::spc SpcR, 
harboring pCN35 with full 










COL, htrA2::spc SpcR, 





COL, htrA2::spc SpcR, 




Accessions for read-mapping 
BAA-42 MRSA ATCC JXZF00000000 
MSSA476 MSSA; Hyper-virulent, 
community acquired 
ATCC JXZG00000000 
NRS156 MSSA; vaginal tampon 
isolate 
NARSA JXZU00000000 
NRS271 MRSA; Linezolid-resistant, 
wound isolate 
NARSA JXZW00000000 
NRS153 MRSA NARSA JXZY00000000 
NRS127 MRSA; sputum source 
from Tenn., oxacillin, 
penicillin, ciprofloxacin 
and erythromycin resistant 
NARSA JXZZ00000000 
NRS387 MRSA; wound Washington 
State 
NARSA JYAD00000000 




NRS143 MSSA NARSA JYAH00000000 
NRS158 MSSA; HT 2000 0319; 
Strain was isolated from 
skin infection in France 
NARSA JYAN00000000 
NRS2 MRSA; Mu3; ATCC 
700698; Purulent sputum, 
cardio thoracic surgery, 
Japan; Oxacillin and Tet 
resistant; VISA= MIC=4; 
white colonies, robust 
growth on BHI 
NARSA JYAO00000000 
E2125 MRSA; Denmark; 
SCCmec1; 1964 
VAF JYAX00000000 
HPV107 MRSA; Portugal; 
SCCmec1a, 1992 
VAF JYAY00000000 




BK2529 MRSA; USA; SCCmecIV; 
1996 
VAF JYBA00000000 
ATCC = American Type Culture Collection 
NARSA = Network on Antimicrobial Resistance in Staphylococcus Aureus 
VAF = Vincent A. Fischetti 
3.13 Whole-genome and extra-chromosomal DNA isolation and 
manipulation  
Whole genome DNA isolations (gDNA) were performed using the QIAGEN DNeasy 
Blood and Tissue Kit, including an added manufacturer-detailed pretreatment step 
for Gram-positive bacteria. Enzymatic lysis buffer was composed of lysostaphin (100 
µg/mL) in 1X phosphate-buffered saline (PBS). Extra-chromosomal DNA isolation 
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was carried out as previously described (Utter et al., 2014).  Extra-chromosomal 
DNA samples were visualized on 0.7% agarose 0.5X TAE gels stained with SYBR 
Safe DNA Gel Stain. Electrophoresis was carried out at 50 V for 1 hr in 0.5X TAE, 
and visualized with UV transillumination. Prior to DNA sequencing, extra-
chromosomal DNA samples were concentrated as needed using Microcon DNA Fast 
Flow centrifugal filters, following manufacturer’s directions (EMD Millipore). 
3.14 DNA sequencing of extra-chromosomal S. aureus samples 
DNA sequencing of extra-chromosomal DNA samples was performed using the 
Illumina MiSeq sequencer. Extra-chromosomal DNA was quality checked prior to 
library construction and sequencing using the Thermo Fisher Scientific Qubit 
Fluorometer High Sensitivity DNA kit to measure quantity of DNA and the Agilent 
Technologies High Sensitivity DNA assay to measure size and quality of DNA.  
DNA libraries were constructed as per manufacturer’s instructions from 1 ng DNA 
per sample using the Illumina Nextera XT DNA Library Preparation kit. Each DNA 
library was barcoded to allow for multiplexing during sequencing using the 
Illumina Nextera XT Index kit. Libraries were quantitated and quality checked 
using Agilent Technologies High Sensitivity DNA kit. Libraries were sequenced 
using the Illumina MiSeq Reagent kit V2 (500 cycle). Prior to sequencing, libraries 
were normalized and pooled together to make a pooled amplicon library at 2 nM 
concentration. Sequencing generated FASTQ files to allow for off-instrument 
analysis.  
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3.15 Bioinformatic sequence analysis of extra-chromosomal DNA samples 
Bioinformatic analysis was performed using CLC Genomics Workbench software 
unless otherwise described. Extra-chromosomal reads were mapped to respective 
chromosomal sequences (Table 3-6), and unmapped reads were saved as a separate 
file and de novo assembled for plasmidial elements. Read-mappings were visually 
examined for regions of increased read-depth corresponding to DNA element 
enrichment in extra-chromosomal DNA samples. Read-mappings were then 
subjected to coverage analysis to identify regions with significantly higher (P < 0.05) 
coverage. Prophage and other mobile DNA element regions with high coverage were 
noted for each sequenced sample. 
3.16 QPCR analysis of S. aureus strains 
For qPCR experiments, strains were grown as described for extra-chromosomal 
DNA sequenced samples, or to other desired optical densities. Cultures were 
divided, with one portion of the culture subjected to the QIAGEN DNeasy Blood and 
Tissue Kit for gDNA isolation, and the rest undergoing extra-chromosomal DNA 
isolation. gDNA samples were used to determine excision rates and phage or 
plasmid copy number per cell of the bacterial population, while exDNA samples 
were used only for phage and plasmid copy number measurements. Primer pairs 
and probe sequences for each target are listed on Table 3-7. All primers and probes 
were designed and purchased from Integrated DNA Technologies (Coralville, IA). 
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Amplification was carried out using the TaqMan Gene Expression Master Mix 
(Thermo Fisher) using the Life Technologies QuantStudio 12K-Flex Instrument 
following manufacturer’s cycling protocol. Standard curves for each primer-probe 
set were generated for each experimental run, with amplification efficiencies and 
linear regression analyzed using QuantStudio Software. All primer-probe sets had 
efficiencies 90-110% and R2 > 0.98. Excision rates, excised prophage copy numbers, 
and plasmid copy numbers were calculated by normalizing target (attB, attP, 
pSAS1, respectively) to gyrA. All targets were measured in biological triplicate and 
technical duplicate. Graphical and statistical analysis was performed using Prism 
GraphPad with significance testing done using two-tailed Student’s t-tests. Values 
are reported as mean ± standard error.  
3.17 Linear DNase and restriction endonuclease treatment of extra-
chromosomal DNA samples and end-point PCR of DNA targets 
Prior to linear DNase and/or treatment with restriction endonucleases, extra-
chromosomal DNA samples were treated with PreCR Repair Mix (NEB) to repair 
nicked DNA. PreCR-treated samples were then either 1) treated with PshAI and 
PspXI (NEB) following manufacturer’s protocol, 2) treated with Plasmid-Safe-ATP-
Dependent DNase (Epicentre), 3) treated with the fSa4ms-specific restriction 
endonucleases PshAI and PspXI, then the Plasmid-Safe-ATP-Dependent DNase, or 
4) left solely PreCR-treated. Plasmid-Safe treated samples were treated over the
course of 16 hours, where 2 µL ATP solution and 2 µL DNase were added at 2 and 4 
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hour time points, with the reaction incubated at 37°C. Samples were heated to 
inactivate enzyme prior to PCR. End-point PCR was carried out using target-
specific primers (Table 3-7) and the KAPA2G Robust Hotstart Polymerase (KAPA 
Biosystems) with the following cycling protocol: 1) Initial denaturation 95°C, 3 min; 
2) Denaturation 95°C, 15s; 3) Annealing 60°C, 15s; 4) Extension 72°C, 15s; 5)
Repeat steps 2-4 33 times. Samples were normalized for total DNA prior to loading 
individual PCR reactions. PCR products were visualized using 1% agarose 0.5X 
TAE gels stained with SYBR Safe DNA Gel Stain. Electrophoresis was carried out 
at 100 V for 25 min in 0.5X TAE, and visualized with UV transillumination. Images 
were captured using Alpha Imager HP software. 
Table 3-7. Primers and probes used in this study. 
Primers Sequence Notes 
qPCR/end-point 
PCR primers 
gyrA_F CGTGAAGGTGACGAAGTTGT For per cell 
normalization 
gyrA_probe TGTTTGCATGAGCTACATCAAGCCC 5' 6-FAM/ZEN/3' 
IBFQ 
gyrA_R CCTTTACCACCACGATTTGA For per cell 
normalization 
phihlb_attB_F ACGTTTATATGTTATCGACCGT for excision rates 
of hlb-converting 
prophage 
phihlb_attB_probe ACGCGCTGATTTAATCGGACAATCTTCT 5' 6-FAM/ZEN/3' 
IBFQ 
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phihlb_attB_R TTGTCTGATGCACCATTATCA for excision rates 
of hlb-converting 
prophage 
phiSa4ms_attB_F GACGCTTACGTCGGTACT for phiSa4ms 
excision rates 
phiSa4ms_attB_probe ACCAATATCCACTAATGTCCACTCCATTCA 5' 6-FAM/ZEN/3' 
IBFQ 
phiSa4ms_attB_R TTGATGTGAAGCGGACAATC for phiSa4ms 
excision rates 





hlb_attP_probe CAACAGTATTTATTGGGTTTGGAGTCC 5' 6-FAM/ZEN/3' 
IBFQ 









phiSa4ms_attP_probe ACGGCCATTCTCAAACGTACACGA 5' 6-FAM/ZEN/3' 
IBFQ 




pSAS1_F CCTCGGAACCCTTAACAATCC for pSAS1 copy 
number 
pSAS1_probe ATGGTCGGCTTAATAGCTCACGCT 5' 6-FAM/ZEN/3' 
IBFQ 
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pSAS1_R GCGTTGAGAAGAACCCTTAACTA for pSAS1 copy 
number 
gapdh_PCR_F GTCAACGAATATTGCAATTAATGGTATGG for measuring 
gapdh target via 
end-point PCR 
gapdh_PCR_R CGCACCAGTAGAAGTAGGAATAATGC for measuring 
gapdh target via 
end-point PCR 
pSAS1_PCR_F GAAGGTCGTCTATCTCTCAGATGTC for measuring 
pSAS1 target via 
end-point PCR 
pSAS1_PCR_R AAGGATGGTCTCAAGAGGAATTAGCC for measuring 
pSAS1 target via 
end-point PCR 
Pint/ex and htrA2- 
related primers 
Pint_upstm GCTTATGGATCCATAAATGATCAAACCACACCACCT 250bp upstream 







Pex_upstm GCTTATGGATCCAAAAATCGCATAAATAATTGATGTGAAG 250bp upstream 






P_dwnstm GCTTATGGTACCCTAAGGAATTACATGTTTTTTACCAATATC 30bp within 5’ 
end of htrA2 gene, 
Kpn1 restriction 
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site, for Pint/ex 
construction 
Pint_upstm_seq ATAAATGATCAAACCACACCACCT for Sanger 
sequencing of 
Pint 
Pex_upstm_seq AAAAATCGCATAAATAATTGATGTGAAG for Sanger 
sequencing of Pex 




full_htrA2_dwnstm GCTTATGGTACCTTATTTTAGTTTAATATTAATTTCTTTC 3' end of htrA2, 
for 
complementation 
of htrA2, Kpn1 
restriction site 
full_htrA2_seq1 GTACTGACTTTTAGGAATTACATGT For Sanger 
sequencing of 
htrA2 constructs 
full_htrA2_seq2 GTAATTACTGAATTAGATGGC For Sanger 
sequencing of 
htrA2 constructs 




3.18 Construction and testing of PhtrA2-GFP reporter system and htrA2-
complemented knockouts 
For construction of a PhtrA2-GFP reporter system, 250 bp upstream of the htrA2 
gene and 30 bp of htrA2 were amplified from MSSA476 gDNA template using 
Phusion High-Fidelity DNA Polymerase with two primer sets 1) 
Pint_upstm/P_dwnstm or 2) Pex_upstm/P_dwnstm (Table 3-7) to amplify two 
versions of the htrA2 promoter and 5’ gene region (Pint or Pex). PCR products were 
gel purified, cut with restriction enzymes KpnI and BamHI (NEB), and further 
purified. pCN56 vector (Charpentier et al., 2004) was mini-prepped, digested with 
KpnI and BamHI, dephosphorylated with Antarctic Phosphatase (NEB), and gel 
purified before ligation with T4 ligase (NEB) to the purified PCR products. 2 µL 
ligation mixture was transformed into One Shot TOP10 Chemically Competent E. 
coli (Thermo Fisher) and resulting colonies screened by PCR and Sanger sequenced 
(GENEWIZ; South Plainfield, NJ) using primers Pint_upstm_seq/P_dwnstm_seq or 
Pex_upstm_seq/P_dwnstm_seq for desired vector insert (Table 3-7). E. coli 
harboring pCN56 with Pint or Pex inserts were grown and miniprepped, and the 
vectors electroporated into electrocompetent S. aureus RN4220 using a Bio-Rad 
Gene Pulser with the following settings: 2.5 kV, 25 µF, 100 W. Empty pCN56 vector 
was also introduced into RN4220. Vectors from RN4220 colonies were transduced 
using fNM4γ4 (Heler et al., 2015) into S. aureus RN6390 htrA2 and S. aureus COL 
htrA2 (Rigoulay et al., 2005) following an established protocol (Olson, 2016). Colonies 
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were screened via PCR and inserts Sanger sequenced to ensure the correct DNA 
sequence.  
To examine GFP fluorescence in each strain, overnight cultures of constructs were 
back-diluted 1:100 in 15 mL BHI supplemented with 5 µg/mL erythromycin and 50 
µg/mL spectinomycin and grown at 37°C, 200 RPM to an OD600 = 0.2. Cultures were 
then grown at 37°C or 44°C with shaking. At 3 and 6 hr time points, 1 mL culture 
was removed, an OD600 value measured, and 200 µL culture pipetted in a quartz 96-
well plate and RFUs measured on a Molecular Devices SpectraMax M5 instrument 
(485 nm excitation, 515 nm emission). Fluorescence of pCN56 (empty vector) 
cultures was subtracted as background, and OD600 normalized RFUs for each 
sample were measured. Comparison of construct-GFP fluorescence was calculated 
as a ratio of Pex/Pint. The experiment was performed in triplicate. 
For construction of htrA2–complement vectors, the htrA2 gene and 250 bp upstream 
of the gene were amplified using the primer set 1) Pint_upstm/full_htrA2_dwnstm 
or 2) Pex_upstm/full_htrA2_dwnstm (Table 3-7) with Q5 DNA Polymerase (NEB) to 
generate two DNA fragments containing the full length htrA2 sequence with 
different 250 bp promoter sequences. PCR products were treated as described above 
but ligated into pCN35 vector (Charpentier et al., 2004). The ligated vectors and 
pCN35 empty vector were transformed into electrocompetent E. coli DC10B 
prepared by standard techniques, shuttled into RN4220, transduced into S. aureus 
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RN6390 htrA2 and S. aureus COL htrA2, then screened and sequenced as previously 
described using primers full_htrA2_seq1, full_htrA2_seq2, full_htrA3_seq3, 
full_htrA2_dwnstm, Pint_upstm_seq, and Pex_upstm_seq (Table 3-7). 
To test viability and survival of complemented and mutant (empty vector-
containing) S. aureus htrA2 strains, constructs were spotted in a log-dilution series 
onto BHI-spectinomycin-erythromycin agar plates and incubated at 37°C and 44°C 
for 24 hours following a protocol from (Rigoulay et al., 2005). Plates were examined 
visually for survival and photographed the following day using a Cell Biosciences 
AlphaImager HP instrument using AlphaImager HP software. 
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CHAPTER 4. CONCLUSIONS AND OUTLOOK 
Despite a wealth of research over the past 100 years, we are still constantly 
surprised by the activities of the most abundant biological entity on earth: 
bacteriophage. While larger themes of phage biology and phage-bacteria 
interactions are clear, many of the details have yet to be filled in. Given the sheer 
number of bacteriophage in the biosphere, and the magnitude of their interactions 
with bacteria, there is clearly a long way to go.  
Phages are the smallest “organism” on earth, and represent an evolutionary unit 
with an extraordinarily rapid turnover time. While their genome size suggests they 
are relatively simple, their dynamics allow nearly boundless opportunities for 
evolution, and thus are far more complex that we can presently appreciate—
explaining our limited knowledge of them and their activities.  The phage genome is 
on average 1% the size of a bacterial chromosome (Hatfull, 2008), and such a 
relatively small genome suggests that elucidating functional roles for phage genes 
should be a straightforward task. However, 80% of bacteriophage genes show no 
homology to known proteins; we simply do not know what the majority of phage 
genes do, how they affect the phage, and likely, how they affect the host (Hatfull 
and Hendrix, 2011). 
From what we do know, phage have an enormous influence on the biosphere and 
their hosts, and play major roles in virulence and bacterial survival (Brussow et al., 
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2004; Feiner et al., 2015; Gillis and Mahillon, 2014; Wilhelm and Suttle, 1999). The 
details of this which we can currently describe are likely just the tip of the iceberg, 
and as we learn more about the phage, we will no doubt uncover their invisible 
hand in many biological processes. One area where phage are likely to be found in 
increasingly important roles is bacterial genomic regulation. It is typically assumed 
that in comparison to eukaryotes, bacteria are relatively simple and do not encode 
the more advanced features of eukaryotic organisms. While true in some cases, 
many analogues of eukaryotic systems have been uncovered in bacteria, i.e. 
CRISPR systems (Marraffini, 2015). Bacteria are not thought to contain as many 
regulatory mechanisms as eukaryotes for transcriptional regulation, however we 
find examples where bacteria utilize phage to achieve the same end goal, either 
through disrupting transcripts (SpyCIM1, hlb-converting phages (Feiner et al., 
2015)) or promoter-sequence alteration (fSa4ms).  It is likely that more eukaryotic 
system-analogues will be found in bacteria, and phage may turn out to be the tools 
to accomplish some of these tasks. 
Even for known prophages, determining why they are maintained by bacteria in 
some cases has proven difficult. The geh-converting phages of S. aureus contain no 
obvious virulence or fitness factors, but are stably maintained in the chromosome. 
Prophage in this case may be kept around to prevent lipase expression or perhaps 
the phage encodes a virulence factor not yet uncovered. It is also a possibility that 
there is an effect beyond an obvious phenotype that we as researchers are currently 
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not measuring. It is hard to imagine that the effects of removing a 40 kb DNA 
element from a genome will be limited to simple on/off production of encoded 
virulence factors. Indeed, curing of SpyCIM1, a 13.5 kb DNA element of S. pyogenes 
SF370, was found to change global gene expression of the organism, affecting 
seemingly non-related portions of the genome (Hendrickson et al., 2015).  
In light of the many ways phage affect their hosts, a new term with a “big tent” 
should be established to cover the all the mechanisms of phage influence, including 
the more recently discovered phage-based switches, phage-driven gene expression 
changes and other novel host-modifying activities. “Conversion” could serve as such 
a term, with modifiers added (e.g., positive, negative, (active) lysogenic, lytic, 
regulatory, etc.) to label specific classes by which phage affect the host (Figure 4). It 
is likely that in almost every case of prophage carriage, there is always conversion, 
we just don’t have the tools or aren’t looking for phenotypes in the right way. 
Regardless of if we can observe conversion phenotypes, it is clear that phage-
bacteria interactions generate diversity within bacterial populations, either 
contributing to altered genotypes and/or phenotypes. With the exception of 
successful bacterial defense against phage infection, almost all other bacteria-phage 
interactions are likely to alter the host and may generate distinct, biologically 
significant subpopulations. (Even successful defense can alter bacterial genome 
content, e.g., new phage spacer acquisition within a CRISPR array.) Whether or not 
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such subpopulations have increased fitness and success depends upon the external 
environment for selection. 
Indeed the work presented in this Thesis for the Gram-positive pathogens B. 
anthracis and S. aureus show that phage do serve to create diverse subpopulations 
in each species.  The research on B. anthracis illustrates a specific example of phage 
biology and a bacteria-phage relationship that we need to better understand: 
selection by lysis for phage-resistant bacterial populations. In S. aureus, a method 
to more easily get at unexplored phage biology is developed, and proves to uncover 
an example of a novel phage-switch: htrA2 promoter alteration driven by active 
lysogenic phage excision/integration. These are two examples in a likely near-
limitless array of phage impacts on the host, and given the ubiquitous nature and 
importance of both phage and bacteria, advances in biology necessitate further 
study of their relationships. 
In infectious disease for example, such research will allow us to 1) better 
understand mechanisms by which phage drive bacterial adaptations in infection 
environments (e.g., htrA2 regulation by phage excision/integration, superantigen 
and DNase upregulation by S. pyogenes via phage lytic induction in the throat 
(Broudy and Fischetti, 2003; Broudy et al., 2001; 2002)), and 2) better understand 
the biology of bacteria’s natural enemy and aid in the development of new 
therapeutics. 
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Figure 4-1. Illustration of “conversion” and phage effects on bacterial 
hosts. Conversion is a broad-acting term, encompassing all of the ways phage affect 
their hosts. i) Positive conversion alters the phenotype of the host, where phage-
encoded factors often contribute to virulence or fitness potential (e.g., conversion of 
S. aureus to SEA+, SAK+, SCIN+, CHIPS+, or promotion of vegetative survival in B. 
anthracis by phage-encoded sigma factors). ii) Negative conversion by phage 
integration can disrupt expression of host-encoded factors (hlb in S. aureus). iii) 
Selection by lysis is the expansion of phage-resistant (R) or lysogenized (L) over -
sensitive (S) cells in a population. In B. anthracis, selection by lysis expands a CsaB-
deficient subpopulation harboring a markedly altered phenotype which may impart 
important survival advantages. iv) Conversion by induction refers to altruistic 
subpopulations of cells where phages induce into the lytic cycle for the benefit of the 
whole population. Phage induction can increase expression of phage-encoded factors 
and help promote infection (e.g., stx phage) or alternatively, cellular debris (eDNA) 
from phage-lysed cells can help increase biofilm formation (Nanda et al., 2015). v) 
Regulatory changes mediated by phage-excision or “active lysogeny” can alter gene 
expression in a number of species, including S. aureus (e.g., fSa4ms and htrA2 
expression). vi) Phage sequences can serve as anchor points for genomic 
rearrangements (S. pyogenes SSI-1); alternatively, phage excision and reintegration 
can alter bacterial genomes. vii) Phage transduction is one of the most important 
HGT mechanisms and can drive the dissemination of virulence and fitness 
determinants. viii) Novel mechanisms by which phage alter their hosts are likely to 
be discovered. In all cases i-viii, phage serve to increase the diversity of their hosts, 

























For research focused on phage-based therapeutics, it is important to study phage-
bacteria interactions not just for antibacterial development, but also to understand 
how resistant variants post-treatment may survive and cause further disease (i.e., 
how selection by lysis affects a bacterial population). For health and wellness in 
general, phage likely play roles in microbiome-associated bacterial species, and 
uncovering these interactions can potentially allow new strategies to improve 
human health. In addition, the more we learn about phage, the more tools we have 
at our disposal (e.g., CRISPR-based genome editing, endolysin and other phage-
based therapies (Fischetti, 2005; Salmond and Fineran, 2015)). 
Bordet suggested nearly a century ago that phage are the products of bacteria and 
not a distinct entity. Today his finding is obviously viewed as inaccurate, but in 
many ways, perhaps it is not far off from reality. Phage are selfish elements and the 
predators of bacteria—but their survival and propagation absolutely depends on the 
bacteria themselves, and clearly bacteria have in turn adapted their predators as 
tools integral to their own survival and success. Regardless of which lens the phage-
bacteria/bacteria-phage relationship is viewed, it is clear we’ve only scratched the 
surface of its intricacies. Uncovering more of the story requires one thing from 
researchers: to look.   
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APPENDIX 1. RAW SEQUENCES OF fBACA1 CONTIGS 
Sequence file is available in FASTA format at: 
https://www.dropbox.com/sh/b3alrq7k5y7q6pq/AABh2Usqstjt2MTzHXh2zJoSa?dl=0 
Password:bacillusphage 







































































































































































































































































































































































































































































































































































































































































































































































































































APPENDIX 2. PRELIMINARY DATA AND SUGGESTED FUTURE 
EXPERIMENTS  
A2.1 Determination of fetal bovine serum (FBS) component(s) responsible 
for dcsaB’s phenotypic switch 
To determine the FBS component(s) involved in dcsaB’s phenotypic switch, we 
fractionated FBS into >10 kD and <10 kD fractions. Briefly, FBS was filtered in 
10,000 MWCO Amicon Ultra-15 Centrifugal Filter Units (EMD Millipore). Flow-
through was collected and sterile filtered through 0.22 µm filters and labelled “FBS 
flow-through”. The >10 kD fraction was washed 3X in 1X PBS and resuspended to 
10% of its original volume (i.e., 1.5 mL from 15 mL starting material) and labelled 
“FBS proteins”. BHI broth was also subjected to this fractionation procedure and 
split into <10 kD “BHI flow-through” and >10 kD “BHI proteins” fractions. 
Sterne dcsaB from an overnight culture grown in BHI at 30°C, 150 RPM was back-
diluted 1:100 and grown in the same conditions, however in four different 
combinations of each fraction component: 1) reconstituted BHI (BHI flow-through + 
BHI proteins); 2) BHI-FBS (BHI proteins + FBS flow-through); 3) FBS-BHI (FBS 
proteins + BHI flow-through); and 4) reconstituted FBS (FBS proteins + FBS flow-
through). The 4 cultures were formulated as 90:10 mixtures, with 90% culture 
volume as flow-through and 10% culture volume as 10X concentrated >10 kD 
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fractions. Cultures were grown for 24-36 hours, the time until reconstituted FBS 
cultures were dispersed and resembled those grown in unfractionated FBS. 
Examination of cultures revealed that the two different fractions of FBS appear to 
play different roles in the dcsaB phenotypic switch (Figure A2-1). Reconstituted 
BHI and reconstituted FBS were used as controls for the dcsaB phenotype and to 
ensure that the fractionation procedure did not alter serum activity. dcsaB grown in 
reconstituted BHI resembled that of dcsaB grown in unfractionated BHI. The 
culture was connected as one bacterial mass that fell to the bottom of culture tubes, 
with the rest of the supernatant clear (Figures A2-1, A2-2a). Reconstituted FBS 
cultures were dispersed with dcsaB in shorter chains and possessing a Sterne-like 
phenotype (Figures A2-1, A2-2b). 
BHI-FBS (BHI proteins, FBS flow-through) cultures were of an intermediate 
phenotype between that of BHI and FBS alone. In BHI-FBS, the bacterial clump 
associated with dcsaB was less compact and its rope-like structures appeared 
unraveled, however dcsaB chains were still of longer length and cells did not 
disperse into the surrounding media (i.e., the culture was not turbid) nor did they 
show any apparent division septa (Figures A2-1, A2-3a). FBS-BHI (FBS proteins, 
BHI flow-through) cultures had a distinct phenotype where a compact bacterial 
pellet was present at the bottom of culture tubes, however, cultures were also turbid 
with dispersed cells harboring clear division septa (Figures A2-1, A2-3b-d). 
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Figure A2-1. dcsaB displays different phenotypes in fractionated FBS. 
Sterne dcsaB was grown in combinations of BHI and FBS previously split into >10 
kD and <10 kD fractions. Left) dcsaB grown in reconstituted BHI (BHI >10 kD and 
BHI <10 kD fractions) displays a bacterial clump at the bottom of the culture tube 
with non-turbid growth. Middle-left) Growth in BHI-FBS (BHI >10 kD and FBS <10 
kD fractions) results in a more loosely-bound bacterial clump, however still 
connected as one mass. Supernatant surrounding the mass is not turbid. Middle-
right) FBS-BHI (FBS >10 kD and BHI <10 kD fractions) culture displays turbid 
growth. Media contains bacteria with clear division septa and a tightly wound 
bacterial mass at the bottom of the culture tube. Right) Reconstituted FBS (FBS 
>10 kD and FBS <10 kD fractions) culture displays turbid growth typical of dcsaB 
in unfractionated FBS. No bacterial mass is present in the culture tube. 
  Reconstituted BHI BHI-FBS FBS-BHI Reconstituted FBS
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Figure A2-2. Sterne dcsaB growth in reconstituted BHI and reconstituted 
FBS. A) dcsaB grown in reconstituted BHI possesses long chains with multi-chain,
rope-like structures, resembling growth in unfractionated BHI media. Image 
captured at 100X magnification. B) dcsaB grown in reconstituted FBS has shorter 
chains and clear division septa, resembling growth in unfractionated FBS. Image 







Figure A2-3. Sterne dcsaB growth in BHI-FBS and FBS-BHI mixed fraction 
cultures. A) dcsaB in BHI-FBS (BHI proteins, FBS flow-through) grows in long 
chains, however tight, rope-like multi-chain structures are less apparent. Image 
captured at 100X magnification. B) and C) dcsaB grown in FBS-BHI (FBS proteins, 
BHI flow-through) displays compact, twisted chains with an aberrant morphology 
(B), however cells contain clear division septa (C). D) dcsaB grown in FBS-BHI 
shows a mix of chain morphologies: 1) rope-like, multi-chain structures without 
clear division septa, 2) long chains without apparent division septa, but not 
associated with rope-like forms, and 3) shorter chains with clear division septa. 









These results suggested that multiple components of FBS likely promote different 
aspects of dcsaB’s phenotypic switch. Components <10 kD (likely small molecules or 
peptide fragments) appear to play a role in breaking-up/unravelling the multi-chain 
structures associated with dcsaB growth in BHI, however, cell separation was not 
observed in these cultures containing BHI proteins and FBS flow-through. The 
formation of multi-chain structures may be due, in part, to increased levels of 
SCWP on the dcsaB cell surface (contributing to dcsaB’s “stickiness” and the 
propensity of chains to bind together). We find in our RNA-seq data that a number 
of the genes associated with SCWP synthesis are upregulated 4-16-fold in dcsaB 
grown in BHI vs. FBS, and 4-8-fold in dcsaB BHI as compared to Sterne BHI. 
Sterne does not show differential expression of SCWP synthesis genes between BHI 
and FBS culture. B. anthracis may therefore respond to components in the FBS <10 
kD fraction and downregulate its SCWP synthesis genes to allow for multi-chain 
unravelling and in part, cellular dispersion associated with FBS and animal-host 
environments. Complementary to the <10 kD FBS fraction, the ability of the FBS-
BHI cultures (FBS proteins, BHI flow-through) to grow with turbidity while still 
containing a dense cellular pellet, suggests that a larger molecular-weight 
component of FBS plays a role in cell separation, however likely indirectly as heat-
killed FBS cultures were capable of turbid growth. When added together, these 
fractions of FBS appear to both unravel the bacterial mass associated with dcsaB 
growth in BHI and allow for cell separation and dispersion, critical events in B. 
anthracis’s pathogenesis. 
	229 
Since multiple components of FBS appear to play different roles in the dcsaB 
phenotypic switch, experiments to specifically uncover these compounds will 
highlight molecular signals that the pathogen uses to sense its external 
environment and precipitate an infectious or non-infectious response. Such work 
will allow for a better understanding B. anthracis’s biology, and in addition, may 
allow avenues for development of novel approaches to treat infection. Interference of 
signaling pathways in B. anthracis may prevent the organism from sensing its 
external environment and executing its infection program (i.e., production of 
anthrax toxins and PDGA capsule in mammalian environments) and allow better 
treatment outcomes. 
Follow-up experiments could elucidate the FBS active principles by a variety of 
approaches. The approach described above could be expanded to fine-tune molecular 
weight cutoffs and find a range in which the active components are found (e.g., the 
“rope-unravelling” compound is <3 kD or <1 kD, or the “cell-separation” compound 
is >30 kD and <50 kD). Getting a better defined molecular weight range followed by 
mass-spectrometry could allow identification of switch signals. In addition, 
treatment of the lower molecular weight fractions could remove non-polar (e.g., 
charcoal stripped FBS) or other serum compounds. The absence or presence of 
fraction activity could help elucidate the nature of the components integral to 
dcsaB’s phenotypic switch.  
	230 
A2.2 Uncovering fBACA1-pXO1 crosstalk in B. anthracis 
During the course of research conducted for this Thesis, it was discovered that 
fBACA1 presents different plaquing efficiency on B. anthracis Sterne compared to 
DSterne indicator strains (Figure A2-4). A similar observation was noted with other 
B. anthracis-infecting phages but not further explored in (Schuch and Fischetti, 
2009). Our result suggests potential fBACA1-pXO1 (and more broadly phage-pXO1) 
crosstalk that could allow for successful phage infection. We have observed DSterne 
lysis by fBACA1 previously, although at a much lower efficiency. 
Figure A2-4. fBACA1 plaquing efficiency on B. anthracis DSterne versus 
Sterne strains. fBACA1 stock at 10-4 dilution was added to either DSterne (left) or 
Sterne (right) in a BHI soft-agar overlay. DSterne does not display any PFUs, 
whereas plaques are apparent on the Sterne plate. DSterne and Sterne displayed 
equivalent growth in BHI-only negative controls (not pictured). 
	231 
Experimental work to uncover potential phage-plasmid crosstalk and the genes 
involved in this event should be a relatively straightforward task. Sterne could be 
cured of its pXO1 plasmid to generate a DSterne strain with a similar chromosomal 
background to Sterne. Following plasmid curing, pXO1 DNA could be purified and 
digested to make a library of ~2-3 kbp fragments hosted in DSterne. This library 
could then be tested for clones harboring increased fBACA1 susceptibility and 
candidates Sanger sequenced to uncover the gene(s) important for increased phage 
sensitivity. Uncovering such phage-plasmid crosstalk would, to our knowledge, be a 
rare finding, however it would be of critical importance in understanding the 
environmental interactions between B. anthracis and its bacteriophages. 
In addition to characterizing this pXO1-driven crosstalk, is also possible that the 
dcsaB phenotypic switch is partially (or fully) precipitated by a pXO1-encoded factor 
as well, as a number of pXO1 genes are differentially expressed with elevated 
temperature and/or CO2/bicarbonate conditions—some of the same conditions which 
appear to cause the dcsaB phenotypic switch. Generating a dcsaB mutant in 
DSterne and testing its ability to execute a phenotypic switch could identify pXO1 
as an integral part of dcsaB’s ability to overcome the limitations associated with 
CsaB-deficiency. If DSterne dcsaB cannot execute the phenotypic switch associated 
with Sterne dcsaB (or perhaps does so less efficiently), then the same library 
screening approach as described above could be undertaken, except in a dcsaB 
chromosomal background, and would uncover the pXO1 gene(s) associated with 
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dispersion and differential expression in FBS and likely in animal-host 
environments. Genes highlighted by this approach would give researchers more 
insights into the mechanisms by which B. anthracis executes its multifaceted 
lifestyle and deals with the threat and consequences of bacteriophage infection.  
APPENDIX 3. RNA-SEQUENCING DIFFERENTIAL EXPRESSION DATA 
Representative pXO1 differential expression (DE) data comparing dcsaB and Sterne in FBS culture are shown. The 
full DE dataset is available at: https://www.dropbox.com/sh/b3alrq7k5y7q6pq/AABh2Usqstjt2MTzHXh2zJoSa?dl=0 
Password: bacillusphage 
Table A3-1. Differential expression (DE) of pXO1-encoded genes comparing dcsaB and Sterne in FBS 
Gene 
Name 






































229.2474758 -0.725721958 0.283674816 -2.558288282 0.0105
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AW20_RS 1442.322615 -0.47248248 0.268809962 -1.757682177 0.0788 0.179528642 metal-
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7802.140801 0.124144625 0.216353865 0.573803593 0.5661
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434.7144813 -0.489971204 0.267041331 -1.834814116 0.0665
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3519.146471 -0.915642326 0.245058324 -3.736426135 0.0001
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AW20_RS 162.4220842 -0.002027731 0.233443662 -0.008686169 0.9930 0.99796839 hypothetical 
243
00490 69527 protein 
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00585 24119 protein 
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